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Abstract 
This thesis describes some novel aspects of the lithiation-trapping of nitrogen and oxygen 
heterocycles, including a systematic study of new methodologies at temperature above ‒78 
°C and the use of the sustainable solvent, 2-MeTHF, as an alternative to Et2O and THF. 
Chapter 2 describes a detailed exploration of the s-BuLi-mediated lithiation-trapping of N-
Boc heterocycles (pyrrolidine, piperidine, piperazine and azepane) using different 
conditions (diamine, solvent, temperature and time). For N-Boc pyrrolidine, two new high 
temperature lithiation conditions were optimised: (i) 0 °C for 5 sec is best for flow system; 
(ii) ‒20 °C for 2 min is best for batch conditions. The stability of the lithiated N-Boc 
pyrrolidine at 0 °C was also investigated. 
 
In Chapter 3, the development of novel methodology for the lithiation-trapping of oxygen 
heterocycles (THF and THP) is presented. Different conditions were optimised for THF 
and THP lithiation to give trapped products in 20-32% yield. 
 
The newly developed methodology was extended to the lithiation-trapping of N-substituted 
morpholines. A full study of the reaction conditions and scope of the methodology was 
carried out for three different N-alkyl groups. The best substrate was the N-methyl 
morpholine and the optimised conditions were s-BuLi/TMEDA in hexane at 0 °C for 1 h, 
giving yields of trapped products in 75-90%. A procedure that is catalytic in TMEDA was 
also discovered. 
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Chapter 1: Introduction 
Nitrogen and oxygen heterocycles are commonly found as building blocks in a wide range 
of natural products and drug molecules. Some examples of natural products and drug 
molecules with substituents α to the nitrogen or oxygen are shown in Figure 1.1.  
An example of an α-substituted piperidine is (+)-himbacine, which is a potential drug for 
the treatment of Alzheimer’s disease.1 (‒)-Indolizidine 167B which contains a pyrrolidine 
ring is one of the simplest indolizidine alkaloids isolated from the skin of a neotropical 
frog caught on the Isla de Colon, Panama. 2  Compounds containing an α-substituted 
piperazine ring include Indinavir which is an antiretroviral drug used for the treatment of 
HIV.3 In the examples of oxygen heterocycles, Zylofuramine is a stimulant,4 Rose oxide is 
a naturally occurring fragrance compound5 and Reboxetine is an anti-depressant.6 Due to 
their useful applications, different synthetic strategies have been employed to construct α-
substituted nitrogen and oxygen heterocyclic rings. However, lithiation-trapping is one of 
the most efficient methodologies to introduce α- functionalities in nitrogen heterocycles, 
and the investigation of this process, together with its extension to oxygen heterocycles, 
are the main topics of the research described in this thesis. 
Figure 1.1 
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1.1 Brief Overview of Lithiation-trapping of N-Boc Heterocycles 
1.1.1 Racemic Lithiation-trapping of N-Boc Heterocycles 
In 1989, Beak and Lee reported a simple protocol for the α- functionalisation of N-Boc 
heterocycles via lithiation-trapping. 7  The use of the tert-butyl carbamate of the cyclic 
amines is the key for the α-deprotonation to take place. For example, the lithiation-trapping 
of N-Boc pyrrolidine 1 was achieved by using the strong base s-BuLi in the presence of the 
diamine ligand TMEDA at –78 °C to generate the organolithium intermediate. This was 
then trapped with a variety of electrophiles to form the desired α- functionalised products 
(Scheme 1.1).  
Scheme 1.1 
 
The presence of a diamine ligand is essential to promote the lithiation in Et2O. Since Et2O 
is a poorly coordinating solvent, the s-BuLi/Et2O complex is not reactive enough to 
complete the lithiation in high yield at –78 °C. Beak showed that the reactions worked well 
with N-Boc pyrrolidine 1, N-Boc piperidine 2 and N-Boc azepane 3. Trapping with 
Me3SiCl gave silylated products 4-6 in 61-94% yield (Scheme 1.2). 
Scheme 1.2 
 
These reaction conditions have been widely used for the α- functionalisation of N-Boc 
heterocycles via lithiation–trapping.8,9,10  Recently, the O'Brien group has applied in situ 
ReactIR spectroscopy to monitor the time required for the lithiation of N-Boc heterocycles 
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using s-BuLi/TMEDA in Et2O at different temperatures (Figure 1.2).
11 It was shown that 
the lithiation of N-Boc pyrrolidine 1 was completed within 5 min at –78 °C and does not 
require the long lithiation time (3.5 h) originally reported by Beak.7 A longer lithiation 
time of 50 min was, however, required for N-Boc piperidine 2 to fully lithiate at a higher 
temperature (–60 °C). The 7-membered ring system present in N-Boc azepane 3 was found 
to undergo the lithiation extremely slowly: full lithiation was observed after 120 min at a 
higher temperature (–50 °C). At present, our group does not have an explanation for the 
difference in reactivity but it could be due to the geometry and conformation of the 
different cyclic rings making the α-protons more difficult to deprotonate than in N-Boc 
pyrrolidine 1.  
Figure 1.2 
 
Lithiation-trapping of N-Boc heterocycles with a range of electrophiles under the s-
BuLi/TMEDA-mediated conditions at –78 °C have been explored by Beak and the results 
are summarised in Scheme 1.3. As the results show, lithiation of N-Boc pyrrolidine 1 and 
N-Boc piperidine 2 gave good yields in general under this period of lithiation time (3.5 
h).7,12 
Scheme 1.3 
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It can be seen from Schemes 1.2 and 1.3 that the yields of the products from the lithiation 
of N-Boc azepane 3 at –78 °C are generally lower than N-Boc pyrrolidine 1 and N-Boc 
piperidine 2. For example, N-Boc azepane 3 gave a 61% yield of Me3Si-trapped product 6 
(Scheme 1.2) and a 41% yield of stannane 12 (Scheme 1.3). The N-Boc azepane 3 results 
reported by Beak are consistent with our group’s ReactIR study shown in Figure 1.2 
suggesting that the lithiation rate of N-Boc azepane 3 would be extremely slow at –78 °C 
and 3.5 h would not be long enough to undergo a full lithiation. Presumably because 
lithiation at higher temperature would require a shorter lithiation time, Beak carried out the 
lithiation of N-Boc azepane 3 at –40 °C for 1 h. 12  Subsequent methylation of N-Boc 
azepane 3 gave a 62% yield of methylated product 13 and DMF-trapping gave a 72% yield 
of aldehyde 14 (Scheme 1.4). 
Scheme 1.4 
 
In 2005, den Hoogenband and van Maarseveen et al. extended Beak’s methodology to the 
lithiation-trapping of N-Boc piperazines using similar conditions (Scheme 1.5).13 N-Boc-
N’-methyl piperazine 15 and N-Boc-N’-benzyl piperazine 16 were lithiated under the s-
BuLi/TMEDA-mediated conditions at –78 °C in Et2O and then at –10 °C for 1 h. Trapping 
with Me3SiCl or Bu3SnCl gave substituted methyl piperazines 17 and 18 in 5% and 82% 
yields respectively. In contrast, the substituted benzyl piperazines 19 and 20 were isolated 
in 68% and 71% respectively. 
Scheme 1.5 
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There was no explanation from the paper about the low yield of the Me3Si-substituted 
methyl piperazine 17, but work in our group showed that with Me3SiCl, trapping is slow 
and a competing ring-fragmentation can occur via β-elimination of the organolithium 
species.14 
In general, Beak’s lithiation conditions of using s-BuLi/TMEDA in Et2O at –78 °C work 
well for most of the N-Boc heterocycles such as N-Boc pyrrolidine 1. However, less 
reactive substrates such as N-Boc azepane 3 require a higher temperature to promote the 
lithiation and thus to obtain a higher yield.  
In 2010, our group developed an experimentally simpler, diamine-free protocol for 
lithiation-trapping of N-Boc pyrrolidine 1 which can also be carried out at higher 
temperatures.15 For example, N-Boc pyrrolidine 1 was lithiated using s-BuLi in a more 
coordinating solvent, THF, at –30 °C for 5 min. The lithiated pyrrolidine was then trapped 
with a range of electrophiles to give products 4, 7-8, 21-22 with high yields (51-77%) 
without the use of TMEDA (Scheme 1.6).  
Scheme 1.6 
 
The optimised reaction conditions of the diamine-free lithiation provide a better approach 
to the principles of Green Chemistry:16 the atom economy was improved as the TMEDA 
ligand was not required. In addition, high temperature lithiation can be carried out in a 
shorter lithiation time while retaining the yield which, if carried out on a process-scale, 
would reduce the energy consumption. The high temperature s-BuLi/THF-mediated 
lithiation of N-Boc-N’-benzyl piperazine 16 was also carried out. Using s-BuLi in THF at 
‒30 °C for 5 min, substituted piperazines 19,23-24 were obtained after trapping with a 
range of electrophiles in high yields (55-83%) (Scheme 1.7).10 
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Scheme 1.7 
 
When the diamine-free lithiation of N-Boc pyrrolidine 1 was carried out at temperatures 
above ‒30 °C and trapping with benzaldehyde, amino alcohols 25 were obtained with 
yields in the range of 0-66% (Table 1.1, entries 4-9). Lower yields were generally obtained 
for longer lithiation times at a particular temperature. For example, lithiation at –20 °C for 
30 min gave a low 10% yield (entry 4) whereas a higher yield (66%) was achieved when 
the lithiation time was reduced to 5 min at the same temperature (entry 5). It was presumed 
that at high temperature, s-BuLi had reacted with THF instead of N-Boc pyrrolidine 1 
which reduced the yield of amino alcohols 25. More information on the reaction of 
organolithiums with THF is discussed in section 1.2.1. 
Table 1.1 
  
Entry Temp (°C) Time (min) Yield (%) 
1 –30 60 37 
2 –30 10 89 
3 –30 5 84 
4 –20 30 10 
5 –20 5 66 
6 –20 2 57 
7 –10 5 29 
8 –10 1 0 
9 0 30 0 
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The diamine-free lithiation protocol was also carried out using the sustainable solvent 2-
MeTHF. 2-MeTHF is a bio-derived solvent generated from sustainable biomass such as 
cellulose and hemicelluloses in lignocelluloses.17 Since 2-MeTHF has a similar structure to 
THF, it is considered to be a greener alternative to THF in some organic synthesis 
applications (see section 1.2.2).18,19 The results of the lithiation-benzaldehyde trapping of 
N-Boc pyrrolidine 1 in 2-MeTHF are shown in Table 1.2. High yields (92-94%) were 
obtained when the lithiation was carried out at temperatures below –30 °C (Table 1.2, 
entries 1-2). Lithiation at –30 °C for 60 min gave no amino alcohol 25 (entry 3) whereas a 
higher yield (73%) was achieved when the lithiation was reduced to 5 min at the same 
temperature (entry 4). The results suggested that the s-BuLi/2-MeTHF complex has a 
similar reactivity to the s-BuLi/THF complex. 
Table 1.2 
 
Entry Temp (°C) Time (min) Yield (%) 
1 –78 60 92 
2 –40 60 94 
3 –30 60 0 
4 –30 5 73 
 
Although the s-BuLi/THF-mediated lithiation is a convenient set of conditions for N-Boc 
pyrrolidine 1 and N-Boc piperazine 16, lithiation-trapping of N-Boc piperidine 2 and N-
Boc azepane 3 under the same diamine-free protocol were unsuccessful (Scheme 1.8). 
Trapped products were not detected with different electrophiles (DMF or MeO2CCl) and 
lower temperature conditions (‒78 °C for 3 h or 6 h and ‒40 °C for 1 h or 3 h) were also 
attempted but were unsuccessful. Presumably, THF is a less coordinating ligand than 
TMEDA, the s-BuLi/THF complex is not reactive enough to complete the lithiation even at 
high temperature. Hence, the lithiation of the less reactive N-Boc heterocycles, N-Boc 
piperidine 2 and N-Boc azepane 3, could not be achieved under diamine-free conditions. 
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Scheme 1.8 
 
A wide range of examples of biologically active molecules have been synthesised via the 
route of racemic lithiation-trapping of N-Boc heterocycles. Examples include (+)-myrtine, 
(+)-himbacine and Telaprevir (Figure 1.3). (+)-Myrtine is a natural quinolizidine alkloid 
that can be isolated from Vaccinium myrtillis (Ericaceae).20 Hurvois et al. demonstrated 
that the key piperidine intermediate of (+)-myrtine can be achieved via the lithiation-
trapping of a substituted N-Boc piperidine. 21 Another piperidine derivative example, (+)-
himbacine, is a potential drug molecule for the treatment of Alzheimer’s disease which was 
isolated from the bark of Galbulimima baccata, a species that belongs to the magnolia 
family.1 Chackalamannil et al. applied the racemic lithiation methodology to lithiate 2-
methyl N-Boc piperidine with s-BuLi/TMEDA complex in Et2O. The resulting 
disubstituted piperidine was further processed to give (+)-himbacine. 22 
Figure 1.3 
 
Telaprevir is a registered drug for the treatment of hepatitis C virus (HCV) infections. 
Tanoury et al. developed a stereoselective lithiation-trapping sequence for N-Boc 
bicyclopyrrolidine 28 via a racemic lithiation-CO2 trapping followed by classical 
resolution with a chiral amine (Scheme 1.9).23  
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Scheme 1.9 
 
Due to the bicyclopyrrolidine system, lithiation using s-BuLi and bispidine ligand 30 
provided diastereoselectivity and the intermediate was then trapped with CO2 to give an 
86% yield of acid rac-29 with 95:5 dr. Use of the chiral amine 31 for the resolution 
followed by recrystallisation gave the salt 32 in 83% yield with 99:1 er and 100:0 dr.  
1.1.2 Asymmetric Lithiation-trapping of N-Boc Heterocycles 
Asymmetric lithiation-trapping of N-Boc heterocycles can be achieved using chiral 
diamine ligands. The first example of the asymmetric lithiation using s-BuLi and the chiral 
diamine, (‒)-sparteine, was reported by Beak and Kerrick in 1991.24,25 In 2002, our group 
reported the (+)-sparteine surrogate which is able to produce opposite enantioselectivity to 
(‒)-sparteine for the asymmetric lithiation.26 
The asymmetric lithiation-trapping of N-Boc pyrrolidine 1 is shown in Scheme 1.10. With 
(‒)-sparteine, silyl pyrrolidine (S)-4 was obtained in high yield (87%) with an er of 95:5 
whereas in the reaction in the presence of (+)-sparteine surrogate silyl pyrrolidine (R)-4 
was obtained in similar yield (84%) with an identical er of 95:5. However, the results from 
a ReactIR study revealed that there is a different behaviour of the two diamines :11 with (+)-
sparteine surrogate, the lithiation of N-Boc pyrrolidine 1 took under 2 min for completion, 
whereas 60 min was needed for s-BuLi/(‒)-sparteine to fully lithiate N-Boc pyrrolidine 1. 
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Scheme 1.10 
 
Similar reactions using these two chiral diamines were carried out for the asymmetric 
lithiation of N-Boc piperidine 2 at ‒78 °C (Scheme 1.11). 27 ,28  A poor yield of silyl 
piperidine (S)-5 (8%) was isolated from the lithiation using s-BuLi/(‒)-sparteine complex. 
In contrast, the s-BuLi/(+)-sparteine surrogate complex gave a good 73% yield of the silyl 
piperidine (R)-5. The results demonstrated that s-BuLi/(+)-sparteine surrogate complex is 
more reactive than the corresponding (‒)-sparteine complex for the lithiation of the less 
reactive substrate, N-Boc piperidine 2. Our group has so far been unable to explain such a 
large difference in rates of lithiation between the s-BuLi/(+)-sparteine surrogate and (‒)-
sparteine complexes. 
Scheme 1.11 
 
Recently, our group reported a new method to synthesise enantiopure α-substituted 
piperazines via an asymmetric lithiation procedure.29 A high yield of a single stereoisomer 
of N-Boc piperazine can be obtained by matching the configuration of the stereogenic α-
methylbenzyl group with a chiral ligand (Scheme 1.12). Lithiation of (S)-33 using s-
BuLi/(+)-sparteine surrogate in Et2O at ‒78 °C followed by trapping with MeO2CCl 
produced a 95:5 mixture of diastereomeric piperazines (S,S)-34 and (R,S)-34. The 
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diastereomers were readily separable and after purification, piperazine (S,S)-34 was 
obtained in 90% yield. In addition, lithiation of enantiomeric (R)-33 using the s-BuLi/(‒)-
sparteine complex gave a >95:5 mixture of (R,R)-34 and (S,R)-34 from which a 91% yield 
of (R,R)-34 was obtained. 
Scheme 1.12 
 
Interestingly, when Et2O was replaced by THF as solvent for s-BuLi/(‒)-sparteine 
complex-mediated reactions, a racemic product was formed. For example, lithiation of N-
Boc pyrrolidine 1 using s-BuLi/(‒)-sparteine in THF at ‒78 °C for 3 h and trapping with 
benzaldehyde gave two separable diastereomers, syn-25 (62%) and anti-25 (35%) (Scheme 
1.13). Both syn-25 and anti-25 were produced in 50:50 er. 
Scheme 1.13 
 
It is known that the coordinating solvent THF can displace (–)-sparteine from the s-
BuLi/(–)-sparteine complex in solution.30,31,32 In contrast, in weaker coordinating solvents 
such as Et2O or toluene, the (–)-sparteine remains associated with organolithium species. 
Hence, the s-BuLi/THF complex is presumably more reactive than the s-BuLi/(–)-sparteine 
in the solution. A detailed NMR spectroscopic investigation of the behaviour of different 
chiral diamines was carried out by the O’Brien and Hilmersson groups.33  The solution 
structures of i-PrLi complexed with (‒)-sparteine and (+)-sparteine surrogate under 
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different conditions were determined using 6Li and 13C NMR spectroscopy. Under 
conditions in Et2O-d10 at ‒80 °C, i-PrLi/(‒)-sparteine exists as Et2O-complexed 
heterodimer 35, whereas i-PrLi/(+)-sparteine surrogate complex exists as a head-to-tail 
homodimer 36 (Figure 1.4). Presumably, the less sterically hindered (+)-sparteine 
surrogate can more readily complex to i-PrLi which allows the homodimer formation in 
Et2O. When the corresponding NMR spectroscopic experiments were carried out in THF-
d8 at ‒80 °C, there was a significant difference in behaviour with the two diamines: a 1:1 
mixture of i-PrLi and (‒)-sparteine did not form a complex, whereas a 1:1 mixture of i-PrLi 
and (+)-sparteine surrogate gave a monomer 37. The NMR spectroscopy results revealed 
that (‒)-sparteine has a weaker coordination with organolithiums such as i-PrLi and s-BuLi 
compared to the (+)-sparteine surrogate in THF.  
Figure 1.4 
 
The result of the NMR spectroscopic study made it possible to carry out the first examples 
of asymmetric lithiation-trapping using s-BuLi/chiral diamine in THF. The 
enantioselectivity experiments of lithiation-benzaldehyde trapping of N-Boc pyrrolidine 1 
at ‒78 °C showed that there was a poor enantioselectivity when using s-BuLi/(‒)-sparteine 
complex in THF or “THF-like” 2-MeTHF, whereas a high enantioselectivity of product 
was obtained by using s-BuLi/(+)-sparteine surrogate complex under the same conditions.  
In more recent work, high temperature asymmetric lithiation-trapping of N-Boc pyrrolidine 
1 in Et2O was attempted using s-BuLi and the (+)-sparteine surrogate (Table 1.3).
34 At ‒78 
°C, both products (1S,2S)-25 and (1R,2S)-25 were isolated in high er (95:5 and 94:6 
respectively) with high yields (81% in total, entry 1). Lithiation was also successful at 
higher temperatures of ‒40 °C, ‒30 °C and ‒20 °C for 2 min while retaining the yields with 
high er of both products (entries 2-4). In contrast, at ‒20 °C for 1 h, products (1S,2S)-25 
  Chapter 1: Introduction 
20 
 
and (1R,2S)-25 were produced with lower er (83:17 and 85:15 respectively) (entry 5). The 
lower enantioselectivity at higher temperature is presumably due to reduced kinetic 
selectivity and partial configurational instability.35,36 The reduction of yields at ‒20 °C for 
1 h is likely due to the chemical instability of the organolithium at this temperature for a 
prolonged period of time. A similar set of results was obtained for experiments using (‒)-
sparteine. 
Table 1.3 
 
Entry 
Temp 
(°C) Time  
(1S,2S)-25  
Yield (%), er 
(1R,2S)-25  
Yield (%), er 
Total yield  
(%) 
1 –78 3 h 58, 95:5 23, 94:6 81 
2 –40 2 min 65, 90:10 30, 92:8 95 
3 –30 2 min 67, 90:10 27, 90:10 92 
4 –20 2 min 50, 89:11 23, 91:9 73 
5 –20 1 h 40, 83:17 20, 85:15 60 
 
The investigation of the high temperature asymmetric lithiation protocol using the (+)-
sparteine surrogate was further extended to the less reactive substrate, N-Boc piperidine 2 
(Table 1.4). At ‒78 °C, 3 h lithiation was required for N-Boc piperidine 2 to fully lithiate 
and give the MeO2CCl-trapped product (S)-26 in good yield (83%) with 87:13 er (entry 1). 
Lower yields of product (S)-26 were obtained in the range of 46-64% with lower er for 
lithiation at temperatures above ‒50 °C (entries 2-4). There was also some recovered 
starting material which indicated that the lithiation was not complete using the s-BuLi/(+)-
sparteine surrogate complex, possibly because reaction with the so lvent is competitive at 
these higher temperatures. 
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Table 1.4 
 
Entry Temp (°C) Time  
(S)-26      
Yield (%) 
er of 
(S)-26 
2           
Yield (%) 
1 –78 3 h 83 87:13 0 
2 –50 30 min 46 79:21 21 
3 –40 20 min 64 80:20 15 
4 –30 5 min 47 77:23 26 
 
The asymmetric lithiation-trapping of N-Boc heterocycles is an effective methodology for 
synthesis of biologically active molecules. A wide range of examples has been published 
including (‒)-Indolizidine 167B, glucokinase activator 37 and Indinavir (Figure 1.5). 
Synthesis of (‒)-Indolizidine 167B via lithiation-allylation of N-Boc pyrrolidine 1 was 
demonstrated by our group in 2008.37 Lithiation of N-Boc pyrrolidine 1 using s-BuLi and a 
chiral diamine followed by lithium-copper transmetallation and allylation generated the 
enantioenriched intermediate which was further processed to give (‒)-Indolizidine 167B. 
Campos et al. applied a lithiation-arylation protocol to the synthesis of glucokinase 
activator 37 on a large scale via the asymmetric lithiation and Negishi methodolgy.38 
Figure 1.5 
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Our group demonstrated a formal synthesis of Indinavir by applying the asymmetric 
lithiation of a single stereoisomeric piperazine (Scheme 1.14).29 As discussed before, (S,S)-
34 was prepared using s-BuLi/(+)-sparteine surrogate complex and subsequent trapping 
using MeO2CCl. Conversion of ester 34 into amide 38 was achieved by ester hydrolysis 
and amide formation. Deprotection of the α-methylbenzyl group in 38 followed by 
alkylation gave 40, the desired fragment of Indinavir. 
Scheme 1.14 
 
In summary, the reactivity of N-Boc heterocycles towards lithiation-trapping decreases as 
the size of the ring increases. The less reactive N-Boc piperidine 2 and N-Boc azepane 3 
only undergo high yielding lithiation using s-BuLi/TMEDA or s-BuLi/(+)-sparteine 
surrogate complex, and sometimes require temperatures above ‒78 °C. In contrast, high 
temperature lithiation-trapping of N-Boc pyrrolidine 1 can be completed using s-BuLi/THF 
or 2-MeTHF via the diamine-free protocol. 
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1.2 Overview of Organolithium Reagents in Ether Solvents 
Ethers such as Et2O and THF are the most commonly used solvents in organolithium 
reactions. They are typically used for the lithiation-trapping of N-Boc heterocycles, as 
discussed in the previous section. Nevertheless, the influence of ether solvents on the 
reactivity of organolithium species can vary. Many alkyllithium reagents, such as s-BuLi 
and n-BuLi, are commercially available as a solution in hydrocarbon solvents (commonly 
in cyclohexane or mixed hexanes). Although organolithium species are conventionally 
written as R-Li, they normally exist in a range of aggregates based on the choice of 
solvents and addition of ligands. For example, n-BuLi exists as hexamers, with an 
octahedral arrangement of Li atoms around the alkyl groups in non-polar hydrocarbons.39 
The more sterically hindered alkyllithiums such as i-PrLi, s-BuLi and t-BuLi aggregate as 
tetramers in hydrocarbons, with a tetrahedron of Li atoms bridged by the alkyl groups. 
When a stronger coordinating solvent such as THF is used, it reduces the aggregation state 
of the organlithium species and the species also become more active. Bauer et al. 
suggested that the s-BuLi/THF complex exists as a 78:22 mixture of monomer and dimer.40 
The addition of a diamine, such as TMEDA, can also reduce the degree of aggregation. 
Diamines are typically used in proportion to the organolithium species which enhances the 
reactivity. However, organolithium reagents can react with Et2O and THF at high 
temperature (above ‒78 °C) causing cleavage reactions.  
1.2.1 Stability of Ethers in the Presence of Organolithium Reagents 
The reaction of organolithium compounds with Et2O to give ethene and lithium ethoxide 
has been known since 1957.41 Although β-elimination was considered as the mechanism of 
this reaction, the details of the decomposition pathway were not studied until 1973 by 
Maercker.42,43 The investigation was carried out by studying the kinetic isotope effects of 
different labelled versions of Et2O. Three different reaction pathways were identified 
which would give ethene and lithium ethoxide. The mechanisms are shown in Scheme 1.15. 
The organolithium could remove the proton at the α- or β-position of Et2O. For β-
elimination, the Et2O will directly break down into ethene and lithium ethoxide. If the 
organolithium deprotonates the α-proton, it can then undergo either a 1,2-hydride shift or 
an intramolecular β-elimination (overall procedure is called α,β-elimination) to give ethene 
and lithium ethoxide. Using detailed deuterium studies, Maercker confirmed that all three 
mechanisms were operating with Et2O.
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Scheme 1.15 
 
The decomposition of Et2O by organolithium reagents depends on the type of 
organolithium reagent, the presence of ligands and the temperature. In 1997, Stanetty et al. 
published a detailed titration study to investigate the stability of Et2O under different 
conditions (Table 1.5).44 At ‒20 °C, s-BuLi and t-BuLi are stable in Et2O in the presence of 
TMEDA due to the strong coordination of alkyllithium and TMEDA (entries 1 and 4). 
Nevertheless, under the same conditions but in the absence of TMEDA, Et2O reacts slowly 
in 8-20 h with s-BuLi and t-BuLi (entries 2 and 6). At 0 °C, s-BuLi and t-BuLi are 
relatively unstable without TMEDA (entries 3 and 6). The instability of the n-
BuLi/TMEDA complex can occur when the temperature is above 0 °C (entry 7). A number 
of studies concerning the cleavage of cyclic ethers by organolithium species have been 
reported.  
Table 1.5 
Entry Organolithium Solvent Temperature (°C) Half-life 
1 t-BuLi Et2O + TMEDA ‒20 Stable at 1.36 M  
2 t-BuLi Et2O ‒20 8.05 h 
3 t-BuLi Et2O 0 1.02 h 
4 s-BuLi Et2O + TMEDA ‒20 Stable at 0.65 M 
5 s-BuLi Et2O ‒20 19.8 h 
6 s-BuLi Et2O 0 2.32 h 
7 n-BuLi Et2O + TMEDA 0 10.1 h 
8 n-BuLi Et2O 20 153 h 
9 n-BuLi Et2O 35 31 h 
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Since THF is the most commonly used solvent for organolithium reactions among other 
cyclic ethers, the mechanistic and kinetic studies of THF cleavage by organolithium 
species were studied by different groups. 45 ,46 In 1957, Gilman and Gaj compared the 
stability of some organolithium compounds in THF.41 Their results showed that MeLi, 
PhLi and n-BuLi are less stable in THF than in Et2O. They also indicated that the workable 
temperatures in THF are as follows: 0 °C for MeLi, 0 to ‒30 °C for PhLi and below ‒30 °C 
for n-BuLi.  
An NMR spectroscopic investigation about the mechanism and half- lives of THF cleavage 
with n-BuLi was carried out by Bates in 1972. 46  The result suggested that THF was 
deprotonated at the α-position followed by a reverse [3+2] cycloaddition to give ethene and 
a lithium enolate (Scheme 1.16). The resulting lithium enolate could be trapped by an 
electrophile, phenyl thiochlorocarbonate in this example, to give enol thiocarbonate 41. 
Ethene can also further react with another equivalent of organolithium to give the 
carbolithiation product 42.42 
Scheme 1.16 
 
In contrast, Fleming showed an example of THF being broken down into an alkene chain 
instead of ethene and a lithium enolate.47 By quenching their lithiated intermediate 43 with 
p-nitrobenzoyl chloride (DNBCl) in THF between ‒78 °C and ‒20 °C, the p-nitrobenzoate 
ester 45 of but-en-1-ol was isolated (Scheme 1.17). They suggested that the source of the 
proton in product 44 is from THF but the mechanism for the deprotonation of THF was not 
discussed. 
Scheme 1.17 
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There are two possible pathways for forming lithium but-3-en-1-oxide 46 from THF. The 
mechanisms are shown in Scheme 1.18. The organolithium could remove a β-proton in a 
β-elimination pathway. However, it should be noted that the geometry is unfavourable for 
E2 elimination in these five-membered ring compounds and the reverse 5-endo-trig is a 
Baldwin-disfavoured reaction (Scheme 1.18).48 The other possible pathway involves the α-
lithiation of THF followed by a 1,2-hydride shift.  
Scheme 1.18 
 
In 2002, Clayden reported the formation of lithium but-3-en-1-oxide 46 from THF.49 In his 
paper, the factors that control the decomposition route of THF were investigated. One of 
the factors focused on was the combination of the ligand and the organolithium and 
whether the presence of ligand would affect the decomposition route of THF. If the α-
deprotonation and reverse [3+2] happens, enol thiocarbonate 41 would be formed (Scheme 
1.19). If the reaction favours the formation of lithium but-3-en-1-oxide 46, but-3-en-1-yl 
thiocarbonate 47 would be seen. 
Scheme 1.19 
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The results suggested that HMPA has a unique role for the formation of lithium but-3-en-
1-oxide 47 compared to the other ligands. However, both α-deprotonation and β-
elimination can lead to the formation of lithium but-3-en-1-oxide 46 and the mechanistic 
pathway that HMPA directs the formation of product 47 has not identified yet (Table 1.6). 
None of the product 47 formed in the absence of ligand (entries 1 and 2). Excess of HMPA 
(6 equivalents) with either n-BuLi, s-BuLi, or t-BuLi encouraged the formation of 47 and 
suppressed the formation of 41 via reverse [3+2] cycloaddition (entries 3-5). The yield of 
47 was reduced when 1 equivalent of HMPA was used (entry 6) and the reverse [3+2] 
cycloaddition route was more favourable for other ligands such as TMEDA and (‒)-
sparteine (entries 9 and 10).  
Table 1.6 
 
Entry Organolithium Ligand 
41 
Yield (%)a  
47 
Yield (%)a  
1 n-BuLi nil 26* 0 
2 t-BuLi nil 25* 0 
3 t-BuLi HMPA (6 eq.) <1 62 
4 s-BuLi HMPA (6 eq.) <1 42 
5 n-BuLi HMPA (6 eq.) <1 24 
6 t-BuLi HMPA (1 eq.) 54 19 
7 s-BuLi TMEDA (1 eq.) 0 0 
8 t-BuLi TMEDA (1 eq.) 98 2 
9 s-BuLi (‒)-sparteine (1 eq.) 99 1 
10 t-BuLi (‒)-sparteine (1 eq.) 98 2 
a
By GC analysis unless otherwise indicated. *Isolated yield. 
 
The titration study from Stanetty also discussed the stability of THF with different 
organolithium species at different temperatures (Table 1.7). At ‒20 °C, t-BuLi is stable in 
THF for around 0.7 h and the presence of TMEDA does not have an effect on the result 
(entries 1 and 2). For s-BuLi, THF is stable at ‒40 °C in the presence of TMEDA (entry 4), 
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but under the same conditions, the half- life of s-BuLi reduced to less than half an hour at 
‒20 °C (entry 5). n-BuLi is relatively stable at temperatures above 0 °C (entries 6-9). In 
general, the half- lives of the organolithium species in THF at ‒20 °C or above are reduced 
when TMEDA is present in the reaction mixture.  
Table 1.7 
Entry Organolithium Solvent Temperature (°C) Half-life 
1 t-BuLi THF ‒20 0.70 h 
2 t-BuLi THF + TMEDA ‒20 0.75 h 
3 s-BuLi THF ‒20 1.30 h 
4 s-BuLi THF + TMEDA ‒40 Stable at 0.52 M 
5 s-BuLi THF + TMEDA ‒20 0.47 h 
6 n-BuLi THF 0 17.3 h 
7 n-BuLi THF 20 1.78 h  
8 n-BuLi THF + TMEDA 0 5.63 h 
9 n-BuLi THF + TMEDA 20 0.63 h 
 
Currently there is no evidence to identify the pathway of forming lithium but-3-en-1-oxide 
47 from THF from the two possible pathways shown in Scheme 1.19. The β-elimination 
pathway is unlikely to happen in these five-membered ring compounds due to the 
unfavourable geometry for E2 elimination. However, as the size of the ring increases to 
seven, oxepane has the required geometry to access the E2 elimination which is shown in 
Scheme 1.20. Although oxepane 48 was not used as a solvent, it is useful to compare its 
results with THF. Bates suggested that oxepane 48 was deprotonated by n-BuLi at the β-
position to give alkene 49. 
Scheme 1.20 
 
Cohen and Stokes have also studied the β-cleavage of oxepane with n-BuLi using kinetic 
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isotope effect experiments.50 Surprisingly, their results confirmed that the initial step for 
cleavage of oxepane 48 takes place via lithiation at the α-position followed by a 
transannular hydrogen shift to form lithium hex-5-en-1-oxide 49. The mechanism of 
cleavage of the oxepane is shown in Scheme 1.21.  
Scheme 1.21 
 
In the last decade, 2-MeTHF has become popular as a greener alternative to THF for use as 
a solvent.51,18 Although there is a growing number of examples of the use 2-MeTHF as 
solvent in a variety of organic synthesis applications, particularly with organolithium 
reagents, the stability of organolithium reagents in 2-MeTHF has not been reviewed in 
detail. Cohen and Stokes studied the mechanism of 2-MeTHF cleavage using n-BuLi.50 
Although 2-MeTHF can undergo α-deprotonation like THF, the methyl group at the α-
position of the five-membered ring favours an alternative β-elimination process (Scheme 
1.22).  
Scheme 1.22 
 
From an isotope labelling experiment shown in Scheme 1.23, the deuterated lithium pent-
4-en-1-oxide 53 was isolated and it contained only two deuteriums. This confirmed that the 
deprotonation of 2-MeTHF occurs at the β-position and that the organolithium 
preferentially deprotonates the proton from the methyl group instead of the C-3 proton on 
the ring. 
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Scheme 1.23 
 
The deprotonation of 2-MeTHF at the β-position on the methyl group is favoured as the 
organolithium is directed by the oxygen atom of the ring via coordination of an oxygen 
lone pair to the lithium (Figure 1.6). The study did not reveal evidence of the α-
deprotonation pathway. 
Figure 1.6 
 
In summary, reactions of organolithium reagents with Et2O and THF can be occur at high 
temperatures (above ‒20 °C) and this can then lead to cleavage reactions. The mechanisms 
of ether cleavage are varied and depend on the ether and the conditions used.  
1.2.2 Sustainable Ether Solvents 
Solvents are essential for almost all synthetic applications and around 20 million tonnes of 
solvents are consumed annually across the world. However, driven by environmental and 
regulatory pressures and concerns of using volatile organic compounds (VOC), the 
development of solvents that are safer and renewable has increased rapidly in the last 
fifteen years. The concepts of green (sustainable) solvents are introduced in the 12 
principles of Green Chemistry. 52,53 ,54   The role of a desirable green solvent should be 
associated with low toxicity, low vapour pressure and minimising environmental impact. 
More desirably, it should have additional benefits such as assisting the reaction. 
As discussed previously, ethers such as Et2O and THF are the most commonly used 
solvents for organolithium reactions. However, there are several drawbacks when these 
two organic solvents are used in commercial production processes: Et2O has a low boiling 
point (34.6 °C) and is highly flammable which limits its use in industrial applications; THF 
has a high water solubility which gives a poor separation from the aqueous waste. This can 
lead to a difficult or expensive work-up process and waste treatment. In addition, Et2O and 
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THF are currently prepared from non-renewable petroleum-based resources. For example, 
there are several industrial processes for THF production and the most widely used in 
commercial processes involves the acid-catalyzed dehydration of 1,4-butanediol 54 (BDO) 
(Scheme 1.24). BDO 54 is a petroleum-derived product which is commercially produced 
from the condensation of acetylene with formaldehyde using a Cu catalyst followed by 
high-pressure hydrogenation using a Ni/Cu catalyst.55 It then undergoes cyclisation using 
an acid catalyst to form THF.56 Alternatively, THF can be prepared by reduction of maleic 
anhydride 56 which is traditionally made from oxidation of benzene or n-butane. 57 
However, oxidation of benzene or n-butane is very exothermic and due to incomplete 
combustion it generates carbon monoxide and carbon dioxide. This makes THF production 
via maleic anhydride 56 less favourable. 
Scheme 1.24 
 
2-Methyltetrahydrofuran (2-MeTHF) is a bio-derived solvent generated from sustainable 
biomass such as cellulose and hemicelluloses in lignocellulosic waste. 58 ,59  There are a 
growing number of examples showing 2-MeTHF can replace THF as a solvent in some 
organic synthesis applications.18,19, 60  For example, Pace reported a highly efficient 
chemoselective preparation of N-TBS-arylamines at high temperature (0 °C) using an 
organolithium reagent in 2-MeTHF where the conventional reaction was carried out in 
THF at ‒78 °C.61 
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There are many routes to produce 2-MeTHF from lignocellulose biomass but most of the 
procedures proceed via 5-hydroxymethylfurfural (HMF) or furfural as key bio-derived 
building blocks, so-called platform molecules.62 Lignocellulose biomass is converted by 
depolymerisation (acid-catalyzed hydrolysis/one or more catalytic processes) and/or 
fermentation (biological enzymes) into lignin (waste), glucose 58 (predominately from 
cellulose) and xylose 60 (predominately from hemicellulose) and then these are converted 
into furfural 61 and HMF 62. The general synthetic routes to furfural 61 and HMF 62 are 
summarised in Scheme 1.25. HMF 62 can be obtained by the acid-catalysed conversion of 
carbohydrates based on the C6 sugars, glucose 58 or fructose 59.63 As glucose 58 is a 6-
ring sugar molecule, isomerization of glucose 58 to form 5-ring fructose 59 is required 
prior to dehydration of fructose 59 to form 5-ring HMF 62. HMF 62 can also be obtained 
directly by degradation of cellulose using various solid acid catalysts and reaction 
media.64,65,66,67,68 There is much research that investigates the conversion of HMF 62 from 
lignocelluloses biomass using greener techniques such as using ionic liquids in biophasic 
system or using supercritical methanol (scMeOH) as solvent.58,64 Furfural 61 is a 5-ring 
molecule that can be prepared by a direct acid-catalysed hydrolysis of hemicelluloses via 
C5 sugar xylose 60 using heterogeneous catalysts.69,70  
Scheme 1.25 
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As HMF 62 and furfural 61 are mostly prepared from abundant lignocelluloses biomass 
with economically and environmentally acceptable processes, they could be scaled up at 
the industrial level and converted into other useful chemicals. Additionally, most of this 
lignocellulose can be acquired as waste from other large-scale processes, such as wheat 
and barley straw and tree toppings from wood production. Other sources of the cellulose or 
saccharides used for HMF production include poor quality paper following extensive 
recycling or washings of fruit press cakes.71 
2-MeTHF can be prepared from two main routes: either from furfural 61 or HMF 62 which 
are summarised in Scheme 1.26. HMF 62 can be hydrolysed and dehydrated by acid 
catalysis to form levulinic acid 63 and formic acid. Although high conversions from HMF 
to levulinic acid 63 were reported using different acid catalysts, the mechanism of this 
transformation is still unknown.72  
Scheme 1.26 
 
Levulinic acid 63 then undergoes hydrogenation and esterification to give γ-valeroactone 
64 (GVL) and 1,4-pentanediol 65 (1,4-PDO) followed by cyclisation to give 2-MeTHF.73 
Leitner reported the production of 2-MeTHF from levulinic acid 63 using ruthenium 
catalysts and suggested a mechanism (Scheme 1.27). 74  Alternatively, furfural 61 can 
undergo catalytic reduction to give 2-MeTHF. From a green chemistry point of view, 2-
MeTHF production from HMF 62 is less favoured. This is due to the loss of one carbon, as 
formic acid, throughout the formation of levulinic acid 63 from HMF 62 and the fact that 
the synthesis requires more steps compared to the direct reduction route from furfural 61. 
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Scheme 1.27 
 
Although THF is currently prepared from non-renewable petroleum-based resources, there 
are examples to show that THF can also be produced in a sustainable manner. As 
mentioned before, BDO 54 and maleic anhydride 56 are key intermediates for THF 
synthesis where they are currently obtained either from oxidation of benzene/n-butane or 
condensation of acetylene with formaldehyde. BDO 54 and maleic anhydride 56 can also 
be generated from a platform molecule, succinic acid 68. The main route for succinic acid 
production is the fermentation of cellulose glucose (Scheme 1.28). 75 , 76  From the 
fermentation process, C6 glucose 58 will break down into a C4 succinate fragment. As 
most fermentation micro-organisms cannot tolerate excessively acidic environments, the 
fermentation needs to be continually neutralized to give succinate salts, following recovery 
from the broth. While the fermentation of glucose route provides a greener way for THF 
synthesis, the purification cost for fermentation-based processes is normally more than 
60% of the total production costs.76 In the case of succinic acid purification, the separation 
of by-products such as acetic acid, formic acid, lactic acid and pyruvic acid have a crucial 
effect on process costs as well as consuming energy. Further improvement of the 
fermentation step to produce purified succinic acid 68 is needed in order to allow the THF 
production from cellulose/glucose resources to become economically favourable. Mascal et 
al. have also recently reported a route from lignocellulose to succinic acid via a wholly 
chemo-catalytic approach, via the oxidation of levulinic acid 63 with H2O2 and TFA.
77 
Alternatively, THF can be synthesised directly from furfural 61 at high selectivity through 
catalytic decarbonylation to furan followed by ring hydrogenation. However, this 
procedure is not favoured due to the loss of one carbon to form CO2 throughout the 
reaction, thus offering poor atom economy. 
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Scheme 1.28 
 
In summary, although there are examples of producing THF from renewable resources, the 
current fermentation process is not economically favoured to produce THF on an industrial 
scale. If the technology for the fermentation step is improved, the industrial scale 
production of THF from sustainable resources could become available, although its cost 
compared to petroleum-derived THF cannot be predicted at this time. Alternatively, 
chemo-catalytic routes to succinic acid from biomass could pave the way for bio-derived 
THF at reduced cost, but this technology is only in its infancy and is as yet un-tested 
beyond lab-scale. 
Apart from the sustainability of 2-MeTHF, its physical and chemical properties offer a 
safer and better application for organic synthesis compared to other ether solvents such as 
Et2O and THF which are summarised in Table 1.8.
78 The lower solubility of 2-MeTHF in 
water gives a better separation from the aqueous phase (i.e. improved liquid- liquid 
separations) in the work-up. Also, the higher boiling point and flash point of 2-MeTHF 
illustrates that they are less volatile; in consequence, 2-MeTHF is safer to handle for large-
scale reaction.  
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Table 1.8 
Properties Et2O THF 2-MeTHF 
Density (20 °C) [g/cm3] 0.71 0.89 0.86 
Boiling point [°C] 34.6 65 80 
Solubility of Solvent in Water 
(23 °C) [g/100g] 
6.5 Infinite 4.1 
Azeotropic temp with water 
(°C) 
34 64 89 
Flash point (°C) –40 –17 –12 
 
In summary, Beak’s lithiation methodology for the α- functionalisation of N-Boc 
heterocycles is efficient and has been widely used for the synthesis of natural products and 
drug molecules. However, there are some drawbacks of the typical reaction conditions 
which are not ideal for process-scale chemistry and against the principles of Green 
Chemistry: low temperature (‒78 °C) and long lithiation time (>3 h) require large energy 
consumption; addition of a diamine decreases the atom economy and use of non-
sustainable solvent (Et2O). The diamine-free lithiation protocol that was developed by our 
group gave a better approach with respect to the principles of Green Chemistry, although 
investigation of using a sustainable solvent is needed further. 
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1.3 Project Outline 
In the first part of the project (Chapter 2), we planned to investigate the racemic lithiation-
trapping of N-Boc heterocycles at temperatures above ‒30 °C. In particular, our interest 
was to optimise the lithiation conditions in terms of the principles of Green Chemistry. The 
initial investigation was based on the diamine-free lithiation-trapping of N-Boc pyrrolidine 
1 at ‒30 °C developed by our group in 2010 (Scheme 1.29). In that work, lithiation of N-
Boc pyrrolidine 1 was carried out at ‒30 °C in THF and trapped with benzaldehyde to give 
an 84% yield of amino alcohols 25 whereas a 73% yield of 25 was obtained in 2-MeTHF. 
Scheme 1.29 
 
The results suggested that the renewable solvent 2-MeTHF performs similarly to THF. 
However, high yields could not be obtained at temperatures above 0 °C in both solvents. 
Hence, our initial aim was to investigate the reasons for the low yields at temperatures 
above 0 °C and to explore the highest possible temperature for lithiation of N-Boc 
pyrrolidine 1 using 2-MeTHF.  
Subsequently, exploration of the high temperature lithiation protocol was extended to N-
Boc piperidine 2, N-Boc azepane 3 and N-Boc piperazine 16 (Scheme 1.30). 
Scheme 1.30 
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In the second part of the project (Chapter 3), we applied the N-Boc α-lithiation-trapping to 
four different types of oxygen heterocycles: tetrahydrofuran (THF), tetrahydropyran (THP), 
oxetane and N-alkyl morpholines. We hoped to find conditions for successful lithiation-
trapping of oxygen heterocycles (Scheme 1.3.1). 
Scheme 1.31 
 
As part of the oxygen lithiation project, we wanted to study the lithiation-trapping of 
oxetane 71. To prepare oxetane 71, a route via double lithiation-trapping of N-Boc 
pyrrolidine 1 (to give 70) would be investigated (Scheme 1.32). 
Scheme 1.3.2 
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Chapter 2: Lithiation-trapping of N-Boc 
Heterocycles Above ‒78 °C 
An exploration of the lithiation-trapping of N-Boc heterocycles performed at temperatures 
above ‒78 °C will be presented in this chapter. As described in Chapter 1, Beak’s lithiation 
methodology for the α-functionalisation of N-Boc heterocycles is simple and widely used 
in the synthesis of natural products and drug molecules. However, two of the major 
drawbacks of these reaction conditions for process-scale chemistry are the low temperature 
(‒78 °C), and the long lithiation times (>3 h). Therefore, the objective of this part of the 
project was to optimise the lithiation conditions in terms of temperature and time of 
lithiation which could lead to a better approach in terms of the principles of Green 
Chemistry. In addition, an exploration of the use of the sustainable ether solvent, 2-MeTHF 
will be presented. Section 2.1 describes our investigation of conditions for the lithiation of 
N-Boc pyrrolidine. To try to understand the low yields, a mechanistic investigation was 
carried out (Section 2.2). In addition, exploration of the high temperature lithiation 
protocol was extended to N-Boc piperidine 2, N-Boc azepane 3 and N-Boc piperazine 16 
(Sections 2.3 and 2.4). 
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2.1 Optimisation of the Lithiation-trapping of N-Boc 
Pyrrolidine in Different Ether Solvents Above ‒78 °C 
To start the investigation of the high temperature lithiation protocol, we chose N-Boc 
pyrrolidine 1 as the substrate. We know that high temperature lithiation of N-Boc 
pyrrolidine 1 can be carried out. In 2010, our group reported a diamine-free lithiation 
protocol which can be achieved with s-BuLi/THF complex at ‒30 °C. More recently, 
asymmetric lithiation of N-Boc pyrrolidine 1 can be performed with s-BuLi/(+)-sparteine 
surrogate complex at ‒20 °C. Thus, we asked ourselves a question: is it possible to use the 
sustainable solvent, 2-MeTHF, to carry out the lithiation at high temperature, ideally above 
‒20 °C, for the racemic lithiation protocol, If successful, the specialist low temperature set-
up for process-scale would not be required. Therefore, two main objectives of this part 
were to find out whether 2-MeTHF can be a good alternative to Et2O in the TMEDA-
mediated lithiation protocol and THF in the diamine-free lithiation protocol and to identify 
the highest temperature conditions that can still provide a good yield.  
The initial investigation was carried out using the high temperature lithiation protocol 
developed by our group. In order to examine the potential replacement of Et2O or THF by 
the sustainable solvent, 2-MeTHF, the lithiation of N-Boc pyrrolidine 1 was carried out 
using s-BuLi at ‒30 °C for 5 min in various ether solvents: Et2O, Et2O with TMEDA (1.3 
eq.), THF, 2-MeTHF and 2-MeTHF with TMEDA (1.3 eq.). The lithiated intermediate was 
then trapped with benzaldehyde to give hydroxyl pyrrolidines 25 (Table 2.1). In all cases, 
there was an approximately 75:25 mixture of diastereomeric alcohols syn-25 and anti-25 in 
the 1H NMR spectrum of the crude product. The stereochemistry of these products has 
previously been assigned (by X-ray crystallography) in our group. To simplify the results, 
only the combined total yield of syn-25 and anti-25 after purification by column 
chromatography is shown. Diamine-free lithiation in THF at ‒30 °C gave the best result of 
73% yield (entry 1). Disappointingly, lithiation in 2-MeTHF gave a 47% yield of hydroxyl 
pyrrolidines 25 (entry 2) although TMEDA-mediated lithiation in 2-MeTHF provided a 
better result (68% yield of 25) (entry 3). Lithiation in Et2O gave a low yield (19% yield) 
with 13% of starting material recovered from the reaction (entry 4). The low yield 
indicates that Et2O is not a very promising solvent for high temperature lithiation. The low 
13% yield of starting material perhaps suggests that lithiation occurred but the lithiated 
intermediate subsequently decomposed before trapping. A better yield was obtained (61% 
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yield) when using s-BuLi/TMEDA in Et2O (entry 5). The main conclusion from these 
initial results was that s-BuLi in Et2O should not be further investigated. The other 
conditions all gave satisfactory yields (>47%).  
Table 2.1 
 
Entry Solvent Yield (%) 
1 THF 73 
2 2-MeTHF 47 
3 2-MeTHF + TMEDA (1.3 eq.) 68 
4 Et2O 19 
5 Et2O + TMEDA (1.3 eq.) 61 
 
Since the use of benzaldehyde as the electrophile gives a mixture of diastereomeric 
products which require more difficult purification by column chromatography, another 
electrophile which does not create a new stereogenic centre was chosen for the next 
experiments for comparison. Thus, a similar study of the high temperature lithiation 
conditions was performed using Me3SiCl as the electrophile. Lithiation was carried out 
with s-BuLi for 5 min in THF, 2-MeTHF, Et2O with TMEDA and 2-MeTHF with TMEDA 
at ‒30 °C (Table 2.2).  
Table 2.2 
 
Entry Solvent Yield (%) 
1 THF 66 
2 2-MeTHF 69 
3 2-MeTHF + TMEDA (1.3 eq.) 76 
4 Et2O + TMEDA (1.3 eq.) 73 
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Lithiation in THF and 2-MeTHF at ‒30 °C gave good 66% and 69% yields of silylated 
pyrrolidine 4 respectively (entries 1 and 2). To check the reproducibility of the 2-MeTHF 
diamine-free method, it was repeated and 69% yield was obtained. TMEDA-mediated 
lithiation in 2-MeTHF and Et2O under the same conditions gave higher yields of 76% and 
73% respectively (entries 3 and 4). Up to this point, similar results were obtained with 
Me3SiCl and benzaldehyde as the electrophiles and, in general, all the reaction conditions 
gave good yields at ‒30 °C. The results suggested that the sustainable solvent, 2-MeTHF, 
is a good alternative to THF for diamine-free lithiation and Et2O for TMEDA-mediated 
lithiation. 
Next, we wanted to know whether high yields of silylated pyrrolidine 4 could be obtained 
in similar solvent systems when the lithiation was carried out at temperatures above ‒30 °C. 
We also wanted to investigate whether lithiation at ‒20 °C was complete within 5 min and 
so a shorter lithiation time of 2 min was investigated (Table 2.3). Lithiation at  ‒20 °C for 5 
min and 2 min in THF gave yields of 64% and 65% respectively (entries 1 and 2). This 
clearly indicated that lithiation was completed within 2 min. However, lithiation for 2 min 
in 2-MeTHF gave a lower yield than for 5 min (52% and 57% respectively; entries 3 and 
4). TMEDA-mediated lithiation in 2-MeTHF for 2 and 5 min gave 68-69% yields (entries 
5 and 6). Similarly, lithiation in Et2O with TMEDA for 2 and 5 min gave 70-71% yields 
(entries 7 and 8). 
Table 2.3 
 
Entry Solvent Time (min) Yield (%) 
1 THF 5 64 
2 THF 2 65 
3 2-MeTHF 5 57 
4 2-MeTHF 2 52 
5 2-MeTHF + TMEDA (1.3 eq.) 5 69 
6 2-MeTHF + TMEDA (1.3 eq.) 2 68 
7 Et2O + TMEDA (1.3 eq.) 5 71 
8 Et2O + TMEDA (1.3 eq.) 2 70 
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In general, results at ‒20 °C are consistent with those at ‒30 °C where most of the reaction 
conditions provide good yields (>64% yield) except for the use of s-BuLi/2-MeTHF 
complex. Lower yields in the 2-MeTHF diamine-free lithiation may suggest that the steric 
hindrance of the methyl group could make the s-BuLi/2-MeTHF complex less reactive 
than the s-BuLi/THF complex. Consequently, a longer lithiation time (5 min) is required 
for s-BuLi/2-MeTHF to lithiate N-Boc pyrrolidine 1. In addition, lithiation of N-Boc 
pyrrolidine 1 at higher temperatures can still lead to good yields even if only left for a short 
time (2 min) before trapping. This matched the results from the high temperature 
asymmetric lithiation (‒20 °C for 2 min) using s-BuLi and the (+)-sparteine surrogate (see 
Table 1.3).34 
Subsequently, lithiation was carried out in similar solvent systems at ‒10 °C (Table 2.4). 
Variable lithiation times (2 min, 1 min and 30 sec) were investigated as we expected 
lithiation would be very fast at such a high temperature. The yields of silylated pyrrolidine 
4 after lithiation-trapping in THF at various reaction times were similar (47-53%) (entries 
1-3). Lithiation in 2-MeTHF for 30 sec gave 46% (entry 6) whereas lower yields were 
formed (28% and 35%) when lithiation was carried out for a longer time respectively (1 
min and 2 min) (entries 4-5). TMEDA-mediated lithiation in both 2-MeTHF and Et2O for 
30 sec gave good 74% and 69% yields respectively. 
Table 2.4 
 
Entry Solvent Time  Yield (%) 
1 THF 2 min 53 
2 THF 1 min 58 
3 THF 30 sec 47 
4 2-MeTHF 2 min 28 
5 2-MeTHF 1 min 35 
6 2-MeTHF 30 sec 46 
7 2-MeTHF + TMEDA (1.3 eq.) 30 sec 74 
8 Et2O + TMEDA (1.3 eq.) 1 min 67 
9 Et2O + TMEDA (1.3 eq.) 30 sec 69 
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In general, diamine- free lithiation gave lower yields comparing to the same systems at ‒30 
°C particularly with the use of s-BuLi/2-MeTHF complex. As mentioned before, the lower 
yield might due to the steric hindrance of the methyl group of the 2-MeTHF. However, the 
result indicated that TMEDA-mediated lithiation still provided good yields (>67% yield) at 
‒10 °C even for shorter reaction times. Two possibilities can explain the lower yields. One 
is that a slower lithiation was carried out in diamine-free conditions than the TMEDA-
mediated protocol thus leading to the lower yields. The other thought is that the lithiated N-
Boc pyrrolidine was not chemically stable at such a high temperature which would lead to 
some decomposition of the lithiated N-Boc pyrrolidine.  
We then explored increasing the lithiation temperature to 0 °C where variable lithiation 
times were investigated (Table 2.5). Since we suspected that the lithiated N-Boc 
pyrrolidine might be chemically unstable at these higher temperatures, we focused on 
lithiation times of less than 1 min at 0 °C. Lithiation in THF for 50 sec gave a 39% yield of 
trapped product (entry 1), 47% yield for 30 sec (entry 2) and 59% yield for only 5 sec 
(entry 3). This indicated that lithiation at 0 °C gave the best yield in just 5 sec. We 
therefore tried this optimised lithiation time for other solvents. Diamine-free lithiation in 2-
MeTHF gave a 50% yield for 5 sec of the trapped product whereas a lower yield (31%) 
was obtained when the reaction was carried out for 10 sec (entry 5).  
Table 2.5 
 
Entry Solvent Time (sec) Yield (%) 
1 THF 50 39 
2 THF 30 47 
3 THF 5 59 
4 2-MeTHF 10 31 
5 2-MeTHF 5 50 
6 2-MeTHF + TMEDA (1.3 eq.) 5 63 
7 Et2O + TMEDA (1.3 eq.) 10 55 
8 Et2O + TMEDA (1.3 eq.) 5 53 
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At 0 °C, there is the similar trend of using THF and 2-MeTHF in diamine-free lithiation 
when a shorter lithiation time provides a better yield. The trend matchs our suspicion that 
the lithiated intermediate is chemically unstable at these higher temperatures over longer 
lithiation times. TMEDA-mediated lithiation in 2-MeTHF gave a 63% yield of the trapped 
product (entry 6) and 53% yield in Et2O (entry 8). In general, TMEDA-mediated lithiation 
gave a higher yield at 0 °C than the diamine-free conditions, which is consistent with 
observations at ‒10 °C. In particular, 2-MeTHF with TMEDA gave the best yield for 
lithiation at 0 °C for 5 sec, indicating that 2-MeTHF can replace Et2O for high temperature 
TMEDA-mediated lithiation, although the use of THF in diamine-free lithiation conditions 
gave a better yield than in 2-MeTHF. 
Finally, the lithiation temperature was then raised to 20 °C and we expected that a very 
short lithiation time would be required at this high temperature. We knew that 5 sec is 
sufficient lithiation time at 0 °C and to avoid decomposition of the lithiated N-Boc 
pyrrolidine, we tried to lithiate N-Boc pyrrolidine for 2 sec before adding Me3SiCl (Table 
2.6). However, we were disappointed by the low yields in all solvent systems. Diamine-
free lithiation in THF gave 22% yield (entry 1) whereas a better yield (33%) was obtained 
in 2-MeTHF (entry 2). TMEDA-mediated lithiation in 2-MeTHF gave a low 16% yield 
(entry 3) and 30% yield in Et2O (entry 4). In summary, diamine-free lithiation using 2-
MeTHF as solvent gave the best yield for lithiation at 20 °C, although the yields overall 
were disappointingly low, suggesting that the lithiated N-Boc pyrrolidine was chemically 
unstable at 20 °C even for a very short period of time.  
Table 2.6 
 
Entry Solvent Yield (%) 
1 THF 22 
2 2-MeTHF 33 
3 2-MeTHF + TMEDA (1.3 eq.) 16 
4 Et2O + TMEDA (1.3 eq.) 30 
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From the optimisation results of high temperature lithiation, lithiation at 0 °C for 5 sec was 
the highest temperature reaction conditions for lithiation that still provide a synthetically 
useful yield. Hence, we wanted to explore other ether solvents for the lithiation of N-Boc 
pyrrolidine 1 under the optimised reaction conditions. Diamine-free and TMEDA-mediated 
lithiation using various ether solvents were investigated and compared: THF, 2-MeTHF, 
Et2O, TBME, CPME and TMEDA as solvent and the results are summarised in Table 2.7. 
In general, TMEDA-mediated lithiation gave a better performance than diamine-free 
lithiation. TMEDA-mediated lithiation in THF gave a high 66% yield (entry 2) whereas the 
diamine-free lithiation in THF gave a lower 59% yield (entry 1). TMEDA-mediated 
lithiation in 2-MeTHF, Et2O and in TBME gave good yield (63%, 53% and 67% 
respectively, entries 4, 6 and 8). Lower yields were obtained for diamine-free lithiation in 
the same solvents under the same reaction conditions (50%, 20%, 14% respectively, entries 
3, 5 and 7). It confirms that TMEDA is the best ligand and gave the best performance in 
lithiation-trapping. However, TMEDA as ligand and solvent gave no product (entry 11). 
TMEDA-mediated lithiation in CPME surprisingly gave a low yield of 29% (entry 10) and 
the reason for this is unknown. 
Table 2.7 
 
Entry Solvent Yield (%) 
1 THF 59 
2 THF + TMEDA (1.3 eq.) 66 
3 2-MeTHF 50 
4 2-MeTHF + TMEDA (1.3 eq.) 63 
5 Et2O 20 
6 Et2O + TMEDA (1.3 eq.) 53 
7 TBME 14 
8 TBME + TMEDA (1.3 eq.) 67 
9 CPME 14 
10 CPME + TMEDA (1.3 eq.) 29 
11 TMEDA 0 
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Subsequently, we wanted to know whether s-BuLi could be substituted by a less strong 
base, n-BuLi, for the high temperature lithiation. The advantages of using n-BuLi are that 
it is more stable, safer to use and cheaper. Lithiation of N-Boc pyrrolidine 1 with n-BuLi 
was carried out in THF or 2-MeTHF with TMEDA at 0 °C for 1 or 5 min (Table 2.8). 
However, after trapping with Me3SiCl no product was found in all reactions. The 
1H NMR 
spectrum of the crude product revealed only unreacted starting material 1 present.  
Table 2.8 
 
Entry Solvent Time (min) Yield (%) 
1 THF 1 0 
2 2-MeTHF + TMEDA (1.3 eq.) 5 0 
3 2-MeTHF + TMEDA (1.3 eq.) 1 0 
 
Based on the results of the optimisation, we concluded that the highest temperature for the 
lithiation‒trapping of N-Boc pyrrolidine 1 that provides good yields is 0 °C for 5 sec for 
both diamine-free and TMEDA-mediated lithiation in 2-MeTHF. Subsequently, lithiation 
of N-Boc pyrrolidine 1 was carried out at 0 °C for 5 sec using diamine-free or TMEDA-
mediated conditions in 2-MeTHF, followed by trapping with benzaldehyde or Me3SiCl. 
The results are presented in Scheme 2.1.  
Scheme 2.1 
 
Although TMEDA-mediated lithiation gave a higher 58% yield of both silylated 
pyrrolidine 4 and hydroxyl pyrrolidines 25, the yields of silylated pyrrolidine 4 (50%) and 
hydroxyl pyrrolidines 25 (52%) in the diamine-free protocol were similar. In general, the 
Chapter 2: Lithiat ion-trapping of N-Boc Heterocycles Above ‒78  C 
48 
 
diamine-free lithiation at 0 °C for 5 sec in 2-MeTHF provides a better Green chemistry 
approach for process-scale chemistry, where a temperature of ‒20 °C or above are 
preferred; high temperature with a short lithiation time reduces the overall energy 
consumption and 2-MeTHF is safer to use and is a sustainable solvent.  
However, the 5 sec lithiation time is too short to apply in a batch process. Hence, we 
suggest that the 0 °C for 5 sec reaction conditions are best for a flow chemistry set-up. For 
the batch process, we recommend that the lithiation is carried out at ‒20 °C for 2 min. We 
selected these conditions for the lithiation of N-Boc pyrrolidine 1 and trapped with a range 
of electrophiles (Scheme 2.2). In general, high product yields (52-71%) were obtained. 
Trapping with Me3SiCl gave a 68% yield in the TMEDA-mediated protocol and a 52% 
yield in the diamine-free conditions. When trapping with PhCHO, product 25 was obtained 
in 71% and 69% yields respectively. Trapping with DMF gave 8 in a 66% and 52% yield 
correspondingly. 
Scheme 2.2 
 
In summary, by exploring new high temperature conditions for the lithiation of N-Boc 
pyrrolidine 1, we revealed that the highest temperature for the lithiation‒trapping of N-Boc 
pyrrolidine 1 that provides good yields is 0 °C for 5 sec for both diamine-free lithiation in 
2-MeTHF and TMEDA-mediated lithiation in 2-MeTHF. However, we suggest that 0 °C 
for 5 sec is the best conditions for flow chemistry and ‒20 °C for 2 min is the best 
conditions for batch scale. In comparison to the original TMEDA-mediated lithiation 
conditions reported by Beak7 (‒78 °C, 3 h in Et2O) and the high temperature diamine-free 
protocol reported by our group recently15 (‒30 °C, 5 min in THF), the newly developed 
lithiation conditions represent an improvement as they occur at a higher temperature and 
require a shorter lithiation time. In addition, the use of the sustainable solvent, 2-MeTHF, 
is a good alternative solvent which is safer to use.  
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2.2 Investigation of the Reasons for Lower Yields at High 
Temperatures (≥ 0 °C) 
During the optimisation of the high temperature lithiation between ‒30 °C and 20 °C, there 
is a significant decrease in the yield of silyl product 4 in all four reaction conditions as the 
temperature goes higher. This is particularly clear from the plot shown in Figure 2.1. In 
particular, at 20 °C, yields were in the range of 16-33% whereas 66-76% yields were 
obtained at ‒30 °C. 
Figure 2.1 
 
 
 
Our two proposals for explaining the lower yield at higher temperatures are as follows. The 
first suggestion is that, at high temperature, s-BuLi started to react with the solvent rather 
than with N-Boc pyrrolidine 1. The second suggestion is that the higher temperature allows 
the lithiated N-Boc pyrrolidine 1 to decompose (via pathways that are discussed later). As 
mentioned in Chapter 1, lithiation of ethereal solvents, in particular THF, by s-BuLi at high 
temperatures is known.46 THF can be deprotonated by s-BuLi to give lithiated THF, which 
can then undergo a reverse [3+2] cycloaddition and break down into ethene and a lithium 
enolate. 2-MeTHF can also undergo a similar decomposition pathway. In both cases, the 
alkene generated can then be carbolithiated to give 72 and hence 73 after electrophile 
trapping (Scheme 2.3). 
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Scheme 2.3 
 
Hence, we wanted to examine the interaction between s-BuLi in THF without N-Boc 
pyrrolidine 1 at 0 °C. Our plan was to stir the s-BuLi in THF at a specific temperature for a 
certain time and then trap with benzaldehyde. If the s-BuLi did not react with THF, only 
the direct addition product 74 would be obtained. If the s-BuLi did react with the THF, it 
should lead to the carbolithiation product 73 after trapping with benzaldehyde. In order to 
prepare a reference sample of the direct addition product 74, 1 equivalent of s-BuLi was 
added to a stirred solution of benzaldehyde (1 eq.) and THF at ‒78 °C. This gave the direct 
addition product 74 which was isolated in 75% yield. Then, we investigated the reactions 
at 0 °C: s-BuLi was stirred in THF for 5 min or 30 min before adding benzaldehyde (Table 
2.9, entries 1 and 2). In both of these cases, none of the direct addition product 74 was 
observed but 48% and 39% yield of the carbolithiated product 73 were isolated 
respectively. As 2 equivalents of s-BuLi are required to form the carbolithiated product 73, 
at least 75% and 95% of s-BuLi has been consumed in these reactions.  
Table 2.9 
 
Entry Temp (°C) Time (min) 74 Yield (%)  73 Yield (%) 
1 0 5 0 48 
2 0 30 0 39 
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Products 73 and 74 can be identified in the 1H NMR spectrum where two different sets of 
signals are produced, one for each diastereomer. By analysing the proton adjacent to the 
phenyl and alcohol group, we can recognise different chemical shifts due to different 
environments between the two compounds. For the mixture of the diastereomic products 
74, the proton adjacent to the phenyl group should give two doublets (one for each 
diastereomer) as it couples to one proton only. In the 1H NMR spectrum of reference 
sample 74, two doublets were obtained at δ 4.53 and δ 4.44. In both of the reactions at 0 °C, 
neither of the doublets from the direct addition product 74 was observed in the 1H NMR 
spectra of the crude product. Instead, two double doublets were obtained at δ 4.64 and δ 
4.63 which are characteristic of the known diastereomeric carbolithiation product 73.15 In 
each diastereomer, the benzylic proton was coupling to an adjacent CH2 group to give the 
double doublet splitting.  
We then wanted to see if any of the carbolithiated product 73 would be formed in the high 
temperature lithiation of N-Boc pyrrolidine 1. For the lithiation, s-BuLi in THF for 5 sec 
and 30 sec at 0 °C was used and trapping with benzaldehyde (Table 2.10). The product(s) 
obtained from these reactions would indicate whether the s-BuLi had reacted with N-Boc 
pyrrolidine 1 and/or THF. In both attempts, only 25 was isolated in good yields (59% and 
60%, entries 1 and 2). No carbolithiated product 73 was found in the 1H NMR spectrum of 
the crude product despite a very careful anaylsis. Hence, the s-BuLi preferred to react with 
the N-Boc pyrrolidine 1 rather than THF at 0 °C. 
Table 2.10 
 
Entry Time (sec) 25 Yield (%) 73 Yield (%) 
1 5 59 0 
2 30 60 0 
 
Since there was no direct evidence of s-BuLi preferring to react with THF rather than N-
Boc pyrrolidine 1 at 0 °C, this led us to think of the other possibility for the decrease in 
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yields at higher temperature, namely the instability of the lithiated N-Boc pyrrolidine 75. 
We knew that the lithiation of N-Boc pyrrolidine 1 using s-BuLi at ‒30 °C for 5 min is 
sufficient to achieve a high degree of lithiation in all solvent systems. Thus, our plan for 
examining the stability of lithiated N-Boc pyrrolidine 75 was to lithiate N-Boc pyrrolidine 
1 at ‒30 °C for 5 min, and then incubate the intermediate 75 at 0 °C for a certain length of 
time. If the lithiated N-Boc pyrrolidine 75 is unstable and decomposed during the 
incubation at higher temperature, there should be a decrease in the yield of trapped product 
4. Also, we would like to see whether the ligand, TMEDA, THF or 2-MeTHF affects the 
stability of the lithiated intermediate 75 throughout the period of temperature change. 
First, 1.0 eq. of s-BuLi was stirred with N-Boc pyrrolidine 1 in THF, 2-MeTHF, Et2O with 
TMEDA or 2-MeTHF with TMEDA at ‒30 °C for 5 min. Then, the resulting solution was 
incubated at 0 °C for 5 min or 30 min before trapping with excess Me3SiCl (2 eq.) to give 
the product 4 (Table 2.11).  
Table 2.11 
 
Entry Solvent Temp (°C) Time  Yield (%) 
1 THF ‒30 5 min 66 
2 THF ‒30 °C 5 min then 0 °C 5 min 51 
3 THF ‒30 °C 5 min then 0 °C 30 min 4 
4 2-MeTHF ‒30 5 min 69 
5 2-MeTHF ‒30 °C 5 min then 0 °C 5 min 18 
6 2-MeTHF ‒30 °C 5 min then 0 °C 30 min 2 
7 Et2O with TMEDA (1.3 eq.) ‒30 5 min 73 
8 Et2O with TMEDA (1.3 eq.) ‒30 °C 5 min then 0 °C 5 min 52 
9 Et2O with TMEDA (1.3 eq.) ‒30 °C 5 min then 0 °C 30 min 0 
10 2-MeTHF with TMEDA (1.3 eq.) ‒30 5 min 76 
11 2-MeTHF with TMEDA (1.3 eq.) ‒30 °C 5 min then 0 °C 5 min 25 
12 2-MeTHF with TMEDA (1.3 eq.) ‒30 °C 5 min then 0 °C 30 min 2 
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The yield for the normal lithiation at ‒30 °C in THF for 5 min was 66% (entry 1), and it 
decreased to 51% yield after incubation for 5 min at 0 °C (entry 2). The yield further 
decreased (to 4%) when the mixture was incubated for 30 min at 0 °C (entry 3). In this 
case, there is a significant decrease of yield when the lithiated intermediate 75 was held at 
0 °C for 30 min. Similar trends were found when the same types of reactions were carried 
out in other solvents. The yield of product 4 in 2-MeTHF decreased from 69% to 18% and 
2% under the same 0 °C incubation conditions for 5 min or 30 min respectively (entries 4- 
6). Similar results were obtained for the TMEDA-mediated lithiation in Et2O or 2-MeTHF 
(entries 7-12). These results suggested that the lithiated N-Boc pyrrolidine 75 was 
chemically stable at ‒30 °C over 5 min but it started to decompose when the temperature 
was increased to 0 °C. 
Two possibilities for the breakdown of lithiated N-Boc pyrrolidine 75 at 0 °C are shown in 
Scheme 2.4. The first one is a similar route to the breakdown of lithiated THF. Lithiated N-
Boc pyrrolidine 75 could undergo reverse [3+2] cycloaddition to give ethene and 
azaenolate 76. Alternatively, the N-C bond in the ring of lithiated N-Boc pyrrolidine 75 
could break to form a carbene 77. However, by analysis of the 1H NMR spectrum of the 
crude products, we could see no evidence of any decomposition products arsing from 76 or 
77. 
Scheme 2.4 
 
From the lithiation-trapping at ‒30 °C for 5 min in all solvent systems, none of the N-Boc 
pyrrolidine 1 was recovered. However, N-Boc pyrrolidine 1 was recovered by 
chromatography from two of the incubation reactions of lithiated N-Boc pyrrolidine 75. 
For example, 20% and 24% of N-Boc pyrrolidine 1 was recovered for the incubation in 
Et2O with TMEDA and 2-MeTHF at 0 °C for 30 min respectively (entries 6 and 9). In 
these cases, we speculated that one possibility for the formation of 1 is that the lithiated N-
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Boc pyrrolidine 75 could be trapped by a proton at 0 °C from the solvents or even TMEDA. 
For example, lithiated N-Boc pyrrolidine 75 could be protonated by α-deprotonation of 
THF/2-MeTHF, β-elimination of 2-MeTHF or α-deprotonation of TMEDA to give N-Boc 
pyrrolidine 1 (Scheme 2.5). The α-deprotonation of TMEDA has been observed by 
Strohmann using t-BuLi at ‒78 °C.79 
Scheme 2.5 
 
 
In summary, the cause of the decrease in yields of lithiation-trapping of N-Boc pyrrolidine 
1 at temperatures above ‒30 °C was investigated. We initially proposed two possibilities 
for explaining the lower yield at higher temperatures. However, based on the results of our 
investigation, it is unlikely that the s-BuLi reacts with the solvent during the lithiation of 
N-Boc pyrrolidine 1 at 0 °C. Instead, we suggest that the cause of the decrease in yields of 
lithiation at temperatures > 0 °C was due to the chemical instability of the lithiated N-Boc 
pyrrolidine 75 leading to the breakdown of the lithiated intermediate. We also believed that 
the protonation of lithiated N-Boc pyrrolidine 75 by THF, 2-MeTHF or TMEDA to give N-
Boc pyrrolidine 1 is possible in certain cases. These two situations presumably also happen 
at the moment when normal lithiation takes place.  
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2.3 High Temperature Lithiation-trapping of N-Boc N'-benzyl 
Piperazine 
The high temperature (‒30 °C) diamine-free lithiation protocol that was developed by our 
group has also been applied to the lithiation-trapping of N-Boc N'-benzyl piperazine 16 as 
mentioned in Chapter 1. N-Boc N'-benzyl piperazine 16 was lithiated using s-BuLi/THF 
complex at ‒30 °C for 5 min and trapped with a range of electrophiles in high yields (55-
83%) (see Scheme 1.7). With the success of using the sustainable solvent 2-MeTHF for the 
lithiation of N-Boc pyrrolidine 1, we wanted to explore whether lithiation of N-Boc N'-
benzyl piperazine 16 could be carried out using 2-MeTHF and higher temperatures (above 
‒30 °C). We started the investigation by repeating the diamine- free lithiation at ‒78 °C 
(Table 2.12). Methyl chloroformate was chosen as the electrophile as it was known in the 
group to work well in trapping lithiated N-Boc piperazine.11  
1.3 equivalents of s-BuLi was added to N-Boc N'-benzyl piperazine 16 in THF at ‒78 °C 
and the resulting solution was stirred for 1 h. Excess of methyl chloroformate (2 eq.) was 
added afterwards to give the desired product 24 in 56% yield (entry 1). Under the same 
conditions, lithiation using 2-MeTHF in place of THF gave a good 69% yield (entry 2).  
Table 2.12 
 
Entry Solvent Yield (%) 
1 THF 56 
2 2-MeTHF 69 
 
The lithiation temperature was then raised to ‒30 °C (Table 2.13). Lithiation of N-Boc N'-
benzyl piperazine 16 in THF gave a 69% yield (entry 1). Then, we altered the reaction time 
to see if the lithiation needed as long as 5 min. By reducing the lithiation time from 5 min 
to 1 min, the yield decreased to 58% (entry 2). However, the yields were slightly better 
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when compared to the result in THF at ‒78 °C. In addition, it suggested that N-Boc N'-
benzyl piperazine 16 requires a longer lithiation time (5 min) at ‒30 °C. Hence, we 
suspected that 5 min is needed for the lithiation in 2-MeTHF. However, lithiation in 2-
MeTHF for 5 min gave a lower yield of product 24 (46%) (entry 3). As discussed in 
section 2.1, this lower yield may due to the fact that the s-BuLi/2-MeTHF complex is less 
reactive than the s-BuLi/THF complex. As a result, a longer lithiation time may be 
required to fully lithiate N-Boc N'-benzyl piperazine 16. 
Table 2.13 
 
Entry Solvent 
Time 
(min) 
24 Yield 
(%) 
Starting material 
recovery (%) 
1 THF 5 69 0 
2 THF 1 58 0 
3 2-MeTHF 5 46 0 
4 Et2O + TMEDA (1.3 eq.) 5 25 31 
5 Et2O + TMEDA (1.3 eq.) 1 24 37 
 
Surprisingly, when we tried the TMEDA-mediated lithiation in Et2O for 5 min at ‒30 °C, a 
low yield was obtained (25% yield, entry 4) with 31% of starting material recovered after 
chromatography. A similar result was achieved when the lithiation time was reduced to 1 
min: only 24% of product 24 was obtained and 37% of the starting material was recovered 
(entry 5). The recovery of the starting material was unexpected, as s-BuLi/TMEDA 
complex is a faster lithiating reagent than the s-BuLi/THF complex and it is unlikely to be 
due to an incomplete lithiation. One of the possibilities to exp lain both the low yield and 
recovery of starting material 16 is that the lithiated piperazine could be protonated by the 
more acidic proton α to the ester in product 24. The mechanism of the protonation is shown 
in Scheme 2.6. The protonation of the lithiated piperazine would give starting N-Boc N'-
benzyl piperazine 16 back as well as an enolate 78. A similar issue was observed 
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previously in our group: lithiation methyl chloroformate-trapping of N-Boc N'-benzyl 
piperazine 16 can sometimes lead to a second trapping with methyl chloroformate due to 
the more acidic α-proton of the lithiated piperazine.11 Nevertheless, this issue occurs with 
methyl chloroformate trapping only. In addition, we suspected that the lithiated 
piperazine/TMEDA complex is more basic than those with THF or 2-MeTHF and, as a 
result, the second deprotonation by the lithiated intermediate was not found in those cases.  
Scheme 2.6 
 
Subsequently, we raised the lithiation temperature to ‒20 °C (Table 2.14). As we know 
from the lithiation-trapping of N-Boc pyrrolidine 1, the lithiation for N-Boc N'-benzyl 
piperazine 16 should be completed in less than 5 min at ‒20 °C. Hence, 5 min and a shorter 
time of 1 min were investigated. Diamine-free lithiation of N-Boc N'-benzyl piperazine 16 
in THF for 5 min gave 53% yield (entry 1). The same yield was obtained when the 
lithiation time was reduced to 1 min (entry 2), suggesting that 1 min is enough to promote 
the lithiation at ‒20 °C.  
Table 2.14 
 
Entry Solvent 
Time 
(min) 
24 Yield 
(%) 
Starting material 
recovery (%) 
1 THF 5 53 0 
2 THF 1 53 0 
3 Et2O + TMEDA (1.3 eq.) 5 18 30 
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When TMEDA-mediated lithiation was carried out in Et2O at ‒20 °C, it gave a low 18% 
yield with 30% starting material recovered (entry 3) as a second deprotonation by the 
lithiated intermediate took place, leading to the recovery of the starting material. At this 
point, our results suggest that the TMEDA-mediated lithiation at high temperature is not 
ideal for N-Boc N'-benzyl piperazine 16 and therefore we only focused on the diamine-free 
lithiation for higher temperature conditions.  
We finally raised the lithiation temperature to 0 °C with lithiation times less than 1 min (30 
and 10 sec) since we believed that a shorter lithiation time would minimise the 
decomposition of lithiated piperazine. The results are summarised in Table 2.15. Lithiation 
in THF for 30 sec gave 50% yield (entry 1) whereas a lower yield was obtained when the 
lithiation time was reduced to 10 sec (33%, entry 2). Lithiation in 2-MeTHF for 30 sec has 
a lower yield than in THF under the same conditions (28%, entry 3) whereas 31% yield 
was obtained in 2-MeTHF over 10 sec (entry 4). In general, lithiation in THF for 30 sec 
provided the highest yield at 0 °C although the yield is lower compared to the same 
conditions at ‒78 °C. 
Table 2.15 
 
Entry Solvent Time (sec) Yield (%) 
1 THF 30 50 
2 THF 10 33 
3 2-MeTHF 30 28 
4 2-MeTHF 10 31 
 
In summary, we revealed that 2-MeTHF can replace THF as solvent for lithiation-trapping 
of N-Boc N'-benzyl piperazine 16 at ‒78 °C, but further work would be needed to see if 
lithiation using 2-MeTHF could give better yields than in THF at higher temperatures. The 
new optimised lithiation conditions for N-Boc N'-benzyl piperazine 16 is 0 °C for 30 sec in 
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THF for diamine-free lithiation. It appears that the high temperature TMEDA-mediated 
lithiation is not ideal for N-Boc N'-benzyl piperazine 16 when trapping with methyl 
chloroformate. For example, lithiation using Et2O with TMEDA at ‒20 °C for 5 min gave a 
low 18% yield with 30% starting material recovered (Table 2.13, entry 3). The recovery of 
the starting N-Boc N'-benzyl piperazine 16 suggested that the lithiated piperazine was 
protonated by the acidic α-proton of the product 24 as it forms. However, other 
electrophiles such as Me3SiCl which do not generate an acidic α-proton should be explored 
to try and improve the results.  
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2.4 High Temperature Lithiation-trapping of N-Boc Piperidine 
and N-Boc Azepane 
As discussed in Chapter 1, N-Boc piperidine 2 and N-Boc azepane 3 are known to undergo 
the lithiation incredibly slowly at ‒78 °C based on the group’s ReactIR study (see Figure 
1.2). Thus, a potentially long lithiation time at a higher temperature would be required for 
both substrates to fully lithiate. In addition, from the previous research by our group, the  s-
BuLi/THF complex is not reactive enough to carry out the lithiation of these substrates 
even at high temperature.15 Hence, in this part of the project, we focused on the TMEDA-
mediated lithiation-trapping of N-Boc piperidine 2 and N-Boc azepane 3 at temperatures 
above ‒78 °C. Our plan was to see if the sustainable solvent 2-MeTHF can replace Et2O 
for the reaction.  
In 1993, Beak carried out the lithiation of N-Boc azepane 3 using s-BuLi/TMEDA 
complex in Et2O at –78 °C followed by warming up to –40 °C for 1 h before the 
electrophile was added (see Scheme 1.4). Therefore, we started the investigation of the 
high temperature lithiation of N-Boc piperidine 2 by lithiating it with s-BuLi/TMEDA at 
‒40 °C in Et2O (Scheme 2.7). After trapping with PhMe2SiCl, a moderate yield (37%) of 
silyl piperidine 79 was obtained with 8% of N-Boc piperidine 2 recovered. 
Scheme 2.7 
 
TMEDA-mediated lithiation of N-Boc piperidine 2 was then carried out in 2-MeTHF under 
the same reaction conditions (Scheme 2.8). The yield of silyl product 79 decreased (23% 
yield) with some N-Boc piperidine 2 recovered (11%). Surprisingly, an unexpected product 
was isolated. The 1H NMR spectrum of this product showed the presence of three alkene 
protons (including a terminal alkene (δH 4.99 and 4.93)) and a triplet (J = 8.0 Hz) of a CH2 
group next to oxygen at δH 3.60. The 
13C NMR spectrum showed that the compound 
contained a five carbon chain with one OCH2 signal (at δC 62.5), two alkene signals (at δC 
138.0 and 114.6, due to CH=CH2) and two CH2 signals which suggested that the 
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compound was not formed from N-Boc piperidine 2. After consideration of the 1H and 13C 
NMR spectra, we suspected that the product was alkene 80 which was formed from the 
solvent 2-MeTHF in 12% yield based on s-BuLi (so was isolated together with some 
PhMe2SiCl). 
Scheme 2.8 
 
To confirm that alkene 80 was a by-product of the above reaction, an independent 
synthesis was carried out. Silylation of 4-penten-1-ol using imidazole and PhMe2SiCl gave 
silyl alkene 80 in 69% yield (Scheme 2.9). The 1H NMR spectrum of this product was 
identical to the by-product. 
Scheme 2.9 
 
As discussed in Chapter 1, we believe that the alkene product 80 was formed from 2-
MeTHF via a β-elimination mechanism to give lithium pent-4-en-1-olate 50 which was 
subsequently trapped by PhMe2SiCl to give 80 (see Scheme 1.22). Since N-Boc piperidine 
2 reacts slowly with s-BuLi/TMEDA in 2-MeTHF even at ‒40 °C, some s-BuLi has the 
chance to react with 2-MeTHF via the β-elimination mechanism (Scheme 2.10). Given that 
the β-elimination of 2-MeTHF is a considerably competitive reaction, there is less s-BuLi 
available for the piperidine lithiation. Hence, the yield of the trapped product 79 was lower 
in 2-MeTHF than in Et2O. 
Scheme 2.10 
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Based on the information of the lithiation time using ReactIR, N-Boc piperidine 2 is more 
reactive than N-Boc azepane 3 towards α-deprotonation. This allows us to consider 
whether a longer lithiation time is needed for N-Boc azepane 3 under the ‒40 °C conditions 
in Et2O or 2-MeTHF. Firstly, different lithiation times (1 or 2 h) in Et2O for lithiation of N-
Boc azepane 3 were investigated and the results are summarised in Scheme 2.11. The 
results showed that similar yields (53% and 55%) of silyl product 6 were obtained for 1 h 
and 2 h lithiation times. Some starting material 3 was recovered (12%) from the 1 h 
reaction suggesting that a 1 h lithiation time is not long enough to fully lithiate N-Boc 
azepane 3. However, leaving the lithiation 1 h longer did not lead to an improved yield of 6, 
and less 3 was recovered (6%). We also carried out the 1 h lithiation and trapped with 
PhMe2SiCl. This gave a 65% yield of silyl product 81 (Scheme 2.11).  
Scheme 2.11 
 
Since the 1 h and 2 h lithiation times gave similar results, we decided to continue the 
exploration of high temperature lithiation of N-Boc azepane 3 using ‒40 °C for 1 h and 
trapping with PhMe2SiCl. We wanted to see if 2-MeTHF can give a similar result for the 
azepane lithiation. Interestingly, the outcome of the TMEDA-mediated lithiation in 2-
MeTHF was very different to that in Et2O. A low yield of silyl product 81 was obtained 
(20%) with 55% of recovered staring material 3. Two side-products were also observed. 
Alkene 80 was isolated in 37% yield based on s-BuLi and forms via a β-elimination 
procedure.  
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Scheme 2.12 
 
A second side-product was identified as silyl-trapped 2-MeTHF 82. It was isolated in only 
1% yield as a 70:30 mixture of diastereomers from its 1H NMR spectrum. Diagnostic 
signals for 82 that allowed its identification include: δH 4.03-3.89 multiplet (1H integral) 
for the CHMe proton and two OCHSiMe2Ph double doublets at δH 3.74 and 3.57 (1H 
integration in total), as well as signals for the PhMe2Si group. The formation of 82 was 
very surprising, as we expected any lithiated 2-MeTHF to decompose via the retro [3+2] 
pathway (see Scheme 1.16) 
Thus, the low yield of silyl azepane 81 (20%) under these conditions (s-BuLi/TMEDA, 2-
MeTHF, ‒40 °C, 1 h) can be accounted for by the s-BuLi reacting in competition with the 
solvent, 2-MeTHF. We provide evidence (via isolation of 80 and 82) for two ways in 
which the s-BuLi interacts with the 2-MeTHF: β-elimination (to give 80) and α- lithiation 
with the associated likely retro [3+2] decomposition. This has revealed a key limitation of 
using 2-MeTHF as a solvent in N-Boc lithiations, especially when the N-Boc hetereocycle 
is slow to lithiate (N-Boc piperidine 2 and N-Boc azepane 3).  
However, there is a positive aspect to these results. The formation of silyl 2-MeTHF 82 is 
very interesting and relatively unprecedented. Therefore, we wondered whether it might be 
possible to optimise procedures for the α-lithiation-trapping of oxygen heterocycles. This 
led to our detailed studies which are described in Chapter 3.  
In conclusion, the slow lithiation process of the less reactive N-Boc heterocycles by s-BuLi 
is the main issue and it allows s-BuLi to react with 2-MeTHF. Hence, 2-MeTHF is a not 
suitable solvent for this chemistry.  
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2.5 Conclusions and Future Work 
The optimisation of high temperature lithiation-trapping of N-Boc pyrrolidine 1 was 
carried out. We concluded that the highest temperature for the lithiation‒trapping of N-Boc 
pyrrolidine 1 that provides good yields is 0 °C for 5 sec for both diamine-free lithiation in 
2-MeTHF and TMEDA-mediated lithiation in 2-MeTHF. The newly developed lithiation 
conditions represent an improvement as they occur at a higher temperature and require a 
shorter lithiation time compared to the original lithiation conditions reported by the Beak 
and O’Brien groups.  
Nevertheless, the lithiation using 0 °C for 5 sec conditions is not appropriate for scaling up 
to the kg-scale in batch production due to the difficult temperature control of the 
exothermic reaction. We suggest two possible solutions for this chemistry: (i) use of a flow 
reactor for the 0 °C for 5 sec conditions and (ii) use of a lower temperature under batch 
conditions (e.g. ‒20 °C). A range of electrophiles was attempted for both reaction 
conditions. In general, most of the electrophiles (benzaldehyde, DMF, Me3SiCl, CO2 and 
PhCONMe2) gave good yields of the trapped products in both reaction conditions (‒20 °C 
for 2 min and 0 °C for 5 sec) except Me2SO4 which gave a very low yield and is a 
limitation of this chemistry. In the future work, we would like to apply the 0 °C conditions 
in a flow chemistry system. 
The stability of the lithiated N-Boc pyrrolidine 75 at temperatures above ‒30 °C was 
studied. The results of the incubation experiments showed that the lithiated N-Boc 
pyrrolidine 75 is chemically unstable when the solution was warmed up from ‒30 °C. Also, 
the presence of the ligand did not significantly affect the stability of the intermediate 75. 
Two possibilities for the breakdown of lithiated N-Boc pyrrolidine 75 at 0 °C were 
proposed (see Scheme 2.4). In addition, the recovery of starting material from the 
incubation of lithiated N-Boc pyrrolidine 75 could be due to α-deprotonation of THF/2-
MeTHF or by β-deprotonation of 2-MeTHF/Et2O to give N-Boc pyrrolidine 1 (see Scheme 
2.5).  
Lithiation-trapping of N-Boc N’-benzyl piperazine 16 at higher temperatures was explored. 
2-MeTHF can replace THF as solvent for the lithiation-trapping of N-Boc N'-benzyl 
piperazine 16 at ‒78 °C, but further work is needed to show if lithiation using 2-MeTHF 
gives better yields than in THF at higher temperatures. The new optimised lithiation 
Chapter 2: Lithiat ion-trapping of N-Boc Heterocycles Above ‒78  C 
65 
 
conditions for N-Boc N'-benzyl piperazine 16 are 0 °C for 30 sec in THF for diamine-free 
lithiation. The recovery of the starting N-Boc N'-benzyl piperazine 16 suggested that the 
lithiated piperazine was protonated by the acidic α-proton of the product 78 as it forms. 
However, other electrophiles such as Me3SiCl which do not generate an acidic α-proton 
will be explored to try and improve the results. 
The exploration of high temperature lithiation-trapping of N-Boc piperidine 2 and N-Boc 
azepane 3 at ‒40 °C was carried out using s-BuLi/TMEDA in Et2O or in 2-MeTHF. Given 
that the β-elimination of 2-MeTHF by s-BuLi is a competitive reaction due to the slow 
lithiation of the less reactive N-Boc heterocycles, 2-MeTHF is a not suitable solvent for 
this chemistry. In future work, the lithiation of N-Boc piperidine 2 and N-Boc azepane 3 
using s-BuLi/TMEDA in Et2O at higher temperatures should be explored more fully. 
Below is a table that summarises the work undertaken in this Chapter. 
Substrate Newly Developed Reaction Conditions 
N-Boc pyrrolidine 1 
Flow conditions: 
0 °C for 5 sec in 2-MeTHF (TMEDA optional) 
Batch conditions: 
‒20 °C for 2 min in 2-MeTHF (TMEDA optional) 
N-Boc N'-benzyl 
piperazine 16 
0 °C for 30 sec in THF 
N-Boc piperidine 2 and 
N-Boc azepane 3 
‒40 °C for 1 h in Et2O  
(Optimal conditions to be confirmed) 
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Chapter 3: Lithiation-trapping of Oxygen 
Heterocycles  
The direct lithiation-trapping of different oxygen heterocycles by s-BuLi will be presented 
in this chapter. As discussed in Chapter 1, organolithium reagents can interact with 
solvents such as THF via α- lithiation. Our plan was to try to discover reaction conditions 
that would allow high yielding α-lithiation-trapping of oxygen heterocycles to be 
accomplished. In section 3.1, the current state of the art for the metallation-trapping of 
cyclic ethers is presented. This highlights some of the limitations. Then, in the next 
sections, lithiation-trapping of THF and 2-MeTHF (section 3.2), THP (section 3.3), 
oxetanes (section 3.4) and N-alkyl morpholines (sections 3.5) are described. 
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3.1 Overview of Routes for the Generation and α-
Functionalisation of Cyclic Ethers 
3.1.1 Direct Metallation-trapping of Cyclic Ethers 
Direct metallation of THF using organolithium reagents has been studied for the past four 
decades. As discussed in Chapter 1, although α-deprotonation of THF can be carried out by 
organolithium reagents such as n-BuLi at high temperature, it is followed by a rapid 
decomposition due to the chemical instability of the lithiated intermediate. As the stability 
of the lithiated THF is key to the metallation taking place, detailed mechanistic and kinetic 
studies of the decomposition of THF by organolithium species were carried out by 
different groups. The lithiation of THF using n-BuLi was studied by Bates and Jung in the 
1970s. Jung showed that when n-BuLi was reacted with THF at 25 °C for 16 h, THF was 
deprotonated at the α-position followed by a reverse [3+2] cycloaddition to give ethene and 
a lithium enolate (Scheme 3.1).80 The lithium enolate was trapped with Me3SiCl to give 
silyl enol ether 83 in 83% yield. Bates investigated the mechanism and half- lives of THF 
cleavage with n-BuLi by using NMR spectroscopy.46 Although he attempted to detect the 
lithiated intermediate by monitoring the reaction in an NMR tube at 35 °C, no signals were 
detected for the intermediate at this high temperature.  
Scheme 3.1 
 
In 2002, Clayden confirmed that organolithium in the presence of diamine ligands such as 
TMEDA, (‒)-sparteine and HMPA can also promote THF decomposition via C-2 or C-3 
deprotonation depending on the choice of ligand (see Scheme 1.19).49 Recently, lithiation 
of THF by a stronger base, s-BuLi, at a lower temperature (0 °C) was studied by our 
group.15 Although THF was lithiated at a lower temperature and shorter period of time (30 
min), the lithiated THF was unstable and broke down into ethene and lithium enolate. In 
this case, the ethene was further carbolithiated to give 72 and hence 73 in 58% yield after 
benzaldehyde trapping (Scheme 3.2). 
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Scheme 3.2 
 
These results suggest that the deprotonation of THF using organolithium reagents can be 
carried out at high temperature but the trapping process is unlikely to happen as the 
lithiated THF will preferentially undergo reverse [3+2] cycloaddition as a decomposition 
pathway. In 1984, Schlosser reported an effective protocol for the metallation-trapping of 
THF by using a more reactive metallating agent, an organopotassium reagent, which 
allowed the metallation to be carried out at low temperature. 81 THF as a substrate and 
solvent was reacted with a solution of n-BuK at low temperature (‒75 °C) for a short 
reaction time (15 min). The presumed organopotassium intermediate was trapped with 
Me3SiCl to give a 76% yield of silyl THF 84 (Scheme 3.3).  
Scheme 3.3 
 
As the result suggested that the organopotassium intermediate is stable at ‒75 °C, 
Schlosser further investigated the stability of the organopotassium intermediate at a higher 
temperature. The metallated intermediate was incubated at ‒50 °C for an unspecified 
length of time. It was found that the organopotassium intermediate decomposed into ethene 
and a potassium enolate.  
Metallation of 2-MeTHF with n-BuK was also carried out at ‒75 °C (Scheme 3.4). After 
trapping with Me3SiCl, a low yield (21%) of a mixture of cis/trans silyl product 85 and a 
9% yield of 4-penten-1-ol were obtained. The ratio of cis/trans diastereomers was not 
reported. 
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Scheme 3.4 
 
4-penten-1-ol was presumably formed from 2-MeTHF via a β-elimination mechanism by 
the n-BuK as shown in Scheme 3.5. This would give potassium pent-4-en-1-olate 86 which 
would give 4-penten-1-ol after work-up. A similar mechanism for organolithium reagents 
proposed by Cohen and Stokes50 was already reviewed in Chapter 1 and we also observed 
this type of product from attempted lithiation-trapping of N-Boc heterocycles as discussed 
in Chapter 2 (see section 2.4). As the methyl group at the α-position of the five-membered 
ring allows an alternative β-elimination process, less α-deprotonation occurs even at low 
temperature which leads to a low yield of the desired product.  
Scheme 3.5 
 
The attempted metallation of 2,5-dimethyl THF using n-BuK provided a similar result to 
that with 2-MeTHF. A mixture of cis/trans-2,5-dimethyl THF was reacted with n-BuK at 
‒75 °C. After initial coordination of n-BuK, β-elimination occurred to give 87 and hence 
88 in 60% yield after trapping by a proton.  
Scheme 3.6 
 
Although metallation of THF using n-BuK provided a good methodology for producing α-
substituted THF compounds, n-BuK is not commercially available and required a highly 
hazardous chemical synthesis which involved use of toxic mercury(II) chloride and very 
reactive potassium metal. The preparation of n-BuK is shown in Scheme 3.7. The process 
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is highly hazardous and against the principles of Green Chemistry and should ideally be 
avoided. This is presumably why Schlosser’s procedure has not attracted any attention 
from the synthetic organic chemistry community.  
Scheme 3.7 
 
In 2009, Mulvey suggested a pathway to stabilise α-metallated THF by using bimetallic 
bases.82,83 The strategy involved alkali-metal-mediated zincation (AMMZn). A bimetallic 
coordination compound containing sodium and zinc was able to direct the α-metallation of 
cyclic ethers. The Zn/Na complex 89 was prepared first and then THF was added as the 
substrate and the solvent. The resulting solution was stirred for an extended period (2-14 
days!). Then, the THF was removed and hexane was added to the residue at ‒30 °C to give 
the crystalline coordinated compound 90, effectively an α-metallated THF (Scheme 3.8). 
The structures of Zn/Na complexes 89 and 90 were characterised by X-ray crystallographic 
and NMR spectroscopic studies. The crystalline compound 90 was isolated and then 
trapped with benzoyl chloride in THF to give a high yield (71%) of ketone 91 (Scheme 
3.8). However, a lower yield (38%) was obtained when the trapping was attempted straight 
after compound 90 was formed in solution. Although the metallation of THF using a 
Zn/Na mixed-metal base generates a complex which is stable at 20 °C and gave a good 
yield of the trapped product, the overall reaction process was extremely slow (taking up to 
2 weeks).  
Scheme 3.8 
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Mulvey reported another bimetallic base, an Al/Li complex, that can also metallate THF. 
The preparation of the Al/Li complex is more straightforward than the Zn/Na complex. A 
2:2:1:1 mixture of n-BuLi, TMP, iBu2AlCl and THF was stirred in hexane to form the 
Al/Li complex 92 which then reacted with one molar equivalent of THF as substrate at 25 
°C overnight to give the crystalline coordinated compound 93 in 35% yield. However, 
trapping of crystalline compound 93 with electrophiles was not successful.  
Scheme 3.9 
 
In 2013, Capriati showed that the direct lithiation-trapping of mono-substituted THF, 2-
phenyltetrahydrofuran 94 (2-PhTHF), can be carried out at low temperature. 84  It is 
presumed that by introducing a phenyl group at the C-2 position of THF, the α‒proton 
becomes more acidic and hence is easier to deprotonate using s-BuLi. 2-PhTHF 94 was 
lithiated in THF at ‒78 °C for 2 min before trapping with MeOD (Table 3.1, entry 1). The 
result gave [D]-95 in 50% yield and 50% of 96 via the decomposition of the lithiated 
intermediate (which initially gives a lithium enolate). A better yield of [D]-95 (80%) was 
obtained with 20% of 96 when the s-BuLi/TMEDA complex in THF was used (entry 2). 
Capriati suggested that the presence of TMEDA slowed down the decomposition of the 
lithiated 2-PhTHF via the retro [3+2] pathway but also slowed down the lithiation rate. 
Hence, a longer lithiation time was needed (10 min). High yields of [D]-95 (90-98%) were 
obtained when non-polar solvents such as hexane and toluene were used in the presence of 
TMEDA and none of 96 was formed (entries 3-4). It is presumed that at ‒78 °C, the 
lithiated intermediate coordinating with TMEDA is stable in a non-polar solvent for a short 
time (2 min). In contrast, no deprotonation occurred in hexane or toluene when TMEDA 
was absent. 
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Table 3.1 
 
Entry 
Time 
(min) 
Temp 
(°C) Solvent 
95 
Yield (%) 
96 
Yield (%) 
1 2 ‒78 THF 50 50 
2 10 ‒78 THF + TMEDA 80 20 
3 2 ‒90 Hexane + TMEDA 90 0 
4 2 ‒78 Toluene + TMEDA >98 0 
 
It can be seen that lithiation of 2-PhTHF 94 using s-BuLi/TMEDA complex in toluene at 
‒78 °C for 2 min gave the optimised yield. A range of electrophiles were explored and the 
results are summarised in Scheme 3.10. As the results show, lithiation of 2-PhTHF 94 gave 
good yields (70-80%) at low temperature and a short lithiation time.  
Scheme 3.10 
 
There are a few examples of the metallation-trapping of the 6-membered ring, THP, mostly 
using the same types of procedures as for THF. For example, metallation-trapping of THP 
using an organopotassium reagent was studied by Schlosser. Unlike THF, metallated THP 
cannot undergo the reverse [3+2] cycloaddition. Therefore, metallation-trapping of THP 
using n-BuK was carried out at higher temperature (‒45 °C) for longer time (5 h) (Scheme 
3.11). The reaction mixture was then cooled back to ‒75 °C before trapping with Me3SiCl 
to give a 68% yield of the silyl THP 100. Using a competition experiment between THF 
and THP, Schlosser reported that THP reacted approximately 25 times slower than THF. 
Hence, a higher temperature and shorter reaction time was needed to promote the 
deprotonation step. 
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Scheme 3.11 
 
Schlosser also studied the metallation of 2-ethyl THP 101. 2-Ethyl THP 101 was 
deprotonated using n-BuK under the standard THP reaction conditions. This gave a 52% 
yield of silyl product cis-102, via a regio- and diastereoselective process.  
Scheme 3.12 
 
Although no explanation was given for the selectivity observed, regioselectivity was 
presumably a result of removal of a proton from the least sterically hindered side. We also 
propose the following explanation for the diastereoselectivity. The most stable  
conformation of 2-ethyl THP 101 will have the ethyl group in the equatorial orientation. 
Then, preferential equatorial deprotonation could occur to give cis-102 (Scheme 3.13). 
Scheme 3.13 
 
Equatorial lithiation is well-known in the lithiation-trapping of substituted N-Boc 
piperidines.29 However, in the case of 2-substituted N-Boc piperidine 103, the substituent 
favours an axial orientation to avoid the unfavourable A1,3-type strain between the Boc 
group and the substituent (Scheme 3.14). Lithiation of 2-substituted N-Boc piperidine 103, 
via equatorial deprotonation, then gives the trapped product trans-105. 
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Scheme 3.14 
 
Metallation of THP using Zn/Na complex 89 was also investigated by Mulvey.82 A mixture 
of THP and the Zn/Na complex 89 was stirred for 5 days and, due to the low reactivity of 
THP, a 1:1 mixture of 89 and 106 was obtained in 29% yield. However, the attempted 
trapping of 106 with benzoyl chloride was not successful.  
Scheme 3.15 
 
Capriati also studied the direct lithiation-trapping of 2-phenyltetrahydropyran 107 (2-
PhTHP) at low temperature.85 After the investigation of different reaction conditions, the 
optimised conditions for the lithiation of 2-PhTHP 107 was using s-BuLi/TMEDA in THF 
at ‒78 °C for 5 min. A range of electrophiles was explored and the results are summarised 
in Scheme 3.16. As the results show, lithiation of 2-PhTHP 107 gave good yields (47-98%) 
at low temperature and a short lithiation time.  
Scheme 3.16 
 
As mentioned in Chapter 1, direct lithiation of a 7-membered ring cyclic ether, oxepane 48, 
using n-BuLi has been studied by Bates and Cohen.46,50 When oxepane 48 was lithiated at 
the α-position, the lithiated intermediate underwent a transannular hydrogen shift to form 
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lithium hex-5-en-1-oxide 49. The mechanism of cleavage of the oxepane is shown in 
Scheme 3.17.  
Scheme 3.17 
 
Schlosser tried to deprotonate oxepane 48 using n-BuK at ‒45 °C for 5 h but a low yield 
(27%) of trapped product 111 was obtained (Scheme 3.18). There was no further 
information about the low yield or the formation of any side products, but it is known that 
N-Boc azepane 3 is much slower to lithiate than N-Boc pyrrolidine 1. 
Scheme 3.18 
 
Finally, Capriati has also expanded the direct lithiation-trapping methodology to the 
substituted 4-membered ring cyclic ether, 2-phenyl oxetane 112.86 2-Phenyl oxetane 112 
was successfully lithiated using s-BuLi/THF complex in THF at ‒78 °C for 5 min. In 
general, a good yield (70-95%) was obtained after the lithiated intermediate was trapped 
with a range of electrophiles (Scheme 3.19).  
Scheme 3.19 
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3.1.2 Alternative Routes to α-Lithiated Cyclic Ethers 
Apart from direct lithiation of cyclic ethers via deprotonation, there are two alternative 
synthetic pathways that can be used to give the desired α-substituted cyclic ethers via 
lithiated intermediates. One approach is tin- lithium exchange and the other is reductive 
lithiation of sulfides. Tin- lithium exchange of N-Boc heterocycles is often used to access 
lithiated intermediates particularly when studying mechanistic features. 87  McGarvey 
showed that α-substituted cyclic ethers can be achieved via tin- lithium exchange of stannyl 
cyclic ethers. 88  As shown in Scheme 3.20, stannyl THF 116 underwent tin- lithium 
exchange using n-BuLi in THF at ‒60 °C for 1 h to give the lithiated THF 117, which was 
then trapped with benzaldehyde to give a 52:48 mixture of diastereomeric alcohols 118 in 
71% yield. The high yield suggests that the lithiated THF has good stability at ‒60 °C and 
the retro [3+2] decomposition pathway is minimised under these conditions. 
Scheme 3.20 
 
Cohen provided another pathway to α- functionalise 5-membered ring cyclic ethers by 
reductive lithiation. 89  Reductive lithiation of a mixture of diastereomeric α-phenylthio 
ethers 119 with Li/DMAN complex at ‒78 °C followed by trapping with benzaldehyde 
gave an unknown mixture of diastereomeric alcohols 120 in 51% yield (Scheme 3.21). 
Scheme 3.21 
 
A similar reaction using tin- lithium exchange was carried out on the 6-membered cyclic 
ether, stannyl THP 121, at ‒60 °C (Scheme 3.22). In this case, a 51:49 mixture of 
diastereomeric alcohols 122 was formed in 76% yield. 
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Scheme 3.22 
 
Reductive lithiation of a 77:23 mixture of a diastereomeric bicyclic THPs 123 using 
Li/DMAN at ‒78 °C is shown in Scheme 3.23. One electron reduction of the C-S bond 
generates a radical which can readily interconvert its configuration. However, the axial 
radical 124 is preferred due to anomeric stabilisation from the axial oxygen lone pair. A 
second one electron reduction then gives an axial organolithium 125 as the major 
intermediate. Trapping with benzaldehyde gave a 78% yield of alcohols 126 in total with a 
95:5 mixture of axial and equatorial configurations.  
Scheme 3.23 
 
As the bicyclic THP 123 is incapable of chair-chair interconversion, Cohen examined the 
configurational stability of the lithiated intermediate by warming the axial lithiated 
intermediate from ‒78 °C to ‒30 °C. During the incubation at ‒30 °C, it was found that the 
lithiated intermediate was configurationally unstable since trapping with benzaldehyde 
gave the equatorial configuration as the major product (Scheme 3.24). 
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Scheme 3.24 
 
In summary, the reactivity of oxygen heterocycles towards α- functionalisation decreases as 
the size of the ring increase. This trend is similar to the reactivity of the ring system in N-
Boc heterocycles. The most reactive 5-membered ring, THF, can be α-metallated by n-
BuK at ‒75 °C whereas the less reactive THP and oxepane 48 require temperatures above 
‒75 °C to promote the metallation. 
 
Metallated THF has good chemical stability at ‒60 °C. When the metallation temperature 
is above ‒60 °C, decomposition via the retro [3+2] pathway occurs. However, the actual 
temperature that the retro [3+2] starts to occur is unknown. In contrast, metallated THP and 
oxepane 48 can not undergo the retro [3+2] pathway like THF. Lithiated THP is 
configurationally stable at ‒78 °C but becomes configurationally unstable when the 
temperature increases to ‒30 °C. 
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3.2 Lithiation-trapping of THF and 2-MeTHF 
As discussed in Chapter 2, we were able to isolate α-substituted silyl 2-MeTHF 82 as a 
side product from the lithiation-trapping of N-Boc azepane 3 (see Scheme 2.12). This led 
us to consider whether we could lithiate THF and 2-MeTHF and trap with electrophiles. In 
order to do this, we needed to investigate lithiation conditions that could stabilise the 
lithiated intermediate before trapping with electrophiles. With THF and 2-MeTHF, key 
factors would be the rate of the desired α- lithiation versus the rate of decomposition of the 
lithiated species via the retro [3+2] pathway. Temperature, solvent, and TMEDA were 
considered to be important factors when trying to identify suitable reac tion conditions 
(Scheme 3.25). In addition, with 2-MeTHF, the β-elimination pathway may also be 
competitive, as Schlosser found with the n-BuK metallation of 2-MeTHF (see Scheme 3.4) 
Scheme 3.25 
 
We started the investigation of THF lithiation at low temperature (‒78 °C) using THF as 
both the substrate and the solvent. We presumed that s-BuLi is relatively stable in the 
presence of TMEDA in THF at ‒78 °C and, therefore, we predicted that THF α- lithiation 
should be slow. s-BuLi was added to a mixture of TMEDA in THF solution at ‒78 °C. It 
was stirred for 1 h before adding PhMe2SiCl as the electrophile and the result is shown in 
Scheme 3.26.  
Scheme 3.26 
 
After purification by column chromatography, only a 1% yield of silyl THF 127 was 
obtained with a 63% yield of the direct trapping product, silane 128. The % yields of each 
product are based on the mmol of s-BuLi used in the reaction (since THF is in large excess 
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as it is both the solvent and the substrate). This result suggested that the s-BuLi/TMEDA 
complex is not reactive enough to lithiate THF effec tively at ‒78 °C. Thus, most of the s-
BuLi was trapped by the electrophile and led to silane 128. 
Characterisation of the two products, 127 and 128, proved their structures. In the 1H NMR 
spectrum of silyl THF 127, there were three 1H signals at δH 3.78 (ddd), 3.68 (ddd) and 
3.47 (dd) which were assigned to the three protons adjacent to oxygen. The double doublet 
(J = 11.0, 7.0 Hz) at δH 3.47 can be assigned to the α-silyl proton, with 
3J coupling to the 
two diastereotopic ring protons. The presence of a 5H multiplet at δH 7.61-7.32 and two 3H 
singlets at δH 0.34 and 0.32 confirmed the presence of the SiMe2Ph group. The 
13C NMR 
spectrum of the silyl THF 127 had 10 signals with the appropriate δC values, including a 
OCH signal at δC 71.6. The 
1H NMR spectrum of silane 128 showed there were four 3H 
signals at δH 0.94 (d), 0.90 (t), 0.25 (s) and 0.24 (s) which were assigned to the methyl 
groups of the s-butyl chain and the SiMe2Ph group. The doublet (J = 7.0 Hz) at δH 0.94 and 
the triplet (J = 7.5 Hz) at δH 0.90 are characteristic of the two methyl groups in the s-butyl 
chain. The two singlet signals at δH 0.25 and 0.24 can be assigned to the methyl groups in 
the SiMe2Ph group. All of signals in the 
13C NMR spectrum of silane 128 fitted with the 
assigned structure. 
Since the s-BuLi/TMEDA complex was not reactive enough to lithiate THF effectively at 
‒78 °C and gave a poor yield, we decided to lithiate THF at a higher temperature. 
Lithiation of THF as both the solvent and the substrate using s-BuLi/TMEDA was carried 
out at ‒40 °C. The resulting solution was stirred for 1 h before trapping with PhMe2SiCl to 
give the crude product which contained a 55:20:25 ratio of silyl THF 127, silane 128 and 
carbolithiation product 129 (by 1H NMR spectroscopy) (Scheme 3.27). Purification by 
flash column chromatography gave a very encouraging yield (29%) of silyl 127 and an 
inseparable 75:25 mixture (by 1H NMR spectroscopy) of silane 128 and carbolithiation 
product 129. This corresponds to a 5% yield of silane 128 and a 6% yield of silane 129.  
Scheme 3.27 
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As discussed in Chapter 2, carbolithiation product 129 would be formed by the retro [3+2] 
cycloaddition of the lithiated THF to give ethene and a lithium enolate, followed by 
carbolithiation of the ethene with another equivalent of s-BuLi (see Scheme 2.3). The 
diagnostic signals of the carbolithiation product 129 in the 1H NMR spectrum included two 
3H signals at δH 0.83 (d, J = 5.5 Hz) and 0.82 (t, J = 7.0 Hz) which were assigned to the 
methyl groups next to the CH and CH2 groups respectively in the s-butyl chain.  
Since silane 128 and carbolithiation product 129 were inseparable, the yields of these two 
products were calculated from the ratio of specific signals in the 1H NMR spectrum of the 
mixture which (Figure 3.1). The doublet (δH 0.94) and triplet (δH 0.90) are assigned to the 
two methyl groups in silane 128; the doublet (δH 0.83) and triplet (δH 0.82) are assigned to 
the carbolithiation product 129. Hence, the ratio of the two products was measured 
according to the integration of these two ranges and the integrations indicated that the 
mixture contains a 25:75 ratio of the silane 128 and the carbolithiation product 129. 
Figure 3.1 
 
The result of the lithiation at ‒40 °C for 1 h was very encouraging (29% yield of silyl THF 
127) and it led us to further explore the lithiation conditions at this temperature. We also 
wanted to investigate whether the TMEDA was needed for the lithiation. Hence, lithiation 
of THF was carried out using s-BuLi/THF or s-BuLi/TMEDA complex at ‒40 °C for 
various lithiation times (1 h, 40 min, 20 min and 10 min) (Table 3.2). In general, a lower 
yield of silyl THF 127 was obtained when a shorter lithiation time was carried out, 
presumably because less THF was lithiated (entries 3-7). The presence of TMEDA did not 
improve the yield of silyl THF 127 when comparing to the diamine-free protocol under the 
same lithiation time (compare entries 1/2, 3/4 and 5/6).  
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Table 3.2 
 
Entry Diamine 
Ratio of 
127:128:129a Time  
127  
Yield (%) 
128  
Yield (%)b 
129  
Yield (%)b 
1 TMEDA 55:20:25 1 h 29 5 6 
2 ‒ 50:30:20 1 h 29 11 5 
3 TMEDA 30:55:15 40 min 31 18 
Not 
recovered 
4 ‒ 40:50:10 40 min 30 27 5 
5 TMEDA 30:70:0 20 min 14 41 0 
6 ‒ 30:70:0 20 min 21 51 0 
7 TMEDA 5:95:0 10 min 11 
Not 
recovered 
0 
a
 Ratio determined from the 
1
H NMR spectrum of the crude product.  
b
 128 and 129 inseparable by chromatography. % yield determined by mass of isolated mixture of 
128 and 129 and ratio determined from the 
1
H NMR spectrum of the mixture. 
 
The presence of the carbolithiation product 129 at ‒40 °C confirmed the breakdown of 
lithiated THF after the lithiation was carried out for 40 min. Nevertheless, in all the cases, 
the total yield of the three products 127, 128 and 129 ranged from 40-72% which 
suggested some mass was lost during the reaction. In particular, reactions with longer 
reaction times gave lower mass balances. One of the possibilities was that some of the 
ethene generated from the breakdown of lithiated THF escaped as a gas (bp ‒104 °C). Thus, 
not all of the ethene reacted with another equivalent of s-BuLi to give the carbolithiation 
product 129. Overall, diamine-free lithiation of THF at ‒40 °C for 40 min provided the 
suitable balance of the lithiation rate and decomposition rate via the retro [3+2] pathway. 
Up to this point, lithiation of THF was carried out in THF as both substrate and solvent. 
We wanted to investigate whether a higher yield could be obtained in another solvent. 
Therefore, 1.0 equivalent of THF was lithiated using s-BuLi/TMEDA complex in toluene 
at ‒40 °C for 20 min (Scheme 3.28). Only a 5% yield of silyl THF 127 was obtained with 
an 8% yield of silane 128. Not surprisingly, due to the excess of toluene and high 
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temperature (‒40 °C), lithiation of toluene was the major pathway which gave a 76% yield 
of benzyl silane 130. The structure of benzyl silane 130 was confirmed by the 1H NMR 
spectrum. The 2H signal at δH 2.31 (s) is characteristic of the benzylic protons adjacent to 
the SiMe2Ph group. The data matched with those reported in the literature.
90 The presence 
of benzyl silane 130 indicated that toluene as solvent is not suitable for this chemistry.  
Scheme 3.28 
 
Subsequently, lithiation-trapping in Et2O was carried out under similar reaction conditions 
(Scheme 3.29). In this case, less than 1% yield of silyl THF 127 and an inseparable 85:15 
mixture (by 1H NMR spectroscopy) of silane 128 and carbolithiation product 129 were 
isloated. This corresponds to a 45% yield of silane 128 and a 23% yield of silane 129.  
Scheme 3.29 
 
The yield of silane 128 is similar to the lithiation in THF as both substrate and solvent 
under the same reaction conditions (Table 3.2, entry 5), which suggests that a similar 
amount of s-BuLi reacted with PhMe2SiCl. However, the yield of the desired product is 
much lower and we suspected the s-BuLi was not only reacting with THF but also with 
Et2O. As discussed in Chapter 1, deprotonation of Et2O using organolithiums can be 
achieved to give ethene and lithium ethoxide (see Scheme 1.15). The carbolithiation of 
ethene with another equivalent of s-BuLi can then be carried out to give the 129 (Scheme 
3.30). In this experiment, 23% yield of the carbolithiation product 129 was isolated and we 
presumed that it could be obtained from THF and Et2O. Based on the result, Et2O as 
solvent is not suitable for THF lithiation.  
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Scheme 3.30 
 
As THF and Et2O can both potentially react with the s-BuLi, we ideally required a non-
polar solvent that would not provide an acidic proton for deprotonation which would 
consume the s-BuLi. Hence, lithiation of THF in hexane under similar reaction conditions 
was carried out. 1.0 equivalent of THF was lithiated using s-BuLi/TMEDA complex in 
hexane at ‒40 °C for 20 min. This gave a 10% yield of the silyl product 127 together with 
a 37% yield of silane 128 (Scheme 3.31). This result was very similar to the one in THF 
under similar conditions (Table 3.2, entry 5).  
Scheme 3.31 
 
In summary, the lithiation-trapping of THF in different solvents was explored and the use 
of THF as both the substrate and the solvent provided the best results. In addition, there 
was no benefit of introducing TMEDA in the reaction mixture. Based on the results of the 
optimisation, we concluded that lithiation using s-BuLi/THF at ‒40 °C for 40 min were the 
best conditions as they provide a suitable balance between the rate of lithiation and the rate 
of decomposition of the lithiated intermediate via the retro [3+2] pathway. Thus, lithiation 
of THF was carried out under the newly developed conditions and trapping with a range of 
electrophiles to give the results shown in Scheme 3.32. Yields ranged from 20-32% of the 
products that were obtained. 
Scheme 3.32 
 
Chapter 3: Lithiat ion-trapping of Oxygen Heterocycles   
85 
 
Both 1H and 13C NMR spectra of these three products confirmed that the lithiation-trapping 
had taken place. For the benzaldehyde trapping of the lithiated THF, it gave a 60:40 
mixture (by 1H NMR spectroscopy) of diastereomeric hydroxy THFs 118 in a total of 20% 
yield. As the diastereomeric hydroxy THFs 118 were inseparable, the ratio was calculated 
from the 1H NMR spectrum of the mixture which (Figure 3.2). The two 1H double doublet 
signals at δH 4.91 and 4.42, which are assigned to the proton adjacent to the phenyl and OH 
group, indicated that the mixture contains a 60:40 ratio of diastereomeric hydroxy THFs 
118. Spectroscopic data were consistent with those reported in the literature.88 
Figure 3.2 
 
For comparison, lithiation-trapping of 2-MeTHF was explored. We started the 
investigation of 2-MeTHF lithiation at low temperature (‒78 °C) in the knowledge that β-
elimination of a proton in the methyl group would probably be a competing reaction.  
Lithiation of 2-MeTHF as substrate and solvent using s-BuLi/TMEDA complex at ‒78 °C 
was carried out for 1 h before trapping with PhMe2SiCl as the electrophile (Scheme 3.33). 
After purification, a 31% yield of β-elimination product, silyl ether alkene 80, was 
obtained with 20% yield of 2-butanol 132 and a 4% yield of silane 128.  
Scheme 3.33 
 
There was no evidence of formation of the α- lithiaiton-trapping product. Clearly, β-
elimination of the methyl group occurs readily at ‒78 °C (31% yield of 80). The formation 
of 2-butanol 132 from s-BuLi reactions normally indicates that some oxygen was present 
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in the reaction set-up. The initial result suggested that 2-MeTHF is more reactive than THF 
at ‒78 °C. However, instead of the α-deprotonation of 2-MeTHF, s-BuLi preferred to 
deprotonate the β-proton in the methyl group which led to product 80. 
Next, the diamine-free version of this lithiation was explored at ‒78 °C (Scheme 3.34). The 
result was disappointing as neither α-substituted 2-MeTHF 82 nor the β-elimination 
product 80 was obtained. Only a 63% yield of direct-trapping product, silane 128 was 
isolated. This result indicated that the s-BuLi/2-MeTHF complex is not reactive to 
deprotonate at ‒78 °C, at either the α- or β-position. 
Scheme 3.34 
 
Since the s-BuLi/2-MeTHF complex is not reactive for deprotonation at low temperature, 
we decided to explore the lithiation at higher temperatures. Lithiation of 2-MeTHF using s-
BuLi/TMEDA complex at ‒40 °C was carried out (Scheme 3.35). After trapping with 
PhMe2SiCl, no α-substituted 2-MeTHF 82 was found but an inseparable 85:15 mixture (by 
1H NMR spectroscopy) of silyl ether alkenes 80 and 133 was isolated. This corresponds to 
a 52% yield of alkene 80 and a 9% yield of alkene 133. 
Scheme 3.35 
 
 
In the 1H NMR spectrum of the silyl ether alkene mixture, there were five 1H signals at δH 
5.79 (ddt), 5.50-5.39 (m), 5.29-5.18 (m), 4.99 (ddt) and 4.93 (ddt) which were assigned to 
alkene protons (Figure 3.3). When comparing the 1H NMR spectrum of this mixture with 
the independent synthesis of the silyl ether alkene 80 (see Scheme 2.9), it indicated that the 
signals at δH 5.50-5.39 (m) and 5.29-5.18 (m) belong to alkene 133 and the chemical shifts 
differ to the terminal alkene 80 (including a terminal alkene (δH 4.99 and 4.93) and a ddt 
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(δH 5.79). Based on the 
1H NMR spectrum, it suggested that the newly formed alkene 133 
has a similar structure to terminal alkene 80 but with a different alkene chain.  
Figure 3.3 
 
Although an independent synthesis of internal alkene 133 was not carried out, we 
compared the 1H NMR spectroscopic data to known internal alkenes 134 and 135 with a 
different silyl protecting group (Figure 3.4). The chemical shifts of the alkene protons for 
(E)-alkene 134 are δH 5.53-5.37
91 and for (Z)-alkene 135 are δH 6.06-4.83.
 92 Based on the 
1H NMR spectroscopic data, we tentatively assigned the internal alkene product as 133 
(with an E-alkene stereochemistry). 
Figure 3.4 
 
The synthesis route of (E)-alkene 133 from 2-MeTHF has not been reported before. We 
suggest two possible pathways for formation of the internal alkene (Scheme 3.36). s-BuLi 
could remove a β-proton in a β-elimination pathway to give lithiated alkoxide 136. 
However, it should be noted that the geometry is unfavourable for E2-elimination in these 
five-membered ring compounds and the reverse 5-endo-trig is a Baldwin-disfavoured 
reaction (see Scheme 1.18).93 The other possible pathway involves the α- lithiation of 2-
MeTHF to give 137 followed by a 1,2-hydride shift to give 136. However, this pathway is 
unlikely to happen due to the steric hindrance of the α-proton by the methyl group.  
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Scheme 3.36 
 
Based on the TMEDA-mediated reactions at ‒78 °C and ‒40 °C, we suspected that the s-
BuLi/TMEDA complex favoured the β-elimination pathway over the α-deprotonation. In 
order to investigate whether the presence of TMEDA is important for the lithiation-
trapping of 2-MeTHF, lithiation of 2-MeTHF was carried out in the absence of TMEDA at 
‒40 °C (Scheme 3.37). In this reaction, two inseparable mixture, a 20:10:70 mixture (by 1H 
NMR spectroscopy) of terminal alkene 80, internal alkene 133 and silyl 2-MeTHF 82 and 
a 75:25 mixture (by 1H NMR spectroscopy) of terminal alkene 80 and internal alkene 133, 
were isolated. In total, this corresponds to a 4.5% yield of the desired silyl 2-MeTHF 82, a 
9% yield of terminal alkene 80 and a 3.5% yield of internal alkene 133. 
Scheme 3.37 
 
The formation of silyl 2-MeTHF 82 under the diamine-free lithiation conditions was 
encouraging. Based on our results, we presume that the TMEDA is a more activating 
ligand for β-elimination than 2-MeTHF. 
We then investigated whether the lithiation could be carried out in Et2O under similar 
reaction conditions (Scheme 3.38). However, the 1H NMR spectrum of the crude product 
showed no identifiable products. 
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Scheme 3.38 
 
In summary, reaction conditions for the lithiation-trapping of 2-MeTHF were explored. 
Based on the results, the lithiation works best when using diamine-free conditions in 2-
MeTHF as substrate and solvent at ‒40 °C for 1 h. However, less than 5% yield of the α-
substituted 2-MeTHF 82 was obtained. TMEDA is considered to be an important factor for 
the 2-MeTHF lithiation as the β-elimination pathway (either at the methyl group or at the 
C-3 position) is more favourable when s-BuLi/TMEDA was used. 
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3.3 Lithiation-trapping of THP 
In this section, lithiation of the 6-membered ring oxygen heterocycle, THP, was studied. 
As discussed before, Schlosser reported that THP reacted approximately 25 times slower 
than THF, so we expected lithiation to be slower and it is likely that higher temperatures 
would be needed.81 Unlike THF, the advantage of THP is that metallated THP could not 
undergo a retro [3+2] pathway for decomposition. Thus, the lithiation of THP might work 
satisfactorily at high temperatures. The inert solvent, hexanes was chosen for the lithiation 
of THP as it could be used at higher temperatures. Therefore, we started the investigation 
using 1 equivalent of THP as substrate lithiated using the s-BuLi/TMEDA in hexane at ‒30 
°C (Scheme 3.39). The solution was stirred at ‒30 °C for 1 h before trapping with 
benzaldehyde as the electrophile. However, no α-substituted THP 122 was found in the 1H 
NMR spectrum of the crude product. Instead, only the direct trapping product, alcohol 74 
was observed.  
Scheme 3.39 
 
As we suspected that the s-BuLi/TMEDA complex was not reactive enough to lithiate THP 
at ‒30 °C, a higher temperature (0 °C) with longer lithiation times (1 or 2 h) were explored 
and the results are summarised in Table 3.3. In general, lithiation for both 1 and 2 h gave 
similar yields of a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 
122 (29% and 26% respectively). As the diastereomeric alcohols 122 were inseparable, the 
ratio was calculated from the 1H NMR spectrum of the mixture. The two 1H doublet 
signals at δH 4.83 and 4.43 which were assigned to the proton adjacent to the phenyl and 
OH group, indicated that the mixture contains a 50:50 ratio of diastereomers. 
Spectroscopic data were consistent with those reported in the literature.127  
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Table 3.3 
 
Entry Time (h) 122 Yield (%) 74 Yield (%) 
1 1 29 38 
2 2 26 18 
 
Based on the yield of the alcohol 74, it appeared that more lithiation occurred for the 2 h 
lithiation. However, less diastereomeric alcohols 122 were formed. Presumably, the 
lithiated THP was chemically unstable and decomposed during the longer lithiation time. 
One of the possible decomposition pathways is the ring-opening of the lithiated THP 
which can generate carbene 138 (Scheme 3.40). Currently, however, we have no evidence 
to identify the decomposition pathway of the lithiated THP. 
Scheme 3.40 
 
Although lithiation for 1 h gave a slightly higher yield of diastereomeric alcohol 122, we 
wanted to see if a better yield could be achieved by using THP as substrate and solvent for 
a 2 h lithiation using s-BuLi/TMEDA (Scheme 3.41). Surprisingly, the 1H NMR spectrum 
of the crude product showed no identified products. We presume that all of the s-BuLi 
reacted with THP to generate lithiated THP which is chemically unstable during 2 h and 
this led to decomposition (via the pathway we suggest in Scheme 3.40) to unidentified 
compounds. 
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Scheme 3.41 
 
In summary, lithiation of THP can be achieved using s-BuLi/TMEDA complex in hexane 
at 0 °C for 1 h. However, as the lithiated THP is chemically unstable at 0 °C for a certain 
amount of time, more investigation is needed to identify the optimised lithiation conditions.  
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3.4 Synthesis and Lithiation-trapping of Substituted Oxetanes 
In this part of the project, we decided to explore the synthesis and α- functionalisation of 
the 4-membered cyclic ether, oxetane. Our proposed plans are summarised in Scheme 3.42. 
In one project, we planned to synthesise bicyclic N-Boc pyrrolidine oxetane 139 (starting 
from N-Boc pyrrolidine 1) and study its lithiation-trapping. There are two possible 
deprotonation sites for s-BuLi to lithiate the α-substituted N-Boc pyrrolidine oxetane 139 
(either α-position to the pyrrolidine ring or the oxetane ring). We hoped to identify 
conditions that would lead to α-nitrogen (to give 140) and α-oxygen (to give 141) lithiation. 
In the second project, more simple oxetane 143 (with suitable R groups to ensure that the 
oxetanes were not too volatile to work with) would be synthesised from diethyl malonate 
142. Then, their α- lithiation-trapping would be studied to give 144, including 
diastereoselectivity aspects.  
Scheme 3.42 
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3.4.1 Introduction to Oxetanes and Oxetane Synthesis 
There is an increase of interest in compounds containing the oxetane in medicinal 
chemistry in the last two decades. The initial attention began as some pharmaceutical 
studies suggested that the 3-substituted oxetane is a good alternative group for carbonyl 
groups. 94 ,95 ,96  By comparing the electrophilic reactivity of the carbonyl group and 3-
substituted oxetanes, compounds containing carbonyl groups might cause undesirable 
covalent binding whereas the more sterically hindered oxetanes could reduce any 
unwanted binding. Moreover, 3-substituted oxetanes and aliphatic carbonyl groups have a 
similarly high hydrogen bonding activity. Thus, compounds with oxetanes as surrogates 
for carbonyls are becoming more common as versatile building blocks in drug- like 
structures. In addition, oxetanes can also be considered a polar alternative to gem-dimethyl 
groups, which are commonly found in medicinal chemistry to introduce steric bulk. By 
comparing the carbonyl, oxetanyl and gem-dimethyl group (Figure 3.5), the oxetanyl group 
has the largest volume of occupancy and deeper oxygen placement suggesting a better 
shielding to prevent unnecessary covalent binding.  
Figure 3.5 
 
The pharmaceutical interest of oxetane was also extended to 2-substituted oxetanes as it is 
present in many natural products with a range of biological activities (Figure 3.6). For 
example, oxetanocin A was first isolated from the soil bacterium Bacillus megaterium 
NK84-0218 which inhibits the replication of HIV. 97  Oxetin was isolated from the 
fermentation broth of Streptomyces sp. OM-2317 and initial studies suggested that it 
presents herbicidal as well as antibacterial effects. 98  Bradyoxetin was found to be an 
extracellular secreted factor that is involved in symbiotic gene regulation in soybean. 99 The 
synthetic routes to these oxetane molecules involve different synthetic strategies but 
generally the formation of 2-substituted oxetanes involves intramolecular Williamson ether 
synthesis. 
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Figure 3.6 
 
In 2008, Roger-Evans et al. studied a selection of spirocyclic oxetane amines which 
provide interesting 3-D-shapes building blocks for drug discovery (Figure 3.7).95 By 
studying the physicochemical and biochemical properties of the spirocyclic oxetane amines 
145-149 and compared them with the corresponding cyclic ketoamines and gem-dimethyl-
substituted amines, they suggested that oxetane could be considered as a surrogate in the 
spirocyclic amines by introducing steric bulk to the molecules without increasing 
lipophilicity, while at the same time increasing aqueous solubility and keeping the 
metabolic stability of the compound.  
Figure 3.7 
 
There are not many published synthetic routes to spirocyclic oxetane amines. In 2008, 
Carreira and co-workers reported a method to synthesise spirocyclic oxetane amine 146 
(Scheme 3.43). Aldehyde 151 was prepared by reaction of commercially available oxetan-
3-one 150 with the formylmethylene Wittig reagent. After the conjugate addition of an 
amine, a Wittig reaction gave 152. Finally, cyclisation via electrophilic addition gave the 
desired oxetane 146. In this approach, the oxetane ring was present at the start. Although 
oxetan-3-one 150 is commercially available, its expensive price is one of the limitations for 
this synthetic route.  
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Scheme 3.43 
 
Xu et al. illustrated a different strategy to construct the oxetane ring from the readily 
available starting material ethyl isonipecotate 153 (Scheme 3.44).100 Boc protection and 
addition of an ester at C-4 gave diester 154. Reduction of diester 154 was carried out using 
LiBH4 to give diol 155 in 39% yield. Diol 155 was cyclised to oxetane 156 via mono-
tosylate. Tosylation of one alcohol of 155 was achieved using 1 equivalent of n-BuLi and 
TsCl. Addition of another 1.0 equivalent of n-BuLi deprotonated the alcohol (at 60 °C) 
which then cyclised to give oxetane 156 in 65% yield (Scheme 3.44). 
Scheme 3.44 
 
3.4.2 Attempted Synthesis of N-Boc 2-oxa-5-azaspiro-[3,4] octane 
Since the synthesis of α-substituted N-Boc pyrrolidine oxetane 139 has not been reported 
before, we wondered whether we could synthesise it via a lithiation route. Our proposed 
plan is shown in Scheme 3.45. In 2010, our group reported the conversion of N-Boc 
pyrrolidine 1 into α,α-disubstituted methyl ester pyrrolidine 70 using 2.6 equivalent of s-
BuLi and 3.0 equivalent of MeO2CCl.
15 Thus, we planned to use this procedure to prepare 
70. Next, based on the procedures in Scheme 3.44, we would synthesise the oxetane ring 
via reduction of diester 70 to diol 157 followed by cyclisation. 
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Scheme 3.45 
 
To start with, we investigated a range of conditions for the double lithiation-trapping of N-
Boc pyrrolidine 1. The results are shown in Table 3.4. In general, double lithiation-
trapping using s-BuLi/THF complex at ‒78 °C gave the best yield (60%) of di-ester 70 
with 10% of single substituted product 22 (entry 1). Subsequently, higher temperature 
lithiation in THF at ‒30 °C was attempted but the yield was lower (50% yield) (entry 2). 
We presumed that the excess of s-BuLi affected the yield and generated more side-
products in the reaction. Thus, lithiation at ‒30 °C for 5 min with a reduced amount (2.0 
eq.) of s-BuLi was tried but the yield of di-ester 70 improved only slightly with more 
mono-ester 22 isolated (18% yield) (entry 3). Lithiation at ‒20 °C gave a lower yield of di-
ester 70 (45% yield) and this possibly suggested that the lithiated intermediate was 
chemically unstable and decomposed (entry 4).  
Table 3.4 
 
 
Entry 
 
Solvent 
s-BuLi 
(eq.) 
Temp 
(°C) 
 
Time  
70 
Yield (%) 
22 
Yield (%) 
1 THF 2.6 ‒78 1 h 60 10 
2 THF 2.6 ‒30 5 min 50 7 
3 THF 2.0 ‒30 5 min 53 18 
4 THF 2.2 ‒20 5 min 45 14 
5 2-MeTHF 2.6 ‒78 1 h 53 24 
6 2-MeTHF 2.2 ‒20 5 min 38 26 
7 Et2O with TMEDA 2.6 ‒30 5 min 21 0 
8 2-MeTHF with TMEDA 2.6 ‒78 1 h 24 30 
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In comparison to diamine-free lithiation in THF, lithiation using the s-BuLi/2-MeTHF 
complex generally gave a lower yield of di-ester 70 (38-53% yield) (entries 5-6). More 
mono-ester 22 were found in the reactions (24-26% yield) suggesting the s-BuLi/2-MeTHF 
complex is less efficient in carrying out the enolate formation. TMEDA-mediated lithiation 
in Et2O and 2-MeTHF generally gave poor yields (21-24%) of di-ester 70 (entries 7 and 8).  
In summary, double lithiation-trapping N-Boc pyrrolidine 1 using the s-BuLi/THF 
complex at ‒78 °C gave the best yield (60%) of di-ester 70. There was no difference in the 
yields of di-ester 70 but more mono-ester 22 generated when the equivalents of s-BuLi 
were reduced. This suggested that 2.0 equivalent was not enough to carry out full double 
lithiation.  
Next, di-ester 70 was reduced using LiAlH4 to give a 51% yield of diol 157 (Scheme 3.46). 
We then tried the cyclisation to give oxetane 139 via the tosylation of diol 157. Treatment 
of diol 157 with 1 equivalent of n-BuLi and TsCl at 0 °C for 1 h should have given the 
mono-tosylate. Addition of another 1.0 equivalent of n-BuLi and reaction for 1 h at 0 °C 
did not give oxetane 139. A longer reaction time for the cyclisation step was attempted but 
no oxetane 139 was found. 
Scheme 3.46 
 
One of the possibilities to explain the unsuccessful cyclisation is that after the tosylation of 
one alcohol, the other alcohol was deprotonated by another equivalent of n-BuLi. Instead 
of attacking the carbon next to the tosylated oxygen to form the oxetane ring, it could 
cyclise onto the carbonyl in the Boc group to give 158 (Scheme 3.47). However, we could 
find no evidence for 158 in the 1H NMR spectrum of the crude product.  
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Scheme 3.47 
 
In summary, the synthesis of N-Boc pyrrolidine oxetane 139 has been explored. The best 
reaction conditions for the double lithiation of N-Boc pyrrolidine 1 are 2.6 equivalent of s-
BuLi at ‒78 °C for 1 h in THF. However, the cyclisation of diol 157 was unsuccessful. It is 
presumed that the second deprotonated alcohol cyclised onto the carbonyl in the Boc group 
instead of the attacking the carbon next to the tosylated oxygen. Further investigation is 
needed for the characterisation the tosylated pyrrolidine separately before the final 
cyclisation step. 
3.4.3 Synthesis and Lithiation-trapping of 3-substitued Oxetanes  
In this part of the project, synthesis and lithiation of 3-substitued oxetanes was carried out. 
Our plan to synthesise 3-substitued oxetanes 168, 169 and 170 is shown in Scheme 3.48. 
The general route involves simple steps 101 , 102  from the inexpensive starting material, 
diethyl malonate 142 or dimethyl benzyl malonate 159, via alkylation of the malonate, 
reduction of the ester, mono-tosylation and cyclisation to give 3-substitued oxetanes 168, 
169 and 170.  
Scheme 3.48 
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We started with the alkylation of diethyl malonate 142 using NaH in DMF at 0 °C 
(Scheme 3.49). The mixture was then stirred with 1-bromohexane overnight at rt to give 2-
hexylmalonate 160 in 85% yield following a literature procedure.103 A second alkylation of 
2-hexylmalonate 160 can be carried out under the same reaction conditions and this gave 
gave 2,2-dihexylmalonate 161 in 87% yield (Scheme 3.49).  
Scheme 3.49 
 
Reduction of 3-substituted malonates 159, 160 and 161 was carried out using 4 equivalents 
of LiAlH4 in Et2O or THF at 0 °C (Scheme 3.50). The reaction mixtures were then warmed 
to rt for 3 h to give diols 162-164 in very good yields (85-93%). The full conversion of the 
reactions was confirmed by the 1H NMR spectrum. For example, the 1H NMR spectrum of 
diol 162 showed that there were two new ddd signals (4H integration) at δH 3.81 and 3.68 
which suggested that the carbonyl group had been reduced to a CH2 group. The 
13C NMR 
spectrum also indicated that the carbon signal for the carbonyl group (δC 174.5 in 160) 
disappeared and there was a new signal at δC 65.7 due to the new OCH2 group. The 
spectroscopic data of diols 162, 163 and 164 were all consistent with those reported in the 
literature.104,105,106 
Scheme 3.50 
 
Subsequently, diols 162, 163 and 164 were deprotonated by 1 equivalent of n-BuLi at 0 °C. 
Then, p-TsCl was added to give good yields (83-90%) of tosylates 165, 166 and 167 
(Scheme 3.51). The 1H and 13C NMR spectra of tosylates 165, 166 and 167 confirmed that 
only one alcohol had been tosylated. 
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Scheme 3.51 
 
A literature procedure for the cyclisation of tosylate 165 was then followed.100 Tosylate 
165 was cyclised by using 1 equivalent of n-BuLi in THF at 0 °C. The reaction solution 
was heated at 60 °C for 6 h to give 3-benzyl oxetane 168 in a moderate 43% yield (Scheme 
3.52). The 1H NMR spectrum of 3-benzyl oxetane 168 confirmed that the product contains 
4 protons adjacent to oxygen, each integrating for 2H, with signals at δH 4.79 (dd) and 4.48 
(dd). 
Scheme 3.52 
 
We then tried an alternative cyclisation pathway to see if the yield could be improved. 
Tosylate 165 was deprotonated by using 3 equivalents of NaH in DMF at 0 °C. Then, the 
solution was allowed to warm to rt for 2 h to give the desired product in 44% yield 
(Scheme 3.53). Although both of the cyclisation procedures gave a very similar yield, we 
decided to cyclise tosylates 166 and 167 using NaH as it did not require heating.  
Scheme 3.53 
 
Cyclisation of tosylate 166 using the NaH reaction conditions gave a good yield of 3-
hexyloxetane 169 (71%). However, frustratingly, when the reaction was repeated under the 
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same reaction conditions, only a 15% yield of oxetane 169 was isolated and a 50:50 
mixture (by 1H NMR spectroscopy) of diastereomeric tosylates 171 (9% yield) was also 
observed. The formation of tosylates 171 was due to the lithium alkoxide reacting with 
another tosylate 166. The presence of this compound explained the low yield of the desired 
product, oxetane 169, as two equivalents of tosylate 166 are consumed for the formation of 
it. This result may also suggest that the intermolecular reaction of tosylate 165 could have 
happened here to account for the low yield (44%) of oxetane 168. However, we did not 
find any evidence for the intermolecular reaction of tosylate 165. 
Scheme 3.54 
 
Next, the cyclisation of tosylate 167 using the NaH reaction conditions was carried out but 
it was unsuccessful (Scheme 3.55). One of the possibilities to explain this result is that an 
intermolecular reaction occurred (as with 166). However, the 1H NMR spectrum of the 
crude product showed no identifiable products. 
Scheme 3.55 
 
After the successful synthesis of oxetanes 168 and 169, the lithiation-trapping of both these 
3-substituted oxetanes was explored at low temperature. 3-Benzyl oxetane 168 was 
lithiated using s-BuLi/TMEDA in Et2O at ‒78 °C before trapping with PhMe2SiCl 
(Scheme 3.56). This gave a 77% yield of silane 128 and an inseparable 66:34 mixture (by 
1H NMR spectroscopy) of silylated oxetane 172 and PhMe2SiCl. This corresponds to a 
16% yield of silylated oxetane 172. In this reaction, deprotonation did not take place at the 
α-oxygen position but at the benzylic position. This suggested that the benzylic proton is 
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more acidic and could be a competitive site for deprotonation. In addition, a significant 
amount of silane 128 was recovered indicating that the lithiation was slow at ‒78 °C. 
Scheme 3.56 
 
Since the s-BuLi/TMEDA complex did not lend to α-deprotonation at low temperature 
(‒78 °C), we decided to explore the lithiation at higher temperatures. The potential 
drawback for high temperature lithiation of 3-benzyl oxetane 168 was that the 
deprotonation of the benzylic proton would be competing with the desired α-deprotonation. 
Lithiation of 3-benzyl oxetane 168 using s-BuLi/TMEDA complex was attempted at ‒40 
°C for 2 h (Scheme 3.57). However, the 1H NMR spectrum of the crude product showed no 
identifiable products. We suspected that some of the s-BuLi might have reacted with Et2O 
at ‒40 °C, so we decided to investigate the lithiation conditions using hexane as solvent at 
similar reaction conditions. Disappointingly, no identifiable product was found. Since there 
was no starting material 168 or direct trapping product, silane 128 recovered, we suspected 
that the s-BuLi reacted with the oxetane 168 and, the lithiated oxetane is chemically 
unstable at ‒40 °C and decomposed. 
Scheme 3.57 
 
Hence, lithiation in hexane was carried out at ‒40 °C for a shorter lithiation time. After 
lithiating in hexane at ‒40 °C for 1 h and trapping with a different electrophile, 
benzophenone, no desired product was formed (Scheme 3.58). 
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Scheme 3.58 
 
Since the lithiation gave no product at ‒40 °C, we decided to lithiate 3-benzyl oxetane 168 
at ‒20 °C. However, lithiation using s-BuLi/TMEDA at ‒20 °C gave the direct trapping 
product, silane 128 (25% yield), and an unidentified mixture (Scheme 3.59). No starting 
material 168 or the α-substituted product 173 was found. 
Scheme 3.59 
 
Next, lithiation-trapping of 3-hexyl oxetane 169 was explored. Unlike the competitive 
benzylic proton deprotonation of 3-benzyl oxetane 168, deprotonation of 3-hexyl oxetane 
169 should only occur at the α-oxygen position. Hence, lithiation of 3-hexyl oxetane 169 
using s-BuLi/TMEDA in Et2O was carried out at ‒78 °C followed by trapping with 
benzaldehyde (Scheme 3.60). In this reaction, a 64% yield of a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 74 was obtained, together with a 57% yield of 
recovered starting material. The recovery of the 3-hexyl oxetane 169 and the large amount 
of the direct trapping product 74 formed suggested that the lithiation of 3-hexyl oxetane 
169 was slow at ‒78 °C. 
Scheme 3.60 
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Subsequently, lithiation of 3-hexyl oxetane 169 was explored at higher temperatures. 3-
hexyl oxetane 169 was lithiated using s-BuLi/TMEDA in Et2O at ‒40 °C (Scheme 3.61). 
After trapping with benzaldehyde, the crude product contained a 56:44 mixture (by 1H 
NMR spectroscopy) of diastereomeric alcohols 74 and starting material 169. As the 1H 
NMR spectroscopy of the crude product showed no α-substituted product, we decided to 
investigate the lithiation conditions using hexane as solvent under similar reaction 
conditions. 
Scheme 3.61 
 
TMEDA-mediated lithiation in hexane was carried out under similar reaction conditions at 
‒40 °C which is shown in Scheme 3.62. Disappointingly, a similar result was obtained. 
The reaction gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 
74 (70% yield) and starting material 169 (64% yield). 
Scheme 3.62 
 
The recovery of a large amount of the starting material 169 for the lithiation at ‒40 °C 
indicated that the 3-hexyl oxetane 169 is not a reactive substrate. Hence, we decided to 
lithiate 3-hexyl oxetane 169 under similar reaction conditions at ‒20 °C (Scheme 3.63). 
However, the 1H NMR spectrum of the crude product showed no desired product, Instead, 
a 55:45 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 74 and starting 
material 169 was formed.  
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Scheme 3.63 
 
Finally, the lithiation of 3-hexyl oxetane 169 was attempted at 0 °C (Scheme 3.64). 
However, 1H NMR spectroscopy of the crude product showed no desired product and 
purification was not attempted. 
Scheme 3.64 
 
In summary, the synthesis and α-functionalisation of 3-substituted oxetanes 168, 169 and 
170 was explored. The synthetic route to 3-substituted oxetanes 168, 169 and 170 via 
alkylation of the malonate, reduction of the ester and tosylation generally gave very good 
yields. Cyclisation of 3-benzyl tosylate 165 using 3 equivalents of NaH in DMF at 0 °C 
gave a moderate yield of 3-benzyl oxetane 168 (44%). When cyclisation of 3-hexyl 
tosylate 166 using similar reaction conditions was carried out, an intermolecular reaction 
of the alkoxide with another tosylate 166 occurred. The lithiation-trapping of 3-benzyl 
oxetane 168 and 3-hexyl oxetane 169 was attempted at ‒78 °C, ‒40 °C, ‒20 °C and 0 °C in 
different solvents. In the lithiation of 168 at ‒78 °C, deprotonation did not take place at the 
α-oxygen position but at the benzylic position to form the silylated oxetane 172. This 
suggested that the benzylic proton is more acidic and it could be a competitive site for 
deprotonation. Disappointingly, all attempts at the α-lithiation-trapping of 3-substituted 
oxetanes were unsuccessful.  
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3.5 Lithiation-trapping of N-Substituted Morpholines 
In this part of the project, an exploration of α- functionalisation of N-substituted 
morpholines using lithiation-trapping methodology will be presented. Based on the 
previous studies with N-Boc heterocycles within our group, the lithiation of N-Boc-N’-
benzyl piperazine 16 takes a relatively shorter time than the lithiation of N-Boc piperidine 
3 (Figure 3.8). Since the lithiation of THP is very slow, this led us to consider whether a 
similar trend will be observed on the reactivity of oxygen heterocycles, and that the N-
substituted morpholines 176 will be more reactive towards lithiation than THP. In addition, 
decomposition of the lithiated morpholine via the retro [3+2] pathway would not be an 
issue. 
Figure 3.8 
 
Hence, lithiation-trapping of N-substituted morpholines 176 with different R groups will be 
studied (including diastereoselectivity by introducing a chiral R group), along with a full 
exploration of the reaction conditions and limitations of the methodology (Scheme 3.65). 
Scheme 3.65 
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3.5.1 Introduction to Morpholines and 2-substituted Morpholine Synthesis 
Morpholines are six-membered heterocycles that contain both amine and ether functional 
groups. Substituted morpholine derivatives are commonly found as sub-units in various 
natural products and biologically active compounds (Figure 3.9). For example, an α-
substituted morpholine, mosapride citrate, is a gastroprokinetic agent that acts as a 
selective 5HT4 agonist to treat severe reflux oesophagitis or gastroesophageal reflux 
disease (GORD), to relieve symptoms like heartburn and dyspepsia. 107 A 2,6-disubstituted 
morpholine derivative, Chelonin C, is a natural product that is isolated from the marine 
sponge Chelonaplysilla sp. It exhibited antimicrobial activity against Bacillus subtilis and 
also an anti- inflammatory effect. 108 ,109  Noradrenaline reuptake inhibitor, Reboxetine, is 
used in the treatment of depressive disorder.6 It is marketed as a racemic mixture of the 
(R,R) and (S,S) enantiomers but recent studies suggested that (S,S)-Reboxetine is more 
potent than its enantiomer with a better affinity and selectivity for the noradrenaline 
transporter (NAT).110 
Figure 3.9 
 
Although 2-substituted morpholines are often used as building blocks for a range of 
biologically active compounds, currently there is a very limited methodology for the direct 
introduction of functionality at the C-2 position α to oxygen.111  Given that there is an 
increase of interest in compounds containing 2-substituted morpholines, there are a 
growing number of publications on developing different synthetic strategies. Generally, the 
synthesis of morpholines with a 2-substituent requires multiple steps to construct the 
morpholine ring, and substituents are often introduced with enantioselectivity at an early 
stage.  
In 1998, Servi reported a chemo-enzymatic synthetic route to construct the N-H 
morpholine ring with a substituent adjacent to the oxygen (Scheme 3.66). 112 
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Enantioselective reduction of aldehyde 178 using an excess of Baker’s yeast and 
XAD1180 resin in water gave bromo alcohol (S)-179 in good yields and good % ee. 
Bromo alcohol (S)-179 was then cyclised using NaOH to give benzyl epoxide 180 with (R) 
configuration. Benzyl epoxide (R)-180 was reacted with ethanolamine-O-sulfate and 
NaOH to give (R)-181 and subsequent cyclisation using NaOH gave 2-benzyl morpholine 
(R)-182. 
Scheme 3.66 
 
Lindsley illustrated a different strategy for the enantioselective synthesis of 2-substituted 
morpholines (R)-187 via α-chlorination of aldehydes using organocatalysis (Scheme 
3.67). 113  2-Chloro alcohol (S)-185 was prepared by α-chlorination of aldehydes using 
Jørgensen catalyst 184.  
Scheme 3.67 
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After the reduction of the aldehyde using NaBH4, activation of 2-chloro alcohol 185 with 
trific anhydride and nucleophilic substitution with N-benzylethanolamine gave (S)-186 in 
good yields. Finally, base- induced cyclisation of (S)-186 gave the desired 2-substituted N-
benzyl morpholine (R)-187 in 35-46% overall yields with 80-98% ee. Four different 
substituents were demonstrated in a five-step procedure. 
As mentioned before, Reboxetine is an effective compound used in the treatment of 
depressive disorder and it has been widely studied for its pharmacological properties. 
Given the higher degree of interest in one of the enantiomers, (S,S)-Reboxetine, there is 
much demand in developing enantiomerically enriched synthesis routes. Generally, the 
synthesis of (S,S)-Reboxetine proceeds via the intermediate hydroxyl morpholine (S,S)-188 
with different N-protecting groups. As a result, numerous research groups have developed 
different strategies for the asymmetric synthesis of hydroxyl morpholine (S,S)-188. The 
challenges for the preparation of enantiomerically pure 2-substituted morpholine (S,S)-188 
are the long synthetic sequences and the choice of starting materials. There are other 
synthetic strategies for the formation of 2-substituted morpholine (S,S)-188 but only three 
examples are listed here for brevity (Scheme 3.68).  
Scheme 3.68 
 
In 2005, Tamagnan reported an asymmetric synthesis of (S,S)-Reboxetine via a new route 
to (S)-2-(hydroxymethyl)morpholine.114 Their approach was to build the chiral morpholine 
moiety 188 before introducing the phenyl group and arloxy groups (Scheme 3.69). The 
synthesis started from commercially available 3-amino-1,2-propanediol (S)-189. Reaction 
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with chloroacetyl chloride gave amide 192 which was cyclised using t-BuOK to give 
morpholinone 193. The morpholinone 13 was then reduced using Red-Al to 194 and Boc-
protected to give 195. Oxidation of 195 was initially attempted under Swern conditions but 
significant epimerization was observed. Consequently, oxidation using TEMPO under 
catalytic conditions gave aldehyde 196 in high enantiomeric purity. The phenyl group was 
introduced by adding aldehyde 196 to Ph2Zn which was prepared in situ from PhMgBr and 
anhydrous ZnBr2. The resulting diastereomers (2S,3S)-197 and (2S,3R)-197 were separated 
by flash chromatography and isolated in 60% and 19% respectively. 
Scheme 3.69 
 
In 2008, Cossy reported an alternative route for the synthesis of intermediate morpholine 
(S,S)-197 via a catalytic stereospecific rearrangement of β-amino alcohols.115 The synthesis 
started with the N,N-dibenzylation of the commercially available 190 to give the 
corresponding tertiary amine 198 (Scheme 3.70). Reaction of amine 198 with (CF3CO)2O 
gave the rearranged amine 199. Subsequently, the benzyl group was removed to give 200 
and substituted with chloroacetyl chloride to obtain 201. Cyclisation using t-BuOK 
followed by another two-step sequence of oxidation and Boc protection gave (2S,3S)-197. 
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Scheme 3.70 
 
Recently, Lee provided a short synthetic sequence that enables simultaneous 
stereochemical control of two contiguous stereogenic centres in a single step. The 
approach involves asymmetric transfer hydrogenation (ATH) of 2-substituted 
morpholinone 203 using a chiral transition metal catalyst (Scheme 3.71).  
Scheme 3.71 
 
  
Chapter 3: Lithiat ion-trapping of Oxygen Heterocycles   
113 
 
The racemic 2-substituted morpholinone 203 was prepared by Claisen condensation of 
morpholinone 191 and morpholine 202 using LDA. When the Ru-cataylst 204 was 
employed for the asymmetric transfer hydrogenation, an enantioselective reduction of the 
ketone took place to give (2R,3S)-205. The excellent stereoselectivity was due to the C-2 
proton in 203 being configurationally labile, which results in a rapid racemisation of the 
substrate under the ATH reaction conditions. The reaction thus proceeds via a dynamic 
kinetic resolution. Finally, morpholinone 205 was reduced using BH3•THF to give (2S,3S)-
197. 
Although these three examples provided (2S,3S)-188 in high enantiomeric purity, most of 
these methods required the utilisation of expensive chiral catalysts or long (6-7 steps) 
reaction sequences.  
The most related precedent for our proposed lithiation-trapping approach to 2-substituted 
morpholines was reported by Breuning. In 2009, Breuning reported an effective protocol 
for the direct lithiation of 9-oxabispidines 207-210 using s-BuLi which enabled stable α-
lithio ethers to be formed and trapped with electrophiles (Table 3.5). Deprotonation of 207-
210 using s-BuLi at ‒78 °C in Et2O followed by quenching with CD3OD gave the 
monodeuterated oxabispidines 211-214 in good yields (75-89%) and with high deuterium 
incorporation (73-100%) (entries 1-3). 
Table 3.5 
 
Entry 
Starting 
material 
 
R1 R2 Product 
Isolated 
yield (%) 
D incorporation 
(%) A/Ba 
1 207 H Me 211A 89 100 211A = 211B 
2 208 Et Me 212A 86 85 100:0 
3 209 Ph Me 213A 75 73 100:0 
4 210 -(CH2)4- 214 85 100 55:45 
a
 Ratio determined from the 
1
H NMR spectrum. 
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The formation of regioisomers 212A and 213A from the unsymmetric bicyclic systems 208 
and 209 indicated a strong steric hindrance of the bridgehead proton at C-1 by the 
substituents (Et and Ph groups) (entries 2 and 3). However, there was no significant 
differentiation in the deprotonation of tricyclic diamine 210 (entry 4). Oxabispidines 207-
210 benefit from double activation (two β-nitrogen atoms) which explains the successful α-
lithiation at ‒78 °C. 
Breuning also investigated the use of a weaker organolithium under the same reaction 
conditions. However, no reaction was observed at ‒78 °C with n-BuLi. The presence of a 
ligand in the reaction was also studied although the result indicated that an extra ligand (e.g. 
(‒)-sparteine or TMEDA) is not required to activate the deprotonation.  
When the tricyclic oxabispidines 210 was lithiated and slowly warmed to room 
temperature in the absence of an electrophile, a rearrangement reaction occurred (Scheme 
3.72). By quenching the crude mixture with D2O, they were able to obtain a 44% yield of a 
32:29:29:10 mixture (by NMR spectroscopy) of compounds 215-217. 
Scheme 3.72 
 
A mechanism for the deprotonation-rearrangement of 210 was proposed. The initial 
unselective deprotonation of 210 would give the lithiated intermediate 219 and 220 at ‒78 
°C (Scheme 3.73). As the temperature increased, the lithiated intermediates would become 
chemically unstable and β-elimination would occur. For the formation of 223 and 224, 
intramolecular cyclisation of the amide group in 221 and 222 towards the enol ether could 
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take place to form 223 and 224, which would then be deuterated to give the observed 
products 215 and 216. In contrast, the formation of 217 and 218 is probably due to the fact 
that the intermediate 221 was lithiated again to give the stabilised allylic anion 225. 
However, the intermediate 222 appeared to be resistant for further lithiation. Hence, 
intermediate 226 is unlikely to happen. 
Scheme 3.73 
 
In summary, there is limited methodology to directly introduce functionalities into 
morpholines at the C-2 position. Functionalisation of morpholine with a 2-substituent often 
requires multiple synthetic steps and substituents are often introduced with 
enantioselectivity at the early stage, mostly before the cyclisation step. However, it 
requires using reactive materials, expensive catalysts and long synthetic steps to construct 
the enantiopure morpholine. The only lithiation-trapping route to 2-substituted 
morpholines is a very specific substrates, oxabispidines, as reported by Breuning. 
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3.5.2 Lithiation-trapping of N-substituted Morpholines 
Since the direct functionalisation of monocyclic N-substituted morpholines has not been 
reported before, we wondered whether we could apply our newly developed α-oxygen 
lithiation methodology to morpholine derivatives. Based on the previous studies within our 
group, N-Boc morpholine 227 was found to undergo lithiation extremely rapidly at the α-
nitrogen position even at low temperature. The lithiation reached completion within one 
minute when using the s-BuLi/(–)-sparteine complex at ‒78 °C (as shown by ReactIR 
spectroscopy).11,12 When the lithiation was carried out using 2.6 equivalents of s-BuLi/(–)-
sparteine, rapid deprotonation resulted in the formation of lithiated intermediate 228 which 
was found to be unstable (Scheme 3.74). Under the reaction conditions, the lithiated 
intermediate 228 undergoes ring-opening to give alkoxide 229. After a subsequent vinylic 
lithiation which gave 230, the intermediate was trapped with benzophenone and 
subsequent intramolecular cyclisation gave oxazolidinone 231 in 40% yield.  
Scheme 3.74 
 
As N-Boc morpholine 227 would lithiate at the α-nitrogen position, we considered whether 
morpholine lithiation could be achieved at the α-oxygen position with a different N-
protecting group. Hence, lithiation-trapping of morpholine with different N-protecting 
groups is studied in this section.  
We started the investigation by using commercially available N-methyl morpholine 232. 1 
equivalent of N-methyl morpholine 232 was lithiated using s-BuLi/TMEDA in hexane at 
‒40 °C (Scheme 3.75). The reaction mixture was stirred for 1 h before trapping with 
benzaldehyde as the electrophile. After purification by column chromatography, an 
inseparable 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 233 was 
isolated in 15% yield. We also isloated an inseparable 50:50 mixture (by 1H NMR 
spectroscopy) of the direct trapping product, diastereomeric alcohols 74, in 81% yield.  
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Scheme 3.75 
 
To confirm that the isolated product was the desired 2-substituted morpholine 233, the 
structure was carefully analysed by 1H NMR spectroscopy. There were three signals at δH 
4.03-3.92 (m, 1H), 3.79-3.67 (m, 1.5H) and 3.62 (ddd, 0.5H) which were assigned to 
protons adjacent to the oxygen, together with signals between δH 2.66-1.85 (4H) which 
were assigned to protons adjacent to the nitrogen. This confirmed that the lithiation-
trapping took place at the C-2 α-oxygen position. As the diastereomeric alcohols 233 were 
inseparable, the ratio was calculated from the two 1H broad singlets at δH 4.89 and 4.52 
which were assigned to the proton adjacent to the phenyl group and OH group.  
Then, lithiation of N-methyl morpholine 232 was carried out using s-BuLi/TMEDA in 
Et2O at ‒40 °C (Scheme 3.76). A similar yield of a 50:50 mixture (by 
1H NMR 
spectroscopy) of diastereomeric alcohols 233 was isolated (16%). The reaction also gave a 
34% yield of diastereomeric alcohols 74 and the carbolithiation product 73 in 30% yield 
(based on 2 equivalents of s-BuLi). Since the carbolithiation product can only a generated 
from the solvent, Et2O is not a suitable solvent for this chemistry.  
Scheme 3.76 
 
The result of the lithiation at ‒40 °C for 1 h was an encouraging 15% yield of 
diastereomeric alcohols 233 with complete α-oxygen regioselectivity. However, the high 
yield of alcohols 74 suggested that the s-BuLi was not reacting completely with the 
morpholine at ‒40 °C for 1 h. It led us to further explore the lithiation conditions. Hence, 
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lithiation of N-methyl morpholine 232 was carried out using s-BuLi/TMEDA at various 
temperatures and lithiation times (Table 3.6). When morpholine 232 was lithiated at ‒40 
°C for a longer time (3 h), the yield of the desired product increased to 42% with a 
decrease in the yield of alcohols 74 (entry 2). In general, as the lithiation temperature 
increased, higher yields of diastereomeric alcohols 233 were isolated. At 0 °C, lithiation 
for 1 h gave an excellent 89% yield of diastereomeric alcohols 233 with only a 2% yield of 
alcohols 74 (entry 6). Since we used an excess of s-BuLi (1.3 eq.) for the lithiation, we 
believe that the lithiation was fully completed in 1 h at 0 °C. When the lithiation was 
carried out at 20 °C for shorter lithiation times, the yields of the desired product 233 were 
lower (entries 7-8) but with no trace of alcohols 74 found. This suggested to us that the 
lithiated morpholine was chemically unstable at 20 °C and decomposed to some extent.  
Table 3.6 
 
Entry Temp (°C) Time  233 Yield (%) 74 Yield (%) 
1 ‒40 1h 15 81 
2 ‒40 3h 42 52 
3 ‒30 1h 40 52 
4 ‒30 2 h 49 37 
5 ‒20 1h 63 43 
6 0 1h 89 2 
7 20 10 min 66 0 
8 20 30 min 48 0 
 
Up to this point, the conditions using s-BuLi/TMEDA in hexane at 0 °C for 1 h gave the 
best yield of the 2-substituted morpholine 232. When the lithiation takes place in 
cyclohexane under similar reaction conditions, a similar high yield of diastereomeric 
alcohols 233 were obtained (82%) (Scheme 3.77). 
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Scheme 3.77 
 
As discussed in section 3.5.1, lithiation of bicyclic morpholines 207-209 does not require 
an extra diamine to activate the lithiation. Hence, we wanted to investigate whether 
TMEDA is needed for our new morpholine lithiation. Lithiation-trapping of N-methyl 
morpholine 232 was performed using s-BuLi with various equivalents of TMEDA at 0 °C 
for various lithiation times. The results are summarised in Table 3.7.  
Lithiation using the standard 1.3 equivalents of TMEDA gave the highest yield of 
diastereomeric alcohols 233 (89%) (entry 1). As the equivalents of TMEDA were reduced 
from 1.3 to 0.1 for reactions under the same conditions, the yields of the desired products 
decreased (68-82%) with more alcohols 74 being generated (5-16%) (entries 2-4). This 
trend suggested that the lithiation of N-methyl morpholine 232 was not completed within 1 
h at 0 °C when catalytic TMEDA was used.  
Subsequently, we decided to carry out the catalytic lithiation for longer lithiation times. 
Despite this, lithiation using 0.05 equivalents of TMEDA for 2 h gave a lower 68% yield 
of diastereomeric alcohols 233 and a 16% yield of alcohols 74 (entry 5). An even worse 
yield of diastereomeric alcohols 233 was obtained (27%) when the lithiation was carried 
out with 0.01 equivalents and a 4 h lithiation time (entry 6). When diamine-free lithiation 
was carried out in hexane for 1 h, there was no desired product 233 formed but a 74% yield 
of alcohols 74 was isolated (entry 6). A longer reaction time (2 h) for the diamine-free 
conditions in hexane was unsuccessful as well (entry 8). Based on the results of the 
catalytic lithiation, TMEDA is required to activate the s-BuLi for lithiation of N-methyl 
morpholine 232. As the equivalents of TMEDA were decreased in the lithiation, a longer 
reaction time was necessary to allow the deprotonation to proceed towards completion. 
However, the fact that a lithiation that is catalytic in TMEDA could be achieved is a 
significant discovery.  
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Table 3.7 
 
Entry TMEDA (eq.) Time (h)  233 Yield (%) 74 Yield (%) 
1 1.3 1 89 2 
2 0.5 1 82 9 
3 0.2 1 79 15 
4 0.1 1 72 15 
5 0.05 2 68 16 
6 0.01 4 27 48 
7 0 1 0 74 
8 0 2 0 89 
 
 
To confirm that the TMEDA is essential to activate the s-BuLi for lithiation of N-methyl 
morpholine 232, we set up a control reaction. Firstly, N-methyl morpholine 232 was 
lithiated in the absence of TMEDA at 0 °C for 1 h (Scheme 3.78). The resulting reaction 
mixture was then mixed with 1.3 equivalents of TMEDA for another hour and trapped with 
benzaldehyde. This gave a 65% yield of diastereomeric alcohols 233 and a 12% yield of 
alcohols 74. 
Scheme 3.78 
 
In summary, reaction conditions for the lithiation-trapping of N-methyl morpholine 232 
were explored. Based on the optimisation, lithiation using s-BuLi and 1.3 equivalents of 
TMEDA in hexane at 0 °C for 1 h gave the highest yield (89%) of the desired 2-substituted 
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morpholine 233. Thus, lithiation of N-methyl morpholine 232 was carried out under the 
newly-developed conditions and trapping with a range of electrophiles gave the results 
shown in Scheme 3.79. Generally, excellent yields, ranging from 75-90% of the products, 
were obtained. 
Scheme 3.79 
 
Both the 1H and 13C NMR spectra of these products confirmed that the lithiation-trapping 
had taken place at the α-oxygen position. For the PhMe2SiCl trapping of the lithiated 
morpholine, a 90% yield of silyl morpholine 234 was obtained and we were able to assign 
all of the protons in the 1H NMR spectrum (Figure 3.10). In the 1H NMR spectrum of silyl 
morpholine 234, there are three 1H signals at δH 3.87 (ddd, HC), 3.60 (ddd, HB) and 3.52 
(dd, HA) which were assigned to protons next to the oxygen. Based on the J values of the 
signals of HA (J = 12.0 and 2.5 Hz), we confirmed that the substituent sits in the expected 
equatorial position. There are four signals with different coupling for protons next to the 
nitrogen of the ring. The signal at δH 2.66 (dddd) was assigned to HD as it has a small W-
coupling (J = 2.0 Hz) with HD.  
Figure 3.10  
 
For comparison, lithiation-trapping of morpholines with different N-protecting groups was 
explored next. We chose to investigate the N-benzyl group due to its ready deprotection via 
hydrogenolysis. Thus, N-benzyl morpholine 237 needed to be prepared. 
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The first attempt for benzyl protection of morpholine was using a procedure reported by 
Khan. 116  Morpholine was reacted with K2CO3 in THF and BnCl to give N-benzyl 
morpholine 237 (Scheme 3.80). However, the 1H NMR spectrum of the crude product 
showed that no N-benzyl morpholine 237 had been formed. 
Scheme 3.80 
 
Subsequently, an alternative synthesis of N-benzyl morpholine 238 was carried out by 
using AcCl in MeOH to form the morpholine hydrochloride salt as an intermediate. 
Afterwards, it was reacted with BnBr and Et3N, but, no N-benzyl morpholine 238 formed 
(Scheme 3.81). 
Scheme 3.81 
 
We then followed a literature procedure from Zhang. 117  BnBr was added to a stirred 
solution of morpholine and Et3N in THF at room temperature. The resulting mixture was 
allowed to stir for 16 h to give a good yield of N-benzyl morpholine 237 (95%) (Scheme 
3.82). 
Scheme 3.82 
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After the successful benzyl protection of morpholine 238, lithiation-trapping of N-benzyl 
morpholine 237 was carried out using the optimised reaction conditions for N-methyl 
morpholine 232. Thus, N-benzyl morpholine 237 was lithiated using s-BuLi with 1.3 
equivalents of TMEDA in hexane at 0 °C for 1 h (Scheme 3.83). The lithiated morpholine 
was then trapped with PhCONMe2 as electrophile to give a 44% yield of ketone 
morpholine 239. The structure of the mono-substituted morpholine 239 was confirmed by 
comparison with the data in the literature.118 Surprisingly, an unexpected product 240 was 
also isolated and characterised.  
Scheme 3.83 
 
The 1H NMR spectrum of the unexpected compound showed the presence of fourteen 
aromatic protons between δH 7.89-7.23 which suggested there were two benzoyl 
substituents attached in the compound. There are three possible sites where N-benzyl 
morpholine 237 could in principle be deprotonated, as shown in Figure 3.11. They are the 
desired α- lithiation process (HA), benzylic deprotonation (HB) and ortho-lithiation (HC). To 
determine which two of these positions had reacted, careful analysis of the 1H and 13C 
NMR spectra was carried out. 
Figure 3.11 
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Firstly, we wanted to confirmed that α-lithiation had also happened in the unexpected 
product 240. Based on the three 1H signals (δH 4.31 (dd), 3.75 (ddd) and 3.26 (ddd)) which 
were assigned to protons adjacent to oxygen, we assumed that α-deprotonation had taken 
place as expected. Since we had observed the deprotonation of the benzylic proton in 3-
benzyl oxetane 168 (see section 3.4.3), we wondered if this could also have happened in 
this case. However, there were two benzylic proton signals at δH 3.52 and 3.48 which 
indicated that the deprotonation of the benzylic proton did not occur. Deprotonation of HC 
via ortho-lithiation is well known and the total number of aromatic protons matched with 
the 1H NMR spectrum, suggesting that ortho-lithiation had indeed occurred. The 13C NMR 
spectrum confirmed that there were three ipso-Ar signals at δC 139.2 , 137.8 and 137.4, 
along with two signals at δC 77.2 (OCH) and 66.3 (OCH2). Therefore, we assigned the 
structure of the di-substituted morpholine as 240. In this reaction, a 14% yield of di-
substituted morpholine 240 was obtained and it shows that the N-benzyl group is not a 
useful protecting group for α- lithiation-trapping. It is interesting that we only observed two 
products (239 and 240) from the reaction. We believe that di-substituted morpholine 240 is 
most likely formed via a dianion in which α- lithiation and ortho-lithiation have occurred. 
For comparison, lithiation of N-benzyl morpholine 237 was carried out under the same 
reaction conditions and subsequently trapped with benzaldehyde (Scheme 3.84). In this 
reaction, a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric mono-substituted 
morpholines 206 in 56% yield was obtained, along with and a 48:32:12:8 mixture (by 1H 
NMR spectroscopy) of diastereomeric di-substituted morpholines 241 in 17% yield.  
Scheme 3.84 
 
As the diastereomeric di-substituted morpholines 241 were inseparable, the ratio of the 
four diastereomers was calculated from the 1H NMR spectrum of the mixture (selected 
signals shown in Figure 3.12). There are two 1H broad singlet signals at δH 5.84 and 5.69 
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which were assigned to HB at the ortho-lithiation position. The dd 1H signal at δH 4.94 and 
the multiplet 1H signal between δH 4.55-4.47 were assigned to HA. Integration of all of 
these signals indicated that the mixture contains a 48:32:12:8 ratio of diastereomers. 
Figure 3.12 
                        
The characterisation of diastereomeric di-substituted morpholines 241 was confirmed by 
performing an oxidation using DMP to oxidize the alcohols to ketones (Scheme 3.85). The 
idea was to reduce the number of chiral centres to one which would simplify the 1H NMR 
spectrum. Furthermore, the spectroscopic data of the oxidized product were consistent with 
those from the PhCONMe2-trapping. DMP oxidation of the mono-substituted morpholine 
206 was also carried out (Scheme 3.85).  
Scheme 3.85 
 
Since the formation of di-substituted morpholine 241 would have consumed 2 equivalents 
of s-BuLi, we wondered if lithiating N-benzyl morpholine 237 at a lower temperature, the 
H
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rate of ortho-lithiation would be reduced. This could lead to an increase in yield of the 
desired mono-substituted product. Hence, lithiation of N-benzyl morpholine 237 at 
different temperatures (0 °C and ‒30 °C) was carried out, trapping with PhMe2SiCl (Table 
3.8). Firstly, lithiation at 0 °C for 1 h gave a 42% yield of mono-silyl morpholine 242 and a 
15% yield of di-silyl morpholine 243 (entry 1). When the lithiation was performed at ‒30 
°C for 1 h, it gave a slightly lower yield of mono-silyl morpholine 242 (37%) and a very 
similar yield of di-silyl product 243 (16%) (entry 2). When the lithiation at ‒30 °C was 
carried out for a longer reaction time (3 h), only mono-silyl morpholine 242 was obtained 
in a very similar yield (40%) (entry 3).  
Table 3.8 
 
Entry Temp (°C) Time (h)  242 Yield (%) 243 Yield (%) 
1 0 1 h 42 15 
2 ‒30 1 h 37 16 
3 ‒30 3 h 40 0 
 
In summary, lithiation-trapping of N-benzyl morpholine 237 was explored. Generally, the 
yields of 2-substituted morpholines were lower than the related products with the N-methyl 
protecting group. This was due to α- and ortho-lithiations occurring to generate a 
dilithiated intermediate, which consumed 2 equivalents of s-BuLi. Scheme 3.86 shows a 
summary of the lithiation of N-benzyl morpholine 237 at 0 °C for 1 h and trapping with a 
range of electrophiles. Yields ranged from 42-55% of the products that were obtained. 
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Scheme 3.86 
 
Since ortho-lithiation appeared to be the major reason for the low yields in the lithiation-
trapping of N-benzyl morpholine 239, we decided to introduce a more sterically hindered 
N-alkyl group, the (S)-α-methylbenzyl group, in the hope that it would reduce the side-
reaction. In addition, the (S)-α-methylbenzyl group could act as a chiral auxiliary. It might 
have slight preference for removal of a specific proton and give high diastereoselectivities. 
The use if this chiral auxiliary on a N-Boc piperazine 16 had previously been shown to be 
successful in our group (see Scheme 1.12) Hence, the lithiation-trapping of morpholine 
(S)-246 with an (S)-α-methylbenzyl group was explored.  
First, (S)-4-(1-phenylethyl) morpholine 246 needed to be synthesised from a chiral amine 
with dichlorodiethyl ether to construct the morpholine ring. The synthesis was carried out 
by followed a literature procedure that was carried out on a similar compound.119 Thus, 
(S)-(‒)-α-methylbenzylamine 245 was treated with K2CO3 and KI in n-BuOH at 0 °C. The 
resulting solution was stirred at 0 °C for 15 min before 2,2'-dichlorodiethyl ether was 
added. The reaction mixture was then heated at 100 °C for 16 h to give (S)-4-(1-
phenylethyl) morpholine 246 in 94% yield (Scheme 3.87). 
Scheme 3.87 
 
After the successful synthesis of (S)-4-(1-phenylethyl) morpholine 246, it was then 
subjected to lithiation using s-BuLi/TMEDA in hexane at 0 °C (Scheme 3.88). The 
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reaction mixture was stirred for 1 h and trapped with PhMe2SiCl to give a 50:50 mixture 
(by 1H NMR spectroscopy) of diastereomeric silyl morpholine 247a and 247b in the crude 
product. After chromatography, silyl morpholines 247a (23%) and 247b (37%) were 
isolated separately. The total yield of silyl morpholines 247a and 247b was 60%. We have 
been unable to assign the stereochemistry in 247a and 247b. 
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Scheme 3.88 
 
When (S)-4-(1-phenylethyl) morpholine 246 was lithiated under the same reaction 
conditions and trapped with benzophenone, it gave a 50:50 mixture of diastereomeric 
alcohols 248a and 248b by 1H NMR spectroscopy of the crude product. Alcohols 248a and 
248b were partially separable and isolated in a total of 52%. 
Scheme 3.89 
 
The overall yield of silyl morpholines 247a and 247b (60%) is higher than the yield of N-
benzyl silyl morpholine 242 (42%) (Scheme 3.86). Similarly, the overall yield of alcohols 
248a and 248b (52%) is higher than the corresponding N-benzyl reaction (44%) (Scheme 
3.86). Thus, greater steric hindrance in the N-alkyl group did appear to have reduced the 
amount of ortho-lithiation. Due to the (S)-α-methylbenzyl group, it was possible to 
separate the diastereomeric silyl morpholines 247a and 247b and alcohols 238a/248b, and 
this provides access to enantiopure α-substituted products. However, with a 
diastereoselectivity of 50:50, the process showed no selectivity. The poor 
diastereoselectivity was disappointing but understandable given the large distance between 
the chiral auxiliary and the site of deprotonation.  
We then decided to carry out the lithiation at a lower temperature to see if the 
diastereoselectivity could be improved. However, lithiation at ‒30 °C for 1 h also gave a 
50:50 mixture (by 1H NMR spectroscopy) of silyl morpholines 247a and 247b (Scheme 
3.90). After purification, an 8% yield of silyl morpholine 247a and a 12% yield of silyl 
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morpholine 247b were obtained. The total yield of silyl morpholines 247a and 247b was 
20%. Clearly, 1 h was not long enough for s-BuLi to deprotonate (S)-4-(1-phenylethyl) 
morpholine 246 at this lower temperature  
Scheme 3.90 
 
Since the diastereoselectivity of the formation of silyl morpholines 247a and 247b did not 
improve at lower temperature, we decided to investigate the asymmetric lithiation of (S)-4-
(1-phenylethyl) morpholine 246 using chiral diamines. Based on the results with a N-Boc 
piperazine, the chiral auxiliary gave a slightly favoured preference for the removal of the 
pro-(R) proton. Thus, introducing a chiral diamine that also favoured the removal of the 
pro-(R) proton should give a ‘matched’ case  and potentially improve the 
diastereoselectivity. In order to improve the diastereoselectivity and to reduce problems 
due to the potential configurational instability of the lithiated intermediate, a lower 
temperature (‒40 °C) and a longer lithiation time (5 h) was employed. To simplify the 
results, only the combined total yield of 248a and 248b after trapping with benzophenone 
and purification by chromatography is shown (Table 3.9).  
Firstly, lithiation using s-BuLi/TMEDA was carried out and trapped with benzophenone. 
The crude product, which contained a 60:40 mixture of 248a and 248b (by 1H NMR 
spectroscopy), was purified and gave 248 in 41% 248a and 248b total yield and recovered 
starting material 246 in 46% yield (entry 1). The large amount of starting material 
recovered indicated that the lithiation did not complete within 5 h. Subsequently, lithiation 
using s-BuLi/(+)-sparteine surrogate was carried out. Disappointingly, the crude product 
contained a 51:49 mixture of 248a and 248b (by 1H NMR spectroscopy) was formed (entry 
2). A better total yield of 248a and 248b was obtained (63%) presumably due to the higher 
reactivity of the s-BuLi/(+)-sparteine surrogate complex. There was also an 11% yield of 
recovered starting material 246. The result suggested that (+)-sparteine surrogate and the 
(S)-α-methylbenzyl group were a mismatched combination. Lithiation using s-BuLi/(‒)-
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sparteine was also carried out under the same conditions to give the crude product, which 
contained a 54:46 mixture of 248a and 248b (by 1H NMR spectroscopy) (entry 3). This 
disappointing result showed that the s-BuLi/(‒)-sparteine complex did not provide a better 
diastereomeric ratio. A lower total yield of 248a and 248b was obtained (31%) with a 62% 
yield of recovered starting material 246, indicating the expected slower rate of lithiation of 
the s-BuLi/(‒)-sparteine complex. 
Table 3.9 
 
Entry Diamine dra 
248  
Yield (%) 
246  
Yield (%) 
1 TMEDA 60:40 41 46 
2 (+)-Sparteine surrogate 51:49 63 11 
3 (‒)-Sparteine 54:46 31 62 
a 
dr determined by 
1
H NMR spectroscopy of the crude product. 
 
In summary, lithiation-trapping of (S)-4-(1-phenylethyl) morpholine 246 using chiral 
diamines was explored. Generally, the yields of 2-substituted morpholines were better than 
the related products with the N-benzyl protecting group as ortho-lithiation did not occur. 
However, diastereomeric ratios were disappointing when the asymmetric lithiations were 
carried out. Scheme 3.91 shows a summary of lithiation of (S)-4-(1-phenylethyl) 
morpholine 246 at 0 °C for 1 h and trapping with selected electrophiles. Yields ranged 
from 52-60% of the diastereomeric products that were obtained. 
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Scheme 3.91 
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3.6 Conclusions and Future Work 
A detailed exploration of lithiation-trapping of THF under different conditions was carried 
out. Based on the results of the optimisation, we concluded that the use of THF as both the 
substrate and the solvent provided the best results. The optimised reaction conditions were 
s-BuLi/THF at ‒40 °C for 40 min, as they provide a suitable balance between the rate of 
lithiation and the rate of decomposition of the lithiated intermediate via the retro [3+2] 
pathway. Moreover, there was no benefit of introducing TMEDA in the reaction mixture.  
The exploration of lithiation-trapping of 2-MeTHF revealed that the rate of decomposition 
via the β-elimination pathway is much faster than the α- lithiation, and TMEDA is 
considered to be an important factor for 2-MeTHF lithiation as the β-elimination pathway 
(either at the methyl group or at the C-3 position) is more favourable when s-
BuLi/TMEDA was used. The best reaction conditions for 2-MeTHF lithiation were using 
diamine-free conditions in 2-MeTHF as substrate and solvent at ‒40 °C for 1 h.  
Lithiation of THP can be achieved using s-BuLi/TMEDA complex in hexane at 0 °C for 1 
h. However, as the lithiated THP is chemically unstable at 0 °C for a certain amount of 
time, more investigation is needed to identify the optimised lithiation conditions. 
The synthesis and α- functionalisation of 3-substituted oxetanes 168, 169 and 170 was 
explored. The lithiation-trapping of 3-benzyl oxetane 168 and 3-hexyl oxetane 169 was 
attempted at ‒78 °C, ‒40 °C, ‒20 °C and 0 °C in different solvents. In the lithiation of 168 
at ‒78 °C, deprotonation did not take place at the α-oxygen position but at the benzylic 
position to form the silylated oxetane 172. This suggested that the benzylic proton is more 
acidic and it could be a competitive site for deprotonation. Disappointingly, all attempts at 
the α- lithiation-trapping of 3-substituted oxetanes were unsuccessful.  
The discovery of the “high” temperature lithiation-trapping of N-substituted morpholines 
was exciting. Exploration of the reaction conditions and N-substituent revealed that the 
best substrate was N-methyl morpholine and the optimised lithiation conditions were s-
BuLi/TMEDA in hexane at 0 °C for 1 h. Asymmetric lithiation of (S)-4-(1-phenylethyl) 
morpholine 246 using chiral diamines was explored. However, diastereomeric ratios were 
disappointing. Further study of the asymmetric lithiation of N-substituted morpholine at 
lower temperature is needed. In addition, exploration of synthetic applications for this 
newly developed methodology is recommended. 
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Below is a table that summarises the work undertaken in this Chapter. 
 
Substrate Newly Developed Reaction Conditions 
THF ‒40 °C for 40 min in THF as substrate and solvent 
2-MeTHF ‒40 °C for 1 h in 2-MeTHF as substrate and solvent 
THP 
0 °C for 1 h in hexane with TMEDA 
(Optimal conditions to be confirmed) 
N-methyl morpholine 
232 
0 °C for 1 h in hexane with TMEDA 
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Chapter 4: Experimental 
4.1 General Methods 
All non-aqueous reactions were carried out under oxygen free Ar using flame-dried 
glassware. Et2O and THF were freshly distilled from sodium and benzophenone 
respectively. 2-MeTHF, TMEDA, Me3SiCl, methyl chloroformate, toluene, hexane, (+)-
sparteine surrogate and (‒)-sparteine were purified by short-path distillation over CaH2 
before use. Me2SO4, benzaldehyde and PhMe2SiCl were purified by Kügelrohr distillation. 
DMF was used directly from the Pure Solv. MD-7 purification system. Dried CO2 was 
freshly prepared by passing through CaOH and then bubbling into the reaction solution 
using a canula. Petrol refers to the fraction of petroleum ether boiling in the range of 40-60 
°C and was purchased in Winchester quantities. Water is distilled water.  
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-440 
mesh). Thin layer chromatography was carried out using commercially available Merck 
F254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) NMR 
spectra were recorded on a Jeol ECX-400 instrument using an internal deuterium lock. For 
samples recorded in CHCl3, chemical shifts are quoted in parts per million relative to 
CHCl3 (δH 7.27) and CDCl3 (δH 77.0, central line of triplet). Carbon NMR spectra were 
recorded with broad band proton decoupling and assigned using DEPT experiments. 
Coupling constants (J) are quoted in Hertz. Boiling points for compounds purified by 
Kügelrohr distillation correspond to the oven temperature during distillation. Infared 
spectra were recorded on a Perkin Elmer Spectrum Two FT-IR spectrometer with UATR 
attachment. Electospray high and low resonance mass spectra were recorded at room 
temperature on a Bruker Daltronics microOTOF spectrometer.  
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4.2 General Procedures 
General procedure A: TMEDA-mediated lithiation-trapping of nitrogen heterocycles  
s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of 
nitrogen heterocycles (N-Boc pyrrolidine 1, N-Boc N'-benzyl piperazine 16, N-Boc 
piperidine 2 or N-Boc azepane 3) (1.0 eq.) and TMEDA (1.3 eq.) in solvent (Et2O, THF, 2-
MeTHF, TBME or CPME) (7 mL) at the specified temperature (‒78 °C ‒ 20 °C) under Ar. 
The resulting solution was stirred at the specified temperature for the specific time (5 sec ‒ 
2 h). Then, the electrophile (DMF, PhCHO, Me2SO4, Me3SiCl, MeOCOCl, PhMe2SiCl or 
Ph2CO) (2.0 eq.) was added. The resulting solution was stirred at the specified temperature 
for 10 min and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product.  
 
General procedure B: Diamine-free lithiation-trapping of nitrogen heterocycles  
s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of 
nitrogen heterocycles (N-Boc pyrrolidine 1 or N-Boc N'-benzyl piperazine 16) (1.0 eq.) and 
TMEDA (1.3 eq.) in solvent (THF or 2-MeTHF) (7 mL) at the specified temperature (‒30 
°C ‒ 20 °C) under Ar. The resulting solution was stirred at the specified temperature for 
the specific time (5 sec ‒ 5 min). Then, the electrophile (DMF, PhCHO, Me2SO4, Me3SiCl, 
MeOCOCl, PhMe2SiCl or Ph2CO) (2.0 eq.) was added. The resulting solution was stirred 
at the specified temperature for 10 min and then allowed to warm to rt over 1 h. Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3   10 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. 
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General procedure C: TMEDA-mediated lithiation-Me3SiCl trapping of N-Boc 
pyrrolidine 1 with variation of temperature after lithiation 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) and TMEDA (151 mg, 195 
µL, 1.3 mmol) in Et2O or 2-MeTHF (7 mL) at ‒30 °C under Ar. The resulting solution was 
stirred at ‒30 °C for 5 min. The reaction flask was transferred to a 0 °C bath and stirred for 
5 or 30 min. Then, Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added. The resulting solution 
was stirred at 0 °C for 10 min and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) 
(10 mL) was added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3   10 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product.  
 
General procedure D: Diamine-free lithiation-Me3SiCl trapping of N-Boc pyrrolidine 
1 with variation of temperature after lithiation 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF or 2-MeTHF (7 mL) 
at ‒30 °C under Ar. The resulting solution was stirred at ‒30 °C for 5 min. The reaction 
flask was transferred to a 0 °C bath and stirred to 0 °C for 5 or 30 min. Then, Me3SiCl (218 
mg, 256 µL, 2.0 mmol) was added. The resulting solution was stirred at 0 °C for 10 min 
and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. 
 
General procedure E: Diamine-mediated lithiation-trapping of oxygen heterocycles  
s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of 
oxygen heterocycles (THF, 2-MeTHF, THP, 3-benzyl oxetane 168, 3-hexyl oxetane 169, 
4-methyl morpholine 232, 4-benzyl morpholine 237, or (S)-4-(1-Phenylethyl) morpholine 
246) (1.0 eq.) and TMEDA (1.3 eq.) in solvent (Et2O, THF, 2-MeTHF, hexane or toluene) 
(7 mL) at the specified temperature (‒78 °C ‒ 20 °C) under Ar. The resulting solution was 
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stirred at the specified temperature for the specific time (5 sec ‒ 4 h). Then, the electrophile 
(PhCHO, PhMe2SiCl or Ph2CO) (2.0 eq.) was added. The resulting solution was stirred at 
the specified temperature for 10 min and then allowed to warm to rt o ver 1 h. Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3   10 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product.  
 
General procedure F: TMEDA-mediated lithiation-trapping of THF and 2-MeTHF 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of TMEDA (151 mg, 195 µL, 1.3 mmol) in THF or 2-MeTHF (7 mL) at ‒78 °C or 
‒40 °C under Ar. The resulting solution was stirred at the specified temperature for the 
specified time (10 min, 20 min or 1 h). Then, PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) was 
added. The resulting solution was stirred at the specified temperature for 10 min and the n 
allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. 
 
General procedure G: Diamine-free lithiation-trapping of THF and 2-MeTHF 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise into THF 
or 2-MeTHF (7 mL) at ‒78 °C or ‒40 °C under Ar. The resulting solution was s tirred at the 
specified temperature for the specified time (20 min, 40 min or 1 h). Then, PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) was added. The resulting solution was stirred at the specified 
temperature for 10 min and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
Et2O (3   10 mL) and the combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product.  
 
  
Chapter 4: Experimental 
139 
 
General procedure H: Diamine-free double lithiation-methyl chloroformate trapping 
of N-Boc pyrrolidine 1 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒78 °C, ‒30 
°C or ‒20 °C under Ar. The resulting solution was stirred at ‒78 °C for 1 h, ‒30 °C for 5 
min or ‒20 °C for 2 min. Then, methyl chloroformate (283 mg, 231µL, 3.0 mmol) was 
added. The resulting solution was stirred at the specified temperature for 10 min and then 
allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. 
 
General procedure I: Catalytic TMEDA-mediated lithiation-trapping of N-methyl 
morpholine 232 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise to a 
stirred solution of N-methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol, 1.0 eq.) and 
TMEDA (0.5 eq., 0.2 eq., 0.1 eq., 0.05 eq., 0.01 eq. or 0 eq.) in hexane (7 mL) at 0 °C 
under Ar. The resulting solution was stirred at 0 °C for 1 h, 2 h or 4 h. Then, benzaldehyde 
(228 mg, 203 µL, 2.0 mmol, 2.0 eq.) was added. The resulting solution was stirred at 0 °C 
for 10 min and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product.  
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4.3 Experimental for Chapter 2 
N-Boc pyrrolidine 1 
 
Pyrrolidine (4.29 g, 4.99 mL, 60.45 mmol) was added dropwise to a stirred solution of di-
tert-butyl dicarbonate (12.0 g, 56.05 mmol) in CH2Cl2 (120 mL) at 0 °C under Ar. The 
resulting solution was allowed to warm to rt and stirred at rt for 3 h. Then, the solvent was 
evaporated under reduced pressure to give the crude product. Purification by Kügelrohr 
short path distillation gave N-Boc pyrrolidine 1 (10.5 g, 61%) as a colourless oil, bp 90-96 
°C/2.0 mmHg (lit.,120 bp 70-75 °C/0.5 mmHg); 1H NMR (400 MHz, CDCl3) δ 3.32-3.29 
(m, 4H, NCH2), 1.86-1.80 (m, 4H, NCH2CH2), 1.46 (s, 9H, CMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 154.8 (C=O), 79.0 (CMe3), 45.9 (NCH2), 28.6 (CMe3), 25.5 (NCH2CH2). 
Spectroscopic data consistent with those reported in the literature.120  
Lab Book Reference: WSK/1/055 
 
2-(Hydroxyphenylmethyl)pyrrolidine-1-carboxylic acid tert-butyl ester syn-25 and 
anti-25 
 
Table 2.1, entry 1 
Using general procedure B, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒30 °C for 5 min and 
benzaldehyde (318 mg, 305 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave starting 
material 1 (22 mg, 13%), pyrrolidine syn-25 (253 mg, 46%) as a colourless oil, RF (98:2 
CH2Cl2-acetone) 0.4; 
1H NMR (400 MHz, CDCl3) δ 7.38-7.27 (m, 5H, Ph), 5.93 (br s, 1 H, 
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OH), 4.53 (br d, J = 7.5 Hz 1H, OCH), 4.09 (td, J = 7.5, 5.0 Hz, 1H, NCH), 3.50-3.42 (m, 
1H, NCH), 3.39-3.28 (m, 1H, NCH), 1.78-1.65 (m, 2H, CH), 1.65-1.56 (m, 2H, CH), 1.52 
(s, 9H, CMe3);
 13C NMR (100.6 MHz, CDCl3) δ 158.5 (C=O), 141.3 (ipso-Ph), 128.8 (Ph), 
128.6 (Ph), 127.2 (Ph), 81.1 (OCH), 79.5 (CMe3), 65.5 (NCH), 47.9 (NCH2), 28.8 (CH2), 
28.7 (CMe3), 24.0 (CH2), a of 40:60 mixture (by 
1H NMR spectroscopy) of pyrrolidine 
syn-25 and anti-25 (11 mg, 2%) as a colourless oil and pyrrolidine anti-25 (140 mg, 25%) 
as a colourless oil, RF (98:2 CH2Cl2-acetone) 0.3; 
1H NMR (400 MHz, CDCl3) (75:25 
mixture of rotamers) δ 7.41-7.22 (m, 5H, Ph), 5.49 (br s, 0.75H, OH), 5.17 (br s, 0.25H, 
OH), 4.86 (br s, 0.75H, OCH), 4.32 (br s, 0.75H, NCH), 3.97 (br s, 0.25H, OCH), 3.57 (br 
s, 0.25H, NCH), 3.30 (br s, 1H, NCH), 2.81 (br s, 0.75H, NCH), 2.30 (br s, 0.25H, NCH), 
2.04-1.87 (m, 1H, CH), 1.86-1.66 (m, 1H, CH), 1.57 (br s, 3.5 H, CMe3), 1.52 (br s, 5.5 H, 
CMe3), 1.20-1.09 (m, 1H, CH), 0.93-0.79 (m, 1H, CH);
 13C NMR (100.6 MHz, CDCl3) δ 
159.8  (C=O), 157.4  (C=O), 141.9 (ipso-Ph), 141.3 (ipso-Ph), 128.5 (Ph), 128.3 (Ph), 
128.1 (Ph), 127.4 (Ph), 127.1 (Ph), 126.1 (Ph), 80.5 (CMe3), 80.4 (CMe3), 76.3 (COH), 
63.3 (NCH), 47.9 (NCH2), 47.7 (NCH2), 28.6 (CMe3), 27.5 (CH2), 26.1 (CH2), 23.6 (CH2), 
22.6 (CH2). Spectroscopic data consistent with those reported in the literature.
121 The total 
yield of syn-25 and anti-25 is 73%. 
Lab Book Reference: WSK/1/036 
 
(Table 2.1, entry 2) 
Using general procedure B, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒30 °C for 5 
min and benzaldehyde (318 mg, 305 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave starting 
material 1 (34 mg, 10%), pyrrolidine syn-25 (200 mg, 36%) as a colourless oil and 
pyrrolidine anti-25 (134 mg, 11%) as a colourless oil. The total yield of syn-25 and anti-25 
is 47%. 
Lab Book Reference: WSK/1/040 
 
(Table 2.1, entry 3) 
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Using general procedure B, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol),  
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in 2-MeTHF (10 mL) at ‒30 °C for 5 min and benzaldehyde (318 mg, 305 µL, 
3.0 mmol) gave the crude product. Purification by flash column chromatography on silica 
with 98:2 CH2Cl2-acetone as eluent gave starting material 1 (4 mg, 1%), pyrrolidine syn-25 
(218 mg, 39%) as a colourless oil, a mixture of pyrrolidines syn-25 and anti-25 (5 mg, 1%) 
as a colourless oil and pyrrolidine anti-25 (155 mg, 28%) as a colourless oil. The total 
yield of syn-25 and anti-25 is 68%. 
Lab Book Reference: WSK/1/042 
 
(Table 2.1, entry 4) 
Using general procedure B, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol), and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in Et2O (10 mL) at ‒20 °C for 5 min and 
benzaldehyde (318 mg, 305 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave starting 
material 1 (54 mg, 16%), pyrrolidine syn-25 (106 mg, 17%) as a colourless oil and 
pyrrolidine anti-25 (334 mg, 4%) as a colourless oil. The total yield of syn-25 and anti-25 
is 21%. 
Lab Book Reference: WSK/1/035 
 
(Table 2.1, entry 5) 
Using general procedure A, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at ‒20 °C for 5 min and benzaldehyde (318 mg, 305 µL, 3.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
98:2 CH2Cl2-acetone as eluent gave starting material 1 (85 mg, 25%), pyrrolidine syn-25 
(160 mg, 29%) as a colourless oil and pyrrolidine anti-25 (87 mg, 16%) as a colourless oil. 
The total yield of syn-25 and anti-25 is 45%. 
Lab Book Reference: WSK/1/033 
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(Scheme 2.1) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at 0 °C for 5 sec and 
benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave pyrrolidine 
syn-25 (92 mg, 33%), a 65:35 mixture (by 1H NMR spectroscopy) of pyrrolidine anti-
25and syn-25 (7 mg, 1%) as a colourless oil and pyrrolidine anti-25 (46 mg, 17%) as a 
colourless oil. The total yield of syn-25 and anti-25 is 52%. 
Lab Reference: WSK/3/074 
 
(Scheme 2.1) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in 2-MeTHF (7 mL) at 0 °C for 5 sec and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 98:2 
CH2Cl2-acetone as eluent gave pyrrolidine syn-25 (50 mg, 18%) and a 60:40 mixture (by 
1H NMR spectroscopy) of pyrrolidine anti-25 and syn-25 (110 mg, 40%) as a colourless oil. 
The total yield of syn-25 and anti-25 is 58%. 
Lab Reference: WSK/3/070 
 
(Scheme 2.2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒20 °C for 2 min 
and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
pyrrolidine syn-25 (119 mg, 43%), a 65:35 mixture (by 1H NMR spectroscopy) of 
pyrrolidine anti-25and syn-25 (4 mg, 1%) as a colourless oil and pyrrolidine anti-25 (70 
mg, 25%) as a colourless oil. The total yield of syn-25 and anti-25 is 69%. 
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Lab Reference: WSK/3/073 
 
(Scheme 2.2) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in 2-MeTHF (7 mL) at ‒20 °C for 2 min and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
98:2 CH2Cl2-acetone as eluent gave pyrrolidine syn-25 (117 mg, 42%) and pyrrolidine 
anti-25 (81 mg, 29%) as a colourless oil. The total yield of syn-25 and anti-25 is 71%. 
Lab Reference: WSK/3/069 
 
(Table 2.10, entry 1) 
Using general procedure B, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol), and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at 0 °C for 5 sec and 
benzaldehyde (318 mg, 305 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave pyrrolidine 
syn-25 (92.5 mg, 34%) as a colourless oil, a mixture of pyrrolidines syn-25 and anti-25 (11 
mg, 4%) as a colourless oil and pyrrolidine anti-25 (59 mg, 21%) as a colourless oil. The 
total yield of syn-25 and anti-25 is 59%. 
Lab Book Reference: WSK/1/058 
 
(Table 2.10, entry 2) 
Using general procedure A, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol), and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at 0 °C for 30 sec and 
benzaldehyde (318 mg, 305 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave pyrrolidine 
syn-25 (105 mg, 38%) as a colourless oil and pyrrolidine anti-25 (62 mg, 22%) as a 
colourless oil. The total yield of syn-25 and anti-25 is 60%. 
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Lab Book Reference: WSK/1/059 
 
2-Trimethylsilyl pyrrolidine-1-carboxylic acid tert-butyl ester 4 
 
 (Table 2.3, entry 2) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒20 °C for 2 min and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (315 
mg, 65%) as a colourless oil, RF (8:2 petrol-Et2O) 0.4; 
1H NMR (400 MHz, CDCl3) δ 3.56-
3.41 (m, 1H, NCH), 3.29-3.23 (m, 1H, NCH), 3.19-3.12 (m, 1H, NCH), 2.06-1.95 (m, 1H, 
CH), 1.82-1.72 (m, 3H, CH), 1.45 (s, 9H, CMe3), 0.04 (s, 9H, SiMe3); 
13C NMR (100.6 
MHz, CDCl3) (rotamers) δ 154.6 (C=O), 79.2 (CMe3), 78.3 (CMe3), 47.6 (NCH), 47.0 
(NCH2), 46.6 (NCH2), 28.5 (CMe3), 27.9 (CH2), 26.0 (CH2) 24.9 (CH2), ‒2.2 (SiMe3). 
Spectroscopic data consistent with those reported in the literature.25  
Lab Book Reference: WSK/1/057 
 
(Table 2.2, entry 1) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒30 °C for 5 min and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (321 
mg, 66%) as a colourless oil. 
Lab Book Reference: WSK/1/051 
(Table 2.2, entry 2) 
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Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒30 °C for 5 
min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (338 mg, 69%) as a colourless oil.  
Lab Book Reference: WSK/1/060 
 
(Table 2.2, entry 3) 
Using general procedure A, s-BuLi (1 2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in 2-MeTHF (10 mL) at ‒30 °C for 5 min and Me3SiCl (326 mg, 381 µL, 3.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (370 mg, 76%) as a colourless oil.  
Lab Book Reference: WSK/1/067 
 
(Table 2.2, entry 4) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at ‒30 °C for 5 min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (356 mg, 73%) as a colourless oil.  
Lab Book Reference: WSK/1/063 
 
(Table 2.3, entry 1) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒20 °C for 5 min and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
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chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (315 
mg, 64%) as a colourless oil.  
Lab Book Reference: WSK/1/056 
 
(Table 2.3, entry 3) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒20 °C for 5 
min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (278 mg, 57%) as a colourless oil. 
Lab Book Reference: WSK/1/058 
 
(Table 2.3, entry 4) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒20 °C for 2 
min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (254 mg, 52%) as a colourless oil.  
Lab Book Reference: WSK/1/092 
 
(Table 2.3, entry 5) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in 2-MeTHF (10 mL) at ‒20 °C for 5 min and Me3SiCl (326 mg, 381 µL, 3.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (338 mg, 69%) as a colourless oil.  
Lab Book Reference: WSK/1/068 
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(Table 2.3, entry 6) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in 2-MeTHF (10 mL) at ‒20 °C for 2 min and Me3SiCl (326 mg, 381 µL, 3.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (331 mg, 68%) as a colourless oil.  
Lab Book Reference: WSK/1/069 
 
(Table 2.3, entry 7) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at ‒20 °C for 5 min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (348 mg, 71%) as a colourless oil.  
Lab Book Reference: WSK/1/064 
 
(Table 2.3, entry 8) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O  (10 mL) at ‒20 °C for 2 min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (339 mg, 70%) as a colourless oil.  
Lab Book Reference: WSK/1/065 
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(Table 2.4, entry 1) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒10 °C for 5 min and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (245 
mg, 50%) as a colourless oil.  
Lab Book Reference: WSK/1/062 
 
(Table 2.4, entry 2) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at ‒10 °C for 1 min and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (284 
mg, 58%) as a colourless oil.  
Lab Book Reference: WSK/1/074 
 
(Table 2.4, entry 3) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒10 °C for 30 sec and 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (114 
mg, 47%) as a colourless oil.  
Lab Book Reference: WSK/2/014 
 
(Table 2.4, entry 4) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒10 °C for 2 
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min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (136 mg, 28%) as a colourless oil.  
Lab Book Reference: WSK/1/076 
 
(Table 2.4, entry 5) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒10 °C for 1 
min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (170 mg, 35%) as a colourless oil.  
Lab Book Reference: WSK/1/075 
 
(Table 2.4, entry 6) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at ‒10 °C for 30 
sec and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 
4 (223 mg, 46%) as a colourless oil.  
Lab Book Reference: WSK/1/079 
 
(Table 2.4, entry 7) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in 2-MeTHF (7 mL) at ‒10 °C for 30 sec and Me3SiCl (218 mg, 256 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (181 mg, 74%) as a colourless oil.  
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Lab Book Reference: WSK/2/015 
 
(Table 2.4, entry 8) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at ‒10 °C for 1 min and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (326 mg, 67%) as a colourless oil.  
Lab Book Reference: WSK/1/089 
 
(Table 2.4, entry 9) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at ‒10 °C for 30 sec and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (336 mg, 69%) as a colourless oil.  
Lab Book Reference: WSK/1/088 
 
(Table 2.5, entry 1) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at 0 °C for 50 sec and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (189 
mg, 39%) as a colourless oil.  
Lab Book Reference: WSK/1/081 
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(Table 2.5, entry 2) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at 0 °C for 30 sec and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (229 
mg, 47%) as a colourless oil. 
Lab Book Reference: WSK/1/080 
 
(Table 2.5, entry 3) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in THF (10 mL) at 0 °C for 5 sec and 
Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (286 
mg, 59%) as a colourless oil.  
Lab Book Reference: WSK/1/096 
 
(Table 2.5, entry 4) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at 0 °C for 10 sec 
and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 
4 (150 mg, 31%) as a colourless oil.  
Lab Book Reference: WSK/1/085 
 
(Table 2.5, entry 5) 
Using general procedure B, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (342 mg, 350 µL, 2.0 mmol) in 2-MeTHF (10 mL) at 0 °C for 5 sec 
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and Me3SiCl (326 mg, 381 µL, 3.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 
4 (167 mg, 50%) as a colourless oil.  
Lab Book Reference: WSK/1/084 
 
(Table 2.5, entry 6) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in 2-MeTHF (10 mL) at 0 °C for 5 sec and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (306 mg, 63%) as a colourless oil. 
Lab Book Reference: WSK/1/095 
 
(Table 2.5, entry 7) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at 0 °C for 10 sec and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (268 mg, 55%) as a colourless oil.  
Lab Book Reference: WSK/1/087 
 
(Table 2.5, entry 8) 
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in hexanes, 2.6 mmol), 
TMEDA (302 mg, 390 µL, 2.6 mmol, 2.6 eq.) and N-Boc pyrrolidine 1 (342 mg, 350 µL, 
2.0 mmol) in Et2O (10 mL) at 0 °C for 5 sec and Me3SiCl (326 mg, 381 µL, 3.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (258 mg, 53%) as a colourless oil.  
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Lab Book Reference: WSK/1/086 
 
(Table 2.6, entry 1) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at rt for 2 sec and 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (53 
mg, 22%) as a colourless oil.  
Lab Book Reference: WSK/2/010 
 
(Table 2.6, entry 2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at 20 °C for 2 sec 
and Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 
4 (80 mg, 33%) as a colourless oil.  
Lab Book Reference: WSK/2/011 
 
(Table 2.6, entry 3) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.)  and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in 2-MeTHF (7 mL) at 20 °C for 2 sec and Me3SiCl (218 mg, 256 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (40 mg, 16%) as a colourless oil.  
Lab Book Reference: WSK/2/012 
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(Table 2.6, entry 4) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.)  and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in Et2O (7 mL) at 20 °C for 2 sec and Me3SiCl (218 mg, 256 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (72 mg, 30%) as a colourless oil.  
Lab Book Reference: WSK/2/013 
 
(Table 2.7, entry 2) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.)  and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in THF (7 mL) at 0 °C for 5 sec and Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave 
the crude product. Purification by flash column chromatography on silica with 8:2 petrol-
Et2O as eluent gave silylated pyrrolidine 4 (161 mg, 66%) as a colourless oil.  
Lab Book Reference: WSK/2/067 
 
(Table 2.7, entry 5) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in Et2O (7 mL) at 0 °C for 5 sec and 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (48 
mg, 20%) as a colourless oil.  
Lab Book Reference: WSK/2/046 
 
(Table 2.7, entry 7) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in TBME (7 mL) at 0 °C for 5 sec and 
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Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (34 
mg, 14%) as a colourless oil.  
Lab Book Reference: WSK/2/025 
 
(Table 2.7, entry 8) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.)  and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in TBME (7 mL) at 0 °C for 5 sec and Me3SiCl (218 mg, 256 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (164 mg, 67%) as a colourless oil.  
Lab Book Reference: WSK/2/026 
 
(Table 2.7, entry 9) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in CPME (7 mL) at 0 °C for 5 sec and 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 4 (34 
mg, 14%) as a colourless oil.  
Lab Book Reference: WSK/2/027 
 
(Table 2.7, entry 10) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.)  and N-Boc pyrrolidine 1 (171 mg, 175 µL, 
1.0 mmol) in CPME (7 mL) at 0 °C for 5 sec and Me3SiCl (218 mg, 256 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (72 mg, 29%) as a colourless oil.  
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Lab Book Reference: WSK/2/028 
 
(Table 2.7, entry 11) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq. ) was added dropwise to a 
stirred solution of  N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol, 1.0 eq.) and TMEDA 
(7 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 5 sec. Then, 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added. The resulting solution was stirred for 10 
min and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and 
the two layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) and 
the combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. The 1H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted.  
Lab Book Reference: WSK/2/070 
 
 
 (Table 2.8, entry 1) 
n-BuLi (1.0 mL of a 2.5 M solution in hexanes, 2.5 mmol, 2.5 eq.) was added dropwise to 
a stirred solution of  N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol, 1.0 eq.) in THF 
(7mL) at 0 °C under Ar. The resulting solution was stirred for 1 min. Then, Me3SiCl (218 
mg, 256 µL, 2.0 mmol) was added. The resulting solution was stirred at 0 °C for 10 min 
and then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. The 1H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted.  
Lab Book Reference: WSK/2/029 
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(Table 2.8, entry 2) 
n-BuLi (11.0 mL of a 2.5 M solution in hexanes, 2.5 mmol, 2.5 eq.) was added dropwise to 
a stirred solution of  N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol, 1.0 eq.) and 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.) in 2-MeTHF (7 mL) at 0 °C under Ar. The 
resulting solution was stirred for 5 min. Then, Me3SiCl (218 mg, 256 µL, 2.0 mmol) was 
added. The resulting solution was stirred at 0 °C for 10 min and then allowed to warm to rt 
over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3   10 mL) and the combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. The 
1H 
NMR spectrum of the crude product showed no identifiable products and therefore 
purification was not attempted. 
Lab Book Reference: WSK/2/061 
 
(Table 2.8, entry 3) 
n-BuLi (11.0 mL of a 2.5 M solution in hexanes, 2.5 mmol, 2.5 eq.) was added dropwise to 
a stirred solution of  N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol, 1.0 eq.) and 
TMEDA (151 mg, 195 µL, 1.3 mmol, 1.3 eq.) in 2-MeTHF (7 mL) at 0 °C under Ar. The 
resulting solution was stirred for 1 min. Then, Me3SiCl (218 mg, 256 µL, 2.0 mmol) was 
added. The resulting solution was stirred at 0 °C for 10 min and then allowed to warm to rt 
over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3   10 mL) and the combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. The 
1H 
NMR spectrum of the crude product showed no identifiable products and therefore 
purification was not attempted. 
Lab Book Reference: WSK/2/062 
 
(Table 2.11, entry 2) 
Using general procedure D, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒30 °C for 5 min 
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before warming to 0 °C for 5 min. Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to give 
the crude product. Purification by flash column chromatography on silica with 8:2 petrol-
Et2O as eluent gave silylated pyrrolidine 4 (125 mg, 51%) as a colourless oil.  
Lab Book Reference: WSK/2/063 
 
(Table 2.11, entry 3) 
Using general procedure D, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒30 °C for 5 min 
before warming to 0 °C for 30 min. Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to 
give the crude product. Purification by flash column chromatography on silica with 8:2 
petrol-Et2O as eluent gave silylated pyrrolidine 4 (9 mg, 4%) as a colourless oil.  
Lab Book Reference: WSK/2/064 
 
(Table 2.11, entry 5) 
Using general procedure D, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒30 °C for 5 min 
before warming to 0 °C for 5 min. Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to give 
the crude product. Purification by flash column chromatography on silica with 8:2 petrol-
Et2O as eluent gave silylated pyrrolidine 4 (44 mg, 18%) as a colourless oil and starting 
material 1 (10 mg, 6%) as a colourless oil.  
Lab Book Reference: WSK/2/071 
 
(Table 2.11, entry 6) 
Using general procedure D, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒30 °C for 5 min 
before warming to 0 °C for 30 min. Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to 
give the crude product. Purification by flash column chromatography on silica with 8:2 
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petrol-Et2O as eluent gave silylated pyrrolidine 4 (6 mg, 2%) as a colourless oil and 
starting material 1 (42 mg, 24%) as a colourless oil.  
Lab Book Reference: WSK/2/066 
 
(Table 2.11, entry 8) 
Using general procedure C, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in Et2O (7 mL) at ‒30 °C for 5 min before warming to 0 °C for 5 min. Me3SiCl 
(218 mg, 256 µL, 2.0 mmol) was added to give the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated pyrrolidine 
4 (128 mg, 52%) as a colourless oil.  
Lab Book Reference: WSK/2/068 
 
(Table 2.11, entry 9) 
Using general procedure C, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in Et2O (7 mL) at ‒30 °C for 5 min before warming to 0 °C for 30 min. Me3SiCl 
(218 mg, 256 µL, 2.0 mmol) was added to give the crude product. Purification by flash 
column chromatography on silica with 8:2 petrol-Et2O as eluent gave starting material 1 
(35 mg, 20%) as a colourless oil.  
Lab Book Reference: WSK/2/069 
 
(Table 2.11, entry 11) 
Using general procedure C, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in 2-MeTHF (7 mL) at ‒30 °C for 5 min before warming to 0 °C for 5 min. 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to give the crude product. Purification by 
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flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (60 mg, 25%) as a colourless oil.  
Lab Book Reference: WSK/3/054 
 
(Table 2.11, entry 12) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in 2-MeTHF (7 mL) at ‒30 °C for 5 min before warming to 0 °C for 30 min. 
Me3SiCl (218 mg, 256 µL, 2.0 mmol) was added to give the crude product. Purification by 
flash column chromatography on silica with 8:2 petrol-Et2O as eluent gave silylated 
pyrrolidine 4 (5 mg, 2%) as a colourless oil.  
Lab Book Reference: WSK/2/053 
 
N-(tert-Butoxycarbonyl)pyrrolidine-2-carboxaldehyde 8 
 
(Scheme 2.2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒20 °C for 2 min 
and DMF (146 mg, 155 µL, 2.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with 1:1 hexane-Et2O as eluent gave aldehyde 8 (105 mg, 
52%) as a colourless oil, RF (1:1 hexane-Et2O) 0.3; 
1H NMR (400 MHz, CDCl3) (60:40 
mixture of rotamers) δ 9.56 (d, J = 2.0 Hz, 0.4H, CHO), 9.46 (d, J = 3.0 Hz, 0.6H, CHO), 
4.24-4.17 (m, 0.4H, NCH), 4.05 (ddd, J = 8.5, 6.0, 3.0 Hz, 0.6H, NCH), 3.61-3.38 (m, 2H, 
NCH), 2.20-1.74 (m, 4H, CH), 1.48 (s, 4H, CMe3), 1.43 (s, 5H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) (rotamers) δ 200.7 (C=O, CHO), 200.5 (C=O, CHO), 154.0 (C=O, Boc), 
80.6 (CMe3), 80.2 (CMe3), 65.0 (NCH), 64.8 (NCH), 46.8 (NCH2), 46.7 (NCH2), 28.4 
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(CMe3), 28.2 (CMe3), 28.0 (CH2), 26.7 (CH2) 24.6 (CH2), 23.9 (CH2). Spectroscopic data 
consistent with those reported in the literature.15  
Lab Book Reference: WSK/3/075 
 
(Scheme 2.2) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 
mmol) in 2-MeTHF (7 mL) at ‒20 °C for 2 min and DMF (146 mg, 155 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 1:1 
hexane-Et2O as eluent gave aldehyde 8 (132 mg, 66%) as a colourless oil.  
Lab Book Reference: WSK/3/061 
 
2-Methyl-1-phenylbutan-1-ol 74 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise to a 
stirred solution of benzaldehyde (1.0 mmol, 138 mg, 132 µL, 1.3 mmol, 1.0 eq.) in THF (7 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 10 min and then 
allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave a 50:50 mixture of diastereomeric alcohols 74 (161 mg, 38%, 75% 
based on s-BuLi consumed) as a colourless oil, RF (9:1 petrol-EtOAc) 0.2; 
1H NMR (400 
MHz, CDCl3) δ 7.37-7.24 (m, 5H, Ph), 4.53 (d, J = 7.0 Hz, 0.5H, OCH), 4.44 (d, J = 7.0 
Hz, 0.5H, OCH), 1.84 (br s, 1H, OH), 1.80-1.65 (m, 1.5H), 1.46-1.33 (m, 0.5H), 1.22-1.03 
(m, 1H), 0.96-0.91 (m, 3H), 0.91-0.86 (m, 1.5H), 0.74 (d, J = 7.0 Hz, 1.5H); 13C NMR 
(100.6 MHz, CDCl3) δ 143.8 (ipso-Ph) , 143.5 (ipso-Ph), 128.1 (Ph), 127.4 (Ph), 127.2 
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(Ph), 126.6 (Ph), 126.3 (Ph), 78.7 (OCH), 78.0 (OCH), 41.9 (CH), 41.6 (CH), 25.8 (CH2), 
24.8 (CH2), 15.0 (Me), 13.9 (Me), 11.6 (Me), 11.2 (Me). Spectroscopic data consistent 
with those reported in the literature.122 
Lab Book Reference: WSK/2/039 
 
4-Methyl-1phenylhexan-1-ol 73 
 
Table 2.9 entry 3 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise to 
THF (7 mL) at 0 °C under Ar for 30 min. Then, benzaldehyde (1.0 mmol, 138 mg, 132 µL, 
1.3 mmol, 1.0 eq.) was added and the resulting solution was stirred at  0 °C for 10 min and 
then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 9:1 
petrol-EtOAc as eluent gave a 50:50 mixture of diastereomeric alcohols 73 (97 mg, 39%, 
77% based on 2 equivalents of s-BuLi being consumed) as a yellow oil, RF (9:1 petrol-
EtOAc) 0.2; 1H NMR (400 MHz, CDCl3) δ 7.37-7.33 (m, 4H, Ph), 7.31-7.27 (m, 1H, Ph), 
4.64 (dd, J = 7.0, 3.0 Hz, 0.5H, OCH), 4.63 (dd, J = 7.0, 3.0 Hz, 0.5H, OCH), 1.89-1.64 (m, 
2H), 1.64-1.54 (br s, 1H, OH), 1.52-1.40 (m, 1H), 1.37-1.24 (m, 3H), 1.15-0.98 (m, 1H), 
0.88-0.78 (m, 6H, CH2Me, CHMe); 
13C NMR (100.6 MHz, CDCl3) δ 144.9 (ipso-Ph) , 
144.8 (ipso-Ph), 128.2 (Ph), 127.34 (Ph), 127.31 (Ph), 125.87 (Ph), 125.82 (Ph), 74.9 
(OCH), 74.8 (OCH), 36.5 (CH2), 36.4 (CH2), 34.2 (CH), 34.2 (CH), 32.5 (CH2), 32.4 
(CH2), 29.26 (CH2), 29.23 (CH2), 19.06 (Me), 19.01 (Me), 11.28 (Me), 11.25 (Me). 
Spectroscopic data consistent with those reported in the literature.122 
Lab Book Reference: WSK/2/017 
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(Table 2.9 entry 2) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise to 
THF (7 mL) at 0 °C under Ar for 5 min. Then, benzaldehyde (1.0 mmol, 138 mg, 132 µL, 
1.3 mmol, 1.0 eq.) was added and the resulting solution was stirred at  0 °C for 10 min and 
then allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 9:1 
petrol-EtOAc as eluent gave a 50:50 mixture of diastereomeric alcohols 73 (118 mg, 48%, 
95% based on 2 equivalents of s-BuLi being  consumed) as a yellow oil.  
Lab Book Reference: WSK/2/040 
 
1-tert-Butyl 2-methyl 4-benzylpiperazine-1,2-dicarboxylate 24 
 
Table 2.13, entry 1 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276 mg, 1.0 mmol), in THF (7 mL) at ‒30 °C for 
5 min and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude p roduct. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (231 mg, 69%) as a colourless oil, RF (7:3 petrol-EtOAc) 0.4; 
1H NMR 
(400 MHz, CDCl3) (50:50 mixture of rotamers) δ 7.34-7.21 (m, 5H, Ph), 4.71 (s, 0.5H, 
NCH), 4.54 (s, 0.5H, NCH), 3.86 (br d, J = 14.0 Hz, 0.5H, NCH), 3.80-3.67 (m, 0.5H, 
NCH), 3.73 (s, 1.5H, OMe), 3.71 (s, 1.5H, OMe), 3.59 (d, J = 13.0 Hz, 0.5H, CHAHBPh), 
3.56 (d, J = 13.0 Hz, 0.5H, CHAHBPh), 3.45 (d, J = 14.0 Hz, 0.5H, CHAHBPh), 3.41 (d, J = 
14.0 Hz, 0.5H, CHAHBPh), 3.35-3.23 (m, 2H, NCH2), 3.18 (td, , J = 13.0, 3.0 Hz, 0.5H, 
NCH), 2.80 (d, J = 11.5 Hz, 0.5H, NCH), 2.75 (d, J = 11.5 Hz, 0.5H, NCH), 2.19 (td, J = 
12.0, 3.0 Hz, 0.5H, NCH), 2.11 (d, J = 11.0 Hz, 0.5H, NCH), 2.08 (d, J = 11.0 Hz, 0.5H, 
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NCH), 1.47 (s, 4.8H, CMe3), 1.42 (s, 4.2H, CMe3). 
13C NMR (100.6 MHz, CDCl3) 
(rotamers) δ172.1 (CO2Me), 171.3 (CO2Me), 157.1 (NC=O), 156.0  (NC=O), 136.0 (ipso-
Ph), 128.9 (Ph), 128.3 (Ph), 127.3 (Ph), 80.4 (CMe3), 62.4 (NCH2), 53.61 (NCH), 53.60 
(NCH), 52.5 (NCH2), 52.4 (NCH2), 52.16 (NCH2), 52.13 (OMe), 42.1 (NCH2), 41.1 
(NCH2), 28.46 (CMe3), 28.40 (CMe3). Spectroscopic data consistent with those reported in 
the literature.123 
Lab Book Reference WSK/2/004 
 
(Table 2.12, entry 1) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at ‒78 °C for 1 
h and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (188 mg, 56%) as a colourless oil.  
Lab Book Reference WSK/2/003 
 
(Table 2.12, entry 2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in 2-MeTHF (7 mL) at ‒78 °C 
for 1 h and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (230 mg, 69%) as a colourless oil.  
Lab Book Reference WSK/2/009 
(Table 2.13, entry 2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at ‒30 °C for 1 
min and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Chapter 4: Experimental 
166 
 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (193 mg, 58%) as a colourless oil.  
Lab Book Reference WSK/2/006  
 
(Table 2.13, entry 3) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in 2-MeTHF (7 mL) at ‒30 °C 
for 5 min and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (155 mg, 46%) as a colourless oil.  
Lab Book Reference WSK/2/008 
 
(Table 2.13, entry 4) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.), TMEDA (90 mg, 117 µL, 1.3 mmol, 1.3 eq.) and N-Boc-N’-benzyl piperazine 16 
(276mg, 1.0 mmol)  in Et2O (7 mL) at ‒30 °C for 5 min and methyl chloroformate (189 mg, 
156µL, 2.0 mmol) gave the crude product. Purification by flash column chromatography 
on silica with 7:3 petrol-EtOAc as eluent gave piperazine 24 (85 mg, 31%) as a colourless 
oil and starting material 16 (85 mg, 31%). 
Lab Book Reference WSK/1/100 
 
(Table 2.13, entry 5) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.), TMEDA (90 mg, 117 µL, 1.3 mmol, 1.3 eq.) and N-Boc-N’-benzyl piperazine 16 
(276mg, 1.0 mmol)  in Et2O (7 mL) at ‒30 °C for 1 min and methyl chloroformate (189 mg, 
156µL, 2.0 mmol) gave the crude product. Purification by flash column chromatography 
on silica with 7:3 petrol-EtOAc as eluent gave piperazine 24 (81 mg, 24%) as a colourless 
oil and starting material 16 (103 mg, 37%). 
Chapter 4: Experimental 
167 
 
Lab Book Reference WSK/2/001  
 
(Table 2.14, entry 1) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at ‒20 °C for 5 
min and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (177 mg, 53%) as a colourless oil. 
Lab Book Reference WSK/2/005 
 
(Table 2.14, entry 2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at ‒20 °C for 1 
min and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (176 mg, 53%) as a colourless oil.  
Lab Book Reference WSK/2/007 
 
(Table 2.14, entry 3) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.), TMEDA (90 mg, 117 µL, 1.3 mmol, 1.3 eq.) and N-Boc-N’-benzyl piperazine 16 
(276mg, 1.0 mmol)  in Et2O (7 mL) at ‒30 °C for 1 min and methyl chloroformate (189 mg,  
156µL, 2.0 mmol) gave the crude product. Purification by flash column chromatography 
on silica with 7:3 petrol-EtOAc as eluent gave piperazine 24 (61 mg, 18%) as a colourless 
oil and starting material 16 (84 mg, 30%). 
Lab Book Reference WSK/1/101 
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(Table 2.15, entry 1) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at 0 °C for 30 
sec and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (167 mg, 50%) as a colourless oil.  
Lab Book Reference WSK/2/019 
 
(Table 2.15, entry 2) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at 0 °C for 10 
sec and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (112 mg, 33%) as a colourless oil.  
Lab Book Reference WSK/2/018 
 
(Table 2.15, entry 3) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in 2-MeTHF (7 mL) at 0 °C 
for 30 sec and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (92 mg, 28%) as a colourless oil.  
Lab Book Reference WSK/2/021 
(Table 2.15, entry 4) 
Using general procedure B, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 
eq.) and N-Boc-N’-benzyl piperazine 16 (276mg, 1.0 mmol) in THF (7 mL) at 0 °C for 10 
sec and methyl chloroformate (189 mg, 156µL, 2.0 mmol) gave the crude product. 
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Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave piperazine 24 (105 mg, 31%) as a colourless oil.  
Lab Book Reference WSK/2/020 
 
N-Boc piperidine 2 
 
Piperidine (11.7 g, 11.7 mL, 137.5 mmol) was added dropwise to a stirred solution of di-
tert-butyl dicarbonate (20.0 g, 91.64 mmol) in THF (100 mL) at 0 °C under Ar. The 
resulting solution was allowed to warm to rt and stirred at rt for 3 h. Then, 10% NaHCO3(aq) 
(100 mL) was added and the two layers were separated. The aqueous was extracted with 
Et2O (2 × 100 mL). The combined organic layers were washed wih saturated brine (300 
mL), dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by Kügelrohr short path distillation gave N-Boc piperidine 2 (16.9 g, 66%) as 
a colourless oil, bp 95-100 °C/0.3 mmHg (lit.,120 bp 60-70 °C/0.5 mmHg); 1H NMR (400 
MHz, CDCl3) δ 3.40-3.30 (m, 4H, NCH2), 1.61-1.53 (m, 2H, CH2), 1.53-1.46 (m, 4H, 
CH2), 1.46 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 154.9 (C=O), 79.1 (CMe3), 
44.6 (br, NCH2), 28.4 (CMe3), 25.7 (CH2), 24.5 (CH2). Spectroscopic data consistent with 
those reported in the literature.120  
Lab Book Reference: WSK/2/083 
 
2-(Dimethyl(phenyl)silyl)piperidine-1carboxylic acid tert-butyl ester 79 
 
(Scheme 2.7) 
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Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc piperidine 2 (185 mg, 192 µL, 1.0 mmol, 
1.0 eq.) in Et2O (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave 
the crude product. Purification by flash column chromatography on silica with 95:5 
hexane-Et2O as eluent gave silyl piperidine 79 (119 mg, 37%) as a colourless oil, RF (95:5 
hexane-Et2O) 0.4; 
1H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers) δ 7.61-7.50 (m, 
2H, Ph), 7.41-7.30 (m, 3H, Ph), 4.32-4.07 (m, 0.5H, NCH), 4.07-3.87 (m, 0.5H, NCH), 
3.87-3.59 (m, 1H, NCH), 3.04-2.81 (m, 0.5H, NCH), 2.71-2.47 (m, 0.5H, NCH), 1.75-1.61 
(m, 2H, CH), 1.61-1.46 (m, 2H, CH), 1.42 (s, 9H, CMe3), 1.38-1.22 (m, 2H, CH), 0.43 (s, 
3H, SiMe3), 0.35 (s, 3H, SiMe3) and starting material 2 (15 mg, 8%). 
Lab Book Reference: WSK/3/085 
 
2-(Dimethyl(phenyl)silyl)piperidine-1carboxylic acid tert-butyl ester 79, dimethyl(pet-
4-enyloxy)(phenyl)silane 80 
 
(Scheme 2.8) 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc piperidine 2 (185 mg, 192 µL, 1.0 mmol, 
1.0 eq.) in 2-MeTHF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 95:5 
hexane-Et2O as eluent gave 8:2 mixture (by 
1H NMR spectroscopy) of PhMe2SiCl and 
silylether 80 (219 mg, 183 mg of PhMe2SiCl and 36 mg, 12% yield of 80) as a colourless 
oil, silyl piperidine 79 (74 mg, 23%) as a colourless oil and starting material 2 (23 mg, 
11%). 
Lab Book Reference: WSK/3/087 
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Dimethyl(pet-4-enyloxy)(phenyl)silane 80 
 
 (Scheme 2.9) 
PhMe2SiCl (171 mg, 182 µL, 1.1 mmol) was added dropwise to a solution of 4-penten-1-ol 
(86 mg, 103 µL, 1.0 mmol) and imidazole (136 mg, 2.0 mmol) in stirred DMF (8 mL) at rt 
under Ar. The resulting solution was stirred at rt for 16 h. The mixture was then diluted 
with Et2O (10 mL) and washed with saturated NH4Cl (10 mL) and the brine(aq) (2 × 10 mL). 
The organic layer was then dried (MgSO4) and evaporated under reduced pressure to give 
the crude product. Purification by flash column chromatography on silica with 98:2 
hexane-EtOAc as eluent gave silylether 80 (153 mg, 69%) as a colourless oil, RF (98:2 
hexane-EtOAc) 0.2; IR (ATR) 2952 cm-1;1H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 2H, 
Ph), 7.42-7.34 (m, 3H, Ph), 5.79 (ddt, J = 17.0, 10.0, 7.0 Hz, CH=CH2), 4.99 (ddt, J = 17.0, 
2.0, 1.0 Hz, 1H, CH=CH2), 4.93 (ddt, J = 10.0, 2.0, 1.0 Hz, 1H, CH=CH2), 3.60 (t, J = 8.0 
Hz, OCH2), 2.08 (dtdd, J = 7.0, 7.0, 1.0, 1.0 Hz, 2.0.H, CH2CH=CH2), 1.63 (tt, J = 8.0, 7.0 
Hz, CH2), 0.38 (s, 6H, SiMe2); 
13C NMR (100.6 MHz, CDCl3) δ 138.4 (ipso-Ph), 138.0 
(CH=CH2), 133.5 (Ph), 129.5 (Ph), 127.8 (Ph), 114.6 (CH=CH2), 62.5 (OCH2), 31.7 (CH2), 
30.0 (CH2), ‒1.8 (SiMe2). Attempted characterisation by ESI mass spectrometry was not 
successful. 
Lab Book Reference: WSK/3/094 
 
N-Boc azepane 3 
 
Hexamethylene imine (5.5 g, 6.19 mL, 55 mmol) was added dropwise to a stirred solution 
of di-tert-butyl dicarbonate (9.8 g, 45 mmol) in THF (15 mL) at 0 °C under Ar. The 
resulting solution was allowed to warm to rt and stirred at rt for 1 h. Then, 10% NaHCO3(aq) 
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(20mL) was added and the two layers were separated. The aqueous layer was extracted 
with Et2O (2 × 20 mL). The combined organic layers were washed with saturated brine (20 
mL), dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by Kügelrohr short path distillation gave N-Boc azepane 3 (7.4 g, 68%) as a 
colourless oil, bp 120-125 °C/1.0 mmHg (lit.,120 bp 60-70 °C/0.5 mmHg); 1H NMR (400 
MHz, CDCl3) (50:50 mixture of rotamers) δ 3.38 (t, J = 6.0 Hz, 2H, NCH2), 3.31 (t, J = 6.0 
Hz, 2H, NCH2),1.72-1.59 (m, 4H, CH2), 1.56-1.49 (m, 4H, CH2), 1.45 (s, 9H, CMe3); 
13C 
NMR (100.6 MHz, CDCl3) (rotamers) δ 155.7 (C=O), 78.9 (CMe3), 46.9 (NCH2), 46.5 
(NCH2), 28.5 (CMe3), 28.4 (CH2), 27.4 (CH2), 26.8 (CH2). Spectroscopic data consistent 
with those reported in the literature.120  
Lab Book Reference: WSK/3/041 
 
2-Trimethylsilyl azepane-1carboxylic acid tert-buyl ester 6 
 
Scheme 2.11 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc azepane 3 (199 mg, 227 µL, 1.0 mmol) 
in Et2O (7 mL) at ‒40 °C for 1 h and Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude 
product. Purification by flash column chromatography on silica with 8:2 hexane-Et2O as 
eluent gave silylated azepane 6 (148 mg, 55%) as a colourless oil, RF (8:2 hexane-Et2O) 
0.4; (ATR) 2925, 1682, 830, 783, 699 cm-1; 1H NMR (400 MHz, CDCl3) (55:45 mixture of 
rotamers) δ 3.88-3.81 (m, 0.45H, NCH), 3.68-3.60 (m, 0.55H, NCH), 3.33 (dd, J = 13.0, 
6.5 Hz, 0.55H, NCH), 3.43 (dd, J = 13.0, 6.5 Hz, 0.45H, NCH), 2.69 (ddd, J = 13.0, 11.0, 
2.0 Hz, 0.55H, NCH), 2.55 (ddd, J = 13.0, 11.0, 2.0 Hz, 0.45H, NCH), 2.00-1.72 (m, 3H, 
CH), 1.72-1.61 (m, 1H, CH), 1.57-1.49 (m, 1H, CH), 1.46 (s, 4.05H, CMe3), 1.44 (s, 4.95H, 
CMe3), 1.40-1.07 (m, 3H, CH), 0.013 (s, 4.05H, SiMe3), 0.010 (s, 4.95H, SiMe3); 
13C 
NMR (100.6 MHz, CDCl3) (rotamers) δ 155.7 (C=O), 155.6 (C=O), 78.9 (CMe3), 78.4 
(CMe3), 47.4 (NCH), 46.9 (NCH), 44.9 (NCH2), 44.1 (NCH2), 29.8 (CH2), 29.7 (CH2), 
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29.6 (CH2), 29.3 (CH2), 29.1 (CH2), 28.9 (CH2), 28.6 (CMe3), 28.5 (CMe3), 27.5 (CH2), 
27.3 (CH2), ‒2.56 (SiMe3), ‒2.66 (SiMe3) and recovered N-Boc azepane 3 (25 mg, 12 %) 
as a colourless oil. Attempted characterisation by ESI mass spectrometry was not 
successful. 
Lab Book Reference: WSK/3/055 
 
Scheme 2.11 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc azepane 3 (199 mg, 227 µL, 1.0 mmol) 
in Et2O (7 mL) at ‒40 °C for 2 h and Me3SiCl (218 mg, 256 µL, 2.0 mmol) gave the crude 
product. Purification by flash column chromatography on silica with 8:2 hexane-Et2O as 
eluent gave silylated azepane 6 (145 mg, 53%) as a colourless oil and recovered N-Boc 
azepane 3 (12 mg, 6%) as a colourless oil.  
Lab Book Reference: WSK/3/050 
 
2-(Dimethyl(phenyl)silyl)azepane-1carboxylic acid tert-butyl ester 81 
 
Scheme 2.11 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc azepane 3 (199 mg, 227 µL, 1.0 mmol) 
in Et2O (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
Et2O as eluent gave silylated azepane 81 (216 mg, 65%) as a colourless oil, RF (8:2 
hexane-Et2O) 0.4; IR (ATR) 3069, 2965, 2928, 2856, 1681 (C=O), 1251, 1150, 1117, 829, 
783, 699 cm-1;1H NMR (400 MHz, CDCl3) (55:45 mixture of rotamers) δ 7.57-7.46 (m, 2H, 
Ph), 7.42-7.29 (m, 3H, Ph), 3.80-3.74 (m, 0.45H, NCH), 3.70 (dd, J = 13.5, 6.0 Hz, 0.55H, 
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NCH), 3.63 (dd, J = 13.5, 6.0 Hz, 0.45H, NCH), 3.58-3.48 (m, 0.55H, NCH), 2.51 (ddd, J 
= 14.0, 11.0, 2.0 Hz, 0.55H, NCH), 2.36 (ddd, J = 14.0, 11.0, 2.0 Hz, 0.45H, NCH), 1.95-
1.63 (m, 3H, CH), 1.44 (s, 4.05H, CMe3), 1.42 (s, 4.95H, CMe3), 1.31-1.00 (m, 3H, CH), 
0.98-0.77 (m, 2H, CH), 0.33 (s, 6H, SiMe3); 
13C NMR (100.6 MHz, CDCl3) (rotamers) δ 
162.9 (C=O), 134.1 (ipso-Ph), 134.0 (ipso-Ph), 133.0 (Ph), 129.2 (Ph), 128.9 (Ph), 127.8 
(Ph), 127.7 (Ph), 127.6 (Ph), 79.0 (CMe3), 78.5 (CMe3), 58.0 (NCH), 57.8 (NCH), 47.3 
(NCH2), 46.8 (NCH2), 29.9 (CH2), 29.6 (CH2), 29.5 (CH2), 29.2 (CH2), 29.1 (CH2), 28.8 
(CH2), 28.52 (CMe3), 28.50 (CMe3), 27.4 (CH2), 27.2 (CH2), ‒4.0 (SiMe), ‒4.66 (SiMe), 
‒4.67 (SiMe). Attempted characterisation by ESI mass spectrometry was not successful.  
Lab Book Reference: WSK/3/077 
 
2-(Dimethyl(phenyl)silyl)azepane-1carboxylic acid tert-butyl ester 81, dimethyl(pet-4-
enyloxy)(phenyl)silane 80, 2-methyl-5-(dimethylphenylsilyl)tetrahydrofuran 82 
 
Scheme 2.12 
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
TMEDA (151 mg, 195 µL, 1.3 mmol) and N-Boc azepane 3 (199 mg, 227 µL, 1.0 mmol) 
in 2-MeTHF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave 
the crude product. Purification by flash column chromatography on silica with 8:2 hexane-
Et2O as eluent gave silylether 80 (107 mg, 37%) as a colourless oil, silyl 2-MeTHF 82 (as 
a 70:30 mixture of diastereomers) (13 mg, 1%) as a colourless oil, silylated azepane 81 (67 
mg, 20%) as a colourless oil, and recovered N-Boc azepane 3 (109 mg, 55%) as a 
colourless oil.  
Lab Book Reference: WSK/3/086 
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4.4 Experimental for Chapter 3 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128 
 
(Scheme 3.26) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THF (7 mL) at ‒78 °C for 1 h and PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 hexane-EtOAc as eluent gave 128 (158 mg, 63%) as a 
colourless oil, RF (98:2 hexane-EtOAc) 0.6;
 1H NMR (400 MHz, CDCl3) δ 7.54-7.47 (m, 
2H, Ph), 7.39-7.31 (m, 3H, Ph), 1.62-1.49 (m, 1H, CH), 1.19-1.05 (m, 1H, CH), 0.94 (d, J 
= 7.0 Hz, 3H, CHMe), 0.90 (t, J = 7.5 Hz, 3H, CH2Me), 0.83-0.71 (m, 1H, CH), 0.25 (s, 
3H, SiMe), 0.24 (s, 3H, SiMe); 13C NMR (100.6 MHz, CDCl3) δ 138.9 (ipso-Ph), 133.9 
(Ph), 128.7 (Ph), 127.6 (Ph), 24.6 (CH2), 21.2 (CH2Me), 13.54 (CHMe), 13.45 (CHMe), 
‒4.7 (SiMe), ‒4.8 (SiMe) and silyl THF 127 (4 mg, 1%) as a colourless oil.  
Lab Book Reference: WSK/3/100 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 3-methylpentanyldimethylphenylsilane 129, vinyloxydimethylphenylsilane 
 
(Scheme 3.27) 
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Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained a 45:15:20:20 
mixture (by 1H NMR spectroscopy) of 127, 128, 129 and the silyl enol ether. Diagnostic 
signals for the silyl snol ether: 1H NMR (400 MHz, CDCl3) δ 6.40 (dd, J = 13.5, 6.0 Hz, 
1H, CH=CH2), 4.47 (d, J = 13.5 Hz, 1H, =CH2), 4.14 (d, J = 6.0 Hz, 1H, =CH2). 
Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as eluent 
gave a 75:25 mixture (by 1H NMR spectroscopy) of 129 and 128 (47 mg, 34 mg (6% yield) 
of 129 and 13 mg (5% yield) of 128) as a colourless oil, RF (98:2 hexane-EtOAc) 0.6; 
diagnostic signals for 129: 1H NMR (400 MHz, CDCl3) δ 1.41-1.20 (m, 2H, CH2), 0.83 (d, 
J = 5.5 Hz, 3H, CHMe), 0.82 (t, J = 7.0 Hz, 3H, CH2Me) and silyl THF 127 (77 mg, 29%) 
as a colourless oil, RF (98:2 hexane-EtOAc) 0.2; 
1H NMR (400 MHz, CDCl3) δ 7.61-7.54 
(m, 2H, Ph), 7.39-7.32 (m, 3H, Ph), 3.78 (ddd, J = 7.0, 7.0, 7.0 Hz, 1H, OCH), 3.68 (ddd, J 
= 7.0, 7.0, 7.0 Hz, 1H, OCH), 3.47 (dd, J = 11.0, 7.0 Hz, 1H, OCH), 2.03-1.92 (m, 1H, 
CH), 1.88-1.77 (m, 2H, CH), 1.70-1.59 (m, 1H, CH), 0.34 (s, 3H, SiMe), 0.32 (s, 3H, 
SiMe); 13C NMR (100.6 MHz, CDCl3) δ 137.2 (ipso-Ph), 134.0 (Ph), 129.1 (Ph), 127.8 
(Ph), 71.6 (OCH), 69.4 (OCH2), 28.1 (CH2), 27.0 (CH2), ‒5.3 (SiMe), ‒5.4 (SiMe). 
Attempted characterisation by ESI and ATCI mass spectrometry was not successful.  
Lab Book Reference: WSK/3/092 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 3-methylpentanyldimethylphenylsilane 129 
 
(Table 3.2, entry 2) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
THF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude 
product, which contained a 50:30:20 mixture (by 1H NMR spectroscopy) of 127, 128 and 
129. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as 
eluent gave a 55:45 mixture (by 1H NMR spectroscopy) of 129 and 128 (59 mg, 30 mg 
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(5% yield) of 129 and 28 mg (11% yield) of 128) as a colourless oil, RF (98:2 hexane-
EtOAc) 0.2 and silyl THF 127 (79 mg, 29%) as a colourless oil.  
Lab Book Reference: WSK/3/093 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 3-methylpentanyldimethylphenylsilane 129, vinyloxydimethylphenylsilane 
 
(Table 3.2, entry 3) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THF (7 mL) at ‒40 °C for 40 min and PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained a 45:40:10:5 mixture 
(by 1H NMR spectroscopy) of 127, 128, 129 and the silyl enol ether. Purification by flash 
column chromatography on silica with 98:2 hexane-EtOAc as eluent gave 128 (44 mg, 
18%) as a colourless oil and silyl THF 127 (84 mg, 31%) as a colourless oil. 
Lab Book Reference: WSK/4/009 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 3-methylpentanyldimethylphenylsilane 129 
 
(Table 3.2, entry 4) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
THF (7 mL) at ‒40 °C for 40 min and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the 
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crude product, which contained a 50:40:10 mixture (by 1H NMR spectroscopy) of 128, 127 
and 129. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc 
as eluent gave a 75:25 mixture (by 1H NMR spectroscopy) of 128 and 129 (92 mg, 67 mg 
(27% yield) of 128 and 26 mg (5%) of 129) as a colourless oil and silyl THF 127 (81 mg, 
30%) as a colourless oil.  
Lab Book Reference: WSK/4/011 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128 
 
(Table 3.2, entry 5) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THF (7 mL) at ‒40 °C for 20 min and PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained a 70:30 mixture (by 
1H NMR spectroscopy) of 128 and 127. Purification by flash column chromatography on 
silica with 98:2 hexane-EtOAc as eluent gave 128 (76 mg, 30%) as a colourless oil, a 
55:45 mixture (by 1H NMR spectroscopy) of 128 and PhMe2SiCl (57 mg, 29 mg (11% 
yield) of 128 and 29 mg of PhSiMe2Cl) as a colourless oil and silyl THF 127 (68 mg, 14%) 
as a colourless oil.  
Lab Book Reference: WSK/4/003 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128 
 
(Table 3.2, entry 6) 
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Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
THF (7 mL) at ‒40 °C for 20 min and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the 
crude product, which contained a 70:30 mixture (by 1H NMR spectroscopy) of 128 and 
127. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as 
eluent gave 128 (128 mg, 51%) as a colourless oil and and silyl THF 127 (26 mg, 21%) as 
a colourless oil. 
Lab Book Reference: WSK/4/002 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128 
 
(Table 3.2, entry 7) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THF (7 mL) at ‒40 °C for 10 min and PhMe2SiCl 
(314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained a 95:5 mixture (by 
1H NMR spectroscopy) of 128 and 127. Purification by flash column chromatography on 
silica with 98:2 hexane-EtOAc as eluent gave silyl THF 127 (30 mg, 11%) as a colourless 
oil.  
Lab Book Reference: WSK/3/099 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, benzylphenyldimethylsilane 130 
 
(Scheme 3.28) 
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Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THF (72 mg, 81 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in toluene (7 
mL) at ‒40 °C for 20 min and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude 
product, which contained a 80:15:5 mixture (by 1H NMR spectroscopy) of 130, 128 and 
127. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as 
eluent gave 128 (19 mg, 8%) as a colourless oil, 130 (224 mg, 76%), RF (98:2 hexane-
EtOAc) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.48-7.44 (m, 2H, Ph), 7.38-7.33 (m, 3H, Ph), 
7.21-7.15 (m, 2H, Ph), 7.10-7.03 (m, 1H, Ph), 6.96-6.91 (m, 2H, Ph), 2.31 (s, 2H, CHPh), 
0.25 (s, 6H, SiMe) and silyl THF 127 (9 mg, 5%) as a colourless oil. Spectroscopic data of 
130 consistent with those reported in the literature.124 
Lab Book Reference: WSK/4/006 
 
2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 3-methylpentanyldimethylphenylsilane 129 
 
(Scheme 3.29) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THF (72 mg, 81 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in Et2O (7 mL) 
at ‒40 °C for 20 min and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude product, 
which contained a 90:10 mixture (by 1H NMR spectroscopy) of 128 and 127. Purification 
by flash column chromatography on silica with 98:2 hexane-EtOAc as eluent gave a 85:15 
mixture (by 1H NMR spectroscopy) of 128 and 129 (136 mg, 113 mg (45% yield) of 128 
and 23 mg of 129) as a colourless oil and silyl THF 127 (2 mg, 0.7%) as a colourless oil.  
Lab Book Reference: WSK/4/010 
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2-(Dimethylphenylsilyl)tetrahydrofuran 127, 1-methylpropyldimethylphenylsilane  
128, 
 
(Scheme 3.31) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THF (72 mg, 81 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in hexane (7 
mL) at ‒40 °C for 20 min and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude 
product, which contained a 90:10 mixture (by 1H NMR spectroscopy) of 128 and 127. 
Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as eluent 
gave 128 (93 mg, 37%) as a colourless oil and silyl THF 127 (21 mg, 10%) as a colourless 
oil.  
Lab Book Reference: WSK/4/007 
 
2-(diphenylhydroxymethyl)-tetrahydrofuran 131 
 
(Scheme 3.32) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
THF (7 mL) at ‒40 °C for 40 min and a solution of benzophenone (364 mg, 2.0 mmol) in 
THF (1 mL) gave the crude product. Purification by flash column chromatography on 
silica with 9:1 petrol-EtOAc as eluent gave hydroxyl THF 131 (107 mg, 32%) as a white 
solid, mp 50-52 °C, RF (9:1 petrol-EtOAc) 0.3; IR (ATR) 3483 (OH), 3024, 2869, 1447, 
1062, 749, 697, 635 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 2H, Ph), 7.43-7.37 
(m, 2H, Ph), 7.34-7.27 (m, 4H, Ph), 7.25-7.15 (m, 2H, Ph), 4.89 (dd, J = 8.0, 6.5 Hz, 1H, 
OCH), 3.99-3.89 (m, 2H, OCH), 2.99 (s, 1H, OH), 1.95-1.78 (m, 4H, CH); 13C NMR 
(100.6 MHz, CDCl3) δ 146.5 (ipso-Ph), 144.4 (ipso-Ph), 128.1 (Ph), 128.0 (Ph), 127.0 (Ph), 
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126.8 (Ph), 126.6 (Ph), 125.5 (Ph), 82.9 (OCH), 78.3 (OCPh), 69.8 (OCH2), 26.8 (CH2), 
26.2 (CH2); MS (ESI) m/z 277 [(M + Na)
+, 100]; HRMS (ESI) m/z calcd for C17H18O2 (M 
+ Na)+ 277.1199, found 277.1194 (+1.5 ppm error).  
Lab Book Reference: WSK/4/013 
 
2-(α-Hydroxybenzyl) tetrahydrofuran 118, 2-methyl-1-phenylbutan-1-ol 74 
 
(Scheme 3.32) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
THF (7 mL) at ‒40 °C for 40 min and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the 
crude product, which contained a 50:50 mixture (by 1H NMR spectroscopy) of 74 and 118 
(both as a 50: 50 mixture of diastereomers). Purification by flash column chromatography 
on silica with 98:2 hexane-EtOAc as eluent gave a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 74 (68 mg, 32%) as a colourless oil and a 60:40 
mixture (by 1H NMR spectroscopy) of diastereomeric hydroxy THFs 118 (71 mg, 20%) as 
a colourless oil, RF (98:2 hexane-EtOAc) 0.2; 
1H NMR (400 MHz, CDCl3) δ 7.42-7.21 (m, 
5H, Ph), 4.91 (d, J = 3.5 Hz, 0.6H, OCHPh), 4.42 (d, J = 7.0 Hz, 0.4H, OCHPh), 4.06 (ddd, 
J = 7.0, 7.0, 4.0 Hz, 0.6H, OCH), 4.00 (ddd, J = 7.0, 7.0 Hz, 0.4H, OCH), 3.94-3.74 (m, 
3H, OCH), 3.07 (br s, 0.4H, OH), 2.63 (br s, 0.6H, OH), 1.96-1.48 (m, 4H, CH); 13C NMR 
(100.6 MHz, CDCl3) δ 140.5 (ipso-Ph), 140.4 (ipso-Ph), 128.3 (Ph), 128.2 (Ph), 127.9 (Ph), 
127.4 (Ph), 126.9 (Ph), 126.0 (Ph), 83.4 (OCHPh), 83.1 (OCHPh), 76.9 (OCH), 73.9 
(OCH), 69.0 (OCH2), 68.4 (OCH2), 27.9 (CH2), 26.0 (CH2), 25.9 (CH2), 24.7 (CH2). 
Spectroscopic data consistent with those reported in the literature.88,125 
Lab Book Reference: WSK/4/012 
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Dimethyl(pet-4-enyloxy)(phenyl)silane 80, 2-butanol 132, 1-methylpropyldimethyl 
phenylsilane 128 
 
(Scheme 3.33) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in 2-MeTHF (7 mL) at ‒78 °C for 1 h and 
PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained a 
35:25:40 mixture (by 1H NMR spectroscopy) of alkene 80, 2-butanol 132 and silane 128. 
Purification by flash column chromatography on silica with 98:2 hexane-EtOAc as eluent 
gave silane 128 (9 mg, 4%) as a colourless oil, RF (98:2 hexane-EtOAc) 0.4 and a 60:40 
mixture (by 1H NMR spectroscopy) of alkene 80 and 2-butanol 132 (83 mg, 68 mg (31% 
yield) of 80 and 15 mg (20% yield) of 132) as a colourless oil, RF (98:2 hexane-EtOAc) 0.2. 
Diagnostic signals for 2-butanol 132: 1H NMR (400 MHz, CDCl3) δ 3.77-3.68 (m, 1H, 
OCH), 1.51-1.36 (m, 2H, CH), 1.10 (d, J = 6.0 Hz, 3H, CHMe), 0.84 (t, J = 7.5 Hz, 
CH2Me). Spectroscopic data for 2-butanol 132 consistent with those reported in the 
literature.126 
Lab Book Reference: WSK/3/091 
 
1-methylpropyldimethyl phenylsilane 128 
 
(Scheme 3.34) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
2-MeTHF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave a 
50:50 mixture (by 1H NMR spectroscopy) of 128 and PhMe2SiCl (333 mg, 156 mg (63%) 
of 128 and 117 mg of PhMe2SiCl) as a colourless oil.  
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Lab Book Reference: WSK/3/098 
 
Dimethyl(pet-4-enyloxy)(phenyl)silane 80, dimethyl(pet-3-enyloxy)(phenyl)silane 133 
 
(Scheme 3.35) 
Using general procedure F, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in 2-MeTHF (7 mL) at ‒40 °C for 1 h and 
PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude product, which contained an 85:15 
mixture (by 1H NMR spectroscopy) of alkenes 80 and 133. Purification by flash column 
chromatography on silica with 98:2 hexane-EtOAc as eluent gave an 85:15 mixture (by 1H 
NMR spectroscopy) of alkenes 80 and 133 (175 mg, 61%, i.e. 52% yield of 80 and 9% 
yield of 133) as a colourless oil, RF (98:2 hexane-EtOAc) 0.1; diagnostic signals for 133: 
1H NMR (400 MHz, CDCl3) δ 5.50-5.39 (m, 1H, =CH), 5.29-5.18 (m, 1H, =CH), 3.50 (t, J 
= 7.0 Hz, 2H, OCH2), 2.18 (dt, J = 7.0, 7.0 Hz, 2H, CH2CH=CH2). 
Lab Book Reference: WSK/3/089 
 
Dimethyl(pet-4-enyloxy)(phenyl)silane 80, dimethyl(pet-3-enyloxy)(phenyl)silane 133, 
2-methyl-5-(Dimethylphenylsilyl)tetrahydrofuran 82 
 
(Scheme 3.37) 
Using general procedure G, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) in 
2-MeTHF (7 mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the 
crude product, which contained a 55:15:30 mixture (by 1H NMR spectroscopy) of 80, 133 
and 82 (as a 70:30 mixture of diastereomers). Purification by flash column 
chromatography on silica with 98:2 hexane-EtOAc as eluent gave a 75:25 mixture (by 1H 
Chapter 4: Experimental 
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NMR spectroscopy) of 80 and 133 (32 mg, 11%, i.e. 8% yield of 80 and 3% yield of 133) 
as a colourless oil, RF (98:2 hexane-EtOAc) 0.2; a 20:10:70 mixture (by 
1H NMR 
spectroscopy) of 80, 133 and 82 (13 mg, 5%, i.e. 1% yield of 80, 0.5% yield of 133 and 
3.5% yield of 82) as a colourless oil, RF (98:2 hexane-EtOAc) 0.2 and 82 (as a 70:30 
mixture of diastereomers) (3 mg, 1%) as a colourless oil, RF (98:2 hexane-EtOAc) 0.1; IR 
(ATR) 2966, 1710, 1696 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.61-7.54 (m, 2H, Ph), 7.40-
7.31 (m, 3H, Ph), 4.03-3.89 (m, 1H, OCHMe), 3.74 (dd, J = 11.0, 6.5 Hz, 0.7H, OCH), 
3.57 (dd, J = 11.0, 6.5 Hz, 0.3H, OCH), 2.05-1.85 (m, 2H, CH), 1.79-1.64 (m, 1H, CH), 
1.46-1.27 (m, 1H, CH), 1.20 (d, J = 6.0 Hz, 2.1H, CHMe), 1.15 (d, J = 6.0 Hz, 0.9H, 
CHMe), 0.33 (s, 4.2H, SiMe), 0.32 (s, 1.8H, SiMe). Attempted characterisation by ESI and 
ATCI mass spectrometry was not successful.  
Lab Book Reference: WSK/3/090 
 
Dimethyl(pet-4-enyloxy)(phenyl)silane 80, dimethyl(pet-3-enyloxy)(phenyl)silane 133 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of TMEDA (151 mg, 195 µL, 1.3 mmol) in 2-MeTHF (7 mL) at ‒40 °C under Ar. 
The resulting solution was stirred at ‒40 °C for 1 h. Then, PhMe2SiCl (314 mg, 336 µL, 
2.0 mmol) was added. The resulting solution was stirred at ‒40 °C for 10 min and then 
allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3   10 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product, which contained an 85:15 mixture (by 1H NMR spectroscopy) of alkenes 80 
and 133. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc 
as eluent gave an 85:15 mixture (by 1H NMR spectroscopy) of alkenes 80 and 133 (175 mg, 
61%, i.e. 52% yield of 80 and 9% yield of 133) as a colourless oil, RF (98:2 hexane-EtOAc) 
0.1; diagnostic signals for 133: 1H NMR (400 MHz, CDCl3) δ 5.50-5.39 (m, 1H, =CH), 
5.29-5.18 (m, 1H, =CH), 3.50 (t, J = 7.0 Hz, 2H, OCH2), 2.18 (dt, J = 7.0, 7.0 Hz, 2H, 
CH2CH=CH2). 
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Lab Book Reference: WSK/3/089 
 
2-methyl-5-(Dimethylphenylsilyl)tetrahydrofuran 82 
 
(Scheme 3.38) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 2-
MeTHF (72 mg, 81 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in Et2O (7 
mL) at ‒40 °C for 1 h and PhMe2SiCl (314 mg, 336 µL, 2.0 mmol) gave the crude product. 
The 1H NMR spectrum of the crude product showed no identifiable products and therefore 
purification was not attempted. 
Lab Book Reference: WSK/3/095 
 
 
(Scheme 3.39) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THP (86 mg, 98 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in hexane (7 
mL) at ‒30 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude 
product. The 1H NMR spectrum of the crude product showed that only 74 was formed. 
Therefore, purification was not attempted.  
Lab Book Reference: WSK/4/026 
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2-(α-Hydroxybenzyl) tetrahydropyran 122, 2-methyl-1-phenylbutan-1-ol 74 
 
(Table 3.3, entry1) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THP (86 mg, 98 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in hexane (7 
mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 9:1 hexane-EtOAc as eluent 
gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 74 (81 mg, 
38%) as a colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 122 (57 mg, 29%) as a colourless oil, RF (9:1 hexane-EtOAc) 0.1; 
1H NMR (400 
MHz, CDCl3) δ 7.39-7.27 (m, 5H, Ph), 4.83 (d, J = 3.5 Hz, 0.5H, OCHPh), 4.70 (s, 1H, 
OH), 4.43 (d, J = 8.0 Hz, 0.5H, OCHPh), 4.12-4.01 (m, 1H, OCH), 3.54-3.44 (m, 1.5H, 
OCH), 3.35-3.28 (m,0.5H, OCH), 1.62-1.20 (m, 6H, CH); 13C NMR (100.6 MHz, CDCl3) 
δ 140.2 (ipso-Ph), 140.0 (ipso-Ph), 128.3 (Ph), 128.1 (Ph), 128.0 (Ph), 127.3 (Ph), 127.3 
(Ph), 126.4 (Ph), 82.0 (OCHPh), 81.0 (OCHPh), 77.8 (OCH), 75.7 (OCH), 68.9 (OCH2), 
68.5 (OCH2), 27.4 (CH2), 26.0 (CH2), 25.8 (CH2), 24.0 (CH2), 22.9 (CH2), 22.8 (CH2). 
Spectroscopic data consistent with those reported in the literature.127 
Lab Book Reference: WSK/4/028 
 
2-(α-Hydroxybenzyl) tetrahydropyran 122, 2-methyl-1-phenylbutan-1-ol 74 
 
(Table 3.3, entry2) 
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Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 
THP (86 mg, 98 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in hexane (7 
mL) at 0 °C for 2 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 9:1 hexane-EtOAc as eluent 
gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 74 (37 mg, 
18%) as a colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 122 (50 mg, 26%) as a colourless oil. 
Lab Book Reference: WSK/5/005 
 
 
(Scheme 3.41) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
TMEDA (151 mg, 195 µL, 1.3 mmol) in THP (7 mL) at 0 °C for 2 h and benza ldehyde 
(228 mg, 203 µL, 2.0 mmol) gave the crude product. The 1H NMR spectrum of the crude 
product showed no identifiable products and therefore purification was not attempted.  
Lab Book Reference: WSK/5/006 
 
Methyl N-(tert-butoxycarbonyl)pyrrolidine-2-carboxylate 22 and pyrrolidine-1,2,2-
tricarboxylic acid 1-tert-butyl ester 2,2-dimethyl ester 70 
 
(Table 3.4, entry 1) 
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Using general procedure H, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒78 °C for 1 h and 
methyl chloroformate (283 mg, 231 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 hexane-EtOAc as eluent gave methyl ester 
22 (24 mg, 10%) as a colourless oil, RF (8:2 hexane-EtOAc) 0.2; 
1H NMR (400 MHz, 
CDCl3) (60:40 mixture of rotamers) δ 4.32 (dd, J = 8.5, 5.0 Hz, 0.4H, NCH), 4.22 (dd, J = 
8.5, 4.5 Hz, 0.6H, NCH), 3.73 (s, 1.2H, OMe), 3.72 (s, 1.8H, OMe), 3.60-3.33 (m, 2H, 
NCH), 2.31-2.09 (m, 1H, CH), 2.07-1.77 ( m, 3H, CH), 1.46 (s, 3.6H, CMe3), 1.41 (s, 5.4H, 
CMe3); 
13C NMR ( 100.6 MHz, CDCl3) (rotamers) δ 173.7 (C=O, CO2Me), 153.7 (C=O, 
Boc), 79.8 (CMe3), 59.0 (NCH), 58.6 (NCH), 52.0 (OMe), 51.9 (OMe), 46.5 (NCH2), 46.2 
(NCH2), 30.8 (CH2), 29.8 (CH2), 28.3 (CMe3), 28.2 (CMe3), 24.3 (CH2), 23.6 (CH2) and 
dimethyl ester pyrrolidine 55 (174 mg, 60%) as a colourless oil, RF (8:2 hexane-EtOAc) 
0.1; 1H NMR (400 MHz, CDCl3) (65:35 mixture of rotamers) δ 3.79 (s, 2.1H, OMe), 3.78 
(s, 3.9H, OMe), 3.59 (t, J = 7.0 Hz, 1.35H, NCH), 3.52 (t, J = 7.0 Hz, 0.65H, NCH), 2.49 (t, 
J = 7.0 Hz, 1.3H, CH2), 2.46 (t, J = 7.0 Hz, CH2), 1.92-1.80 (m, 2H, CH2), 1.46 (s, 3.15H, 
CMe3), 1.39 (s, 5.85H, CMe3); 
13C NMR (100.6 MHz, CDCl3) (rotamers) δ 169.8 (C=O, 
CO2Me), 169.7 (C=O, CO2Me), 153.8 (C=O, Boc), 153.2 (C=O, Boc), 80.5 (CMe3), 80.2 
(CMe3), 71.9 (NCCH2), 71.8 (NCCH2), 52.9 (OMe), 52.7 (OMe), 47.3 (NCH2), 47.2 
(NCH2), 38.2 (CH2), 36.7 (CH2), 28.2 (CMe3), 28.0 (CMe3), 23.6 (CH2), 22.8 (CH2). 
Spectroscopic data for 22128 and 7015 consistent with those reported in the literature.  
Lab Book Reference: WSK/3/028 
 
(Table 2.4, entry 2) 
Using general procedure H, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒30 °C for 5 min and 
methyl chloroformate (283 mg, 231 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 hexane-EtOAc as eluent gave methyl ester 
22 (16 mg, 7%) as a colourless oil and dimethyl ester pyrrolidine 70 (143 mg, 50%) as a 
colourless oil. 
Lab Book Reference: WSK/3/031 
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(Table 2.4, entry 3) 
s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) was added dropwise to a stirred 
solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒30 °C 
under Ar. The resulting solution was stirred at ‒30 °C for 5 min. Then, methyl 
chloroformate (283 mg, 231 µL, 3.0 mmol) was added. The resulting solution was stirred 
at ‒30 °C for 10 min and allowed to warm to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was 
added and the two layers were separated. The aqueous layer was extracted with Et2O (3 × 
10 mL) and the combined layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on silica 
with 8:2 hexane-EtOAc as eluent gave methyl ester 22 (41 mg, 18%) as a colourless oil 
and dimethyl ester pyrrolidine 5 (151 mg, 53%) as a colourless oil.  
Lab Book Reference: WSK/3/040 
 
(Table 2.4, entry 4) 
Using general procedure H, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in THF (7 mL) at ‒20 °C for 5 min and 
methyl chloroformate (283 mg, 231 µL, 3.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with 8:2 hexane-EtOAc as eluent gave methyl ester 
22 (32 mg, 14%) as a colourless oil and dimethyl ester pyrrolidine 70 (129 mg, 45%) as a 
colourless oil. 
Lab Book Reference: WSK/3/033 
 
(Table 2.4, entry 5) 
Using general procedure H, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒78 °C for 1 h 
and methyl chloroformate (283 mg, 231 µL, 3.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 8:2 hexane-EtOAc as eluent 
gave methyl ester 22 (54 mg, 24%) as a colourless oil and dimethyl ester pyrrolidine 70 
(152 mg, 53%) as a colourless oil.  
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Lab Book Reference: WSK/3/027 
 
(Table 2.4, entry 6) 
Using general procedure H, s-BuLi (2.0 mL of a 1.3 M solution in hexanes, 2.6 mmol) and 
N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) in 2-MeTHF (7 mL) at ‒20 °C for 5 min 
and methyl chloroformate (283 mg, 231 µL, 3.0 mmol) gave the crude product. 
Purification by flash column chromatography on silica with 8:2 hexane-EtOAc as eluent 
gave methyl ester 22 (59 mg, 26%) as a colourless oil and dimethyl ester pyrrolidine 70 
(109 mg, 38%) as a colourless oil. 
Lab Book Reference: WSK/3/034 
 
(Table 2.4, entry 7) 
s-BuLi (1.6 mL of a 1.3 M solution in hexanes, 2.08 mmol) was added dropwise to a 
stirred solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) and TMEDA (302 mg, 
390 µL, 2.6 mmol) in Et2O (7 mL) at ‒30 °C under Ar. The resulting solution was stirred at 
‒30 °C for 5 min. Then, methyl chloroformate (283 mg, 231 µL, 3.0 mmol) was added. 
The resulting solution was stirred at ‒30 °C for 10 min and allowed to warm to rt over 1 h. 
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated. The aqueous 
layer was extracted with Et2O (3 × 10 mL) and the combined layers were dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 8:2 hexane-EtOAc as eluent gave dimethyl ester 
pyrrolidine 70 (60 mg, 21%) as a colourless oil.  
Lab Book Reference: WSK/3/032 
 
(Table 2.4, entry 8) 
s-BuLi (1.6 mL of a 1.3 M solution in hexanes, 2.08 mmol) was added dropwise to a 
stirred solution of N-Boc pyrrolidine 1 (171 mg, 175 µL, 1.0 mmol) and TMEDA (302 mg, 
390 µL, 2.6 mmol) in 2-MeTHF (7 mL) at ‒30 °C under Ar. The resulting solution was 
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stirred at ‒78 °C for 1 h. Then, methyl chloroformate (283 mg, 231 µL, 3.0 mmol) was 
added. The resulting solution was stirred at ‒30 °C for 10 min and allowed to warm to rt 
over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL) and the combined layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 8:2 hexane-EtOAc as eluent gave methyl ester 
22 (68 mg, 30%) as a colourless oil and dimethyl ester pyrrolidine 70 (70 mg, 24%) as a 
colourless oil. 
Lab Book Reference: WSK/3/025 
 
tert-Butyl 2,2-bis(hydroxymethyl)pyrrolidine-1-carboxylate 157 
 
(Scheme 3.46) 
A solution of dimethyl ester pyrrolidine 70 (915 mg, 3.2 mmol) in THF (2 mL) was added 
dropwise to a stirred suspension of LiAlH4 (241 mg, 6.4 mmol) in THF (20 mL) at 0 °C. 
The resulting suspension was stirred at 0 °C for 1 h. Then, H2O (2 mL), 20% NaOH(aq) (4 
mL) and H2O (10 mL) were added dropwise. The two layers were separated and the 
organic layer was dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 9:1 EtOAc-hexane as 
eluent gave diol 157 (376 mg, 51%) as a white solid, RF (9:1 EtOAc-hexane) 0.3; 
1H NMR 
(400 MHz, CDCl3) δ 3.88 (d, J = 11.5 Hz, 2H, CHOH), 3.58 (d, J = 11.5 Hz, 2H, CHOH), 
3.37 (t, J = 7.0 Hz, 2H, NCH2), 2.64-2.32 (br s, 2H, OH), 1.84-1.72 (m, 4H, CH2), 1.45 (s, 
9H, SiMe3). 
Lab Book Reference: WSK/3/043 
 
  
Chapter 4: Experimental 
193 
 
Diethyl 2-hexylmalonate 160 
 
(Scheme 3.49) 
A solution of diethyl malonate 142 (5.22 g, 5.0 mL, 32.6 mmol) in DMF (5 mL) was added 
dropwise to a stirred solution of NaH (1.44 g of a 60% dispersion in mineral oil, 35.9 
mmol) in DMF (100 mL) at 0 °C under Ar. The resulting mixture was then stirred with 1-
bromohexane at rt for 16 h. Ice-H2O (40 mL) and EtOAc (120 mL) were added and the two 
layers were separated. The aqueous layer was extracted with EtOAc (3   50 mL). The 
combined organic layers were washed with brine (5   50 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 hexane-EtOAc as eluent gave hexylmalonate 160 (6.76 
g, 85%) as a colourless oil, RF (9:1 hexane-EtOAc) 0.3; IR (ATR) 2928, 2858, 1731 (C=O), 
1150 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.19 (q, J = 7.0 Hz, 4H, OCH2), 3.30 (t, J = 7.5 
Hz, 1H, CH), 1.94-1.81 (m, 2H), 1.34-1.23 (m, 8H), 1.24 (t, J = 7.0 Hz, 6H, OCH2Me), 
0.87 (t, J = 7.0 Hz, 3H, CH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 169.6 (C=O), 61.2 
(OCH2), 52.1 (CH), 31.5 (CH2), 28.8 (CH2), 28.7 (CH2), 27.3 (CH2), 22.5 (CH2), 14.1 (Me), 
14.0 (Me). Spectroscopic data consistent with those reported in the literature.129 
Lab Book Reference: WSK/4/090 
 
Diethyl 2,2-dihexylmalonate 161 
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(Scheme 3.49) 
A solution of diethyl 2-hexylmalonate 160 (2.70 g, 11.0 mmol) in DMF (10 mL) was 
added dropwise to a stirred solution of NaH (485 mg of a 60% dispersion in mineral oil, 
12.1 mmol, 1.1 eq.) in DMF (80 mL) at 0 °C under Ar. The resulting mixture was then 
stirred with 1-bromohexane at rt for overnight. Ice-H2O (20 mL) and EtOAc (50 mL) were 
added and the two layers were separated. The aqueous layer was extracted with EtOAc (3 
  20 mL). The combined organic layers were washed with brine (5   20 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 9:1 hexane-Et2O as eluent gave 
dihexylmalonate 161 (3.16 g, 87%) as a colourless oil, RF (9:1 hexane-Et2O) 0.4; IR (ATR) 
2956, 2925, 2858, 1730 (C=O), 1180 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.16 (q, J = 7.0 
Hz, 4H, OCH2), 1.90-1.81 (m, 4H, CH), 1.35-1.20 (m, 18H, CH), 1.19-1.08 (m, 4H, CH), 
0.93-0.83 (m, 6H, Me); 13C NMR (100.6 MHz, CDCl3) δ 172.1 (C=O), 61.0 (OCH2), 57.5 
(C(CH2)), 32.0 (CH2), 31.5 (CH2), 29.5 (CH2), 23.8 (CH2), 22.5 (CH2), 14.1 (Me), 14.0 
(Me); MS (ESI) m/z 351 [(M + Na)+, 100], 329 [(M + H)+, 100]; HRMS (ESI) m/z calcd 
for C19H36O4 (M + Na)
+ 351.2506, found 351.2501 (+1.2 ppm error), (M + H)+ 329.2686, 
found 329.2680 (+1.4 ppm error).  
Lab Book Reference: WSK/5/013 
 
2-Benzylpropane-1,3-diol 162 
 
(Scheme 3.50) 
A solution of diethylbenzylmalonate (1.00 g, 941 µL, 4.0 mmol) in Et2O (3 mL) was added 
dropwise to a stirred suspension of LiAlH4 (660 mg, 16 mmol) in Et2O (15 mL) at 0 °C 
under Ar. The resulting suspension was stirred at rt for 3 h. Then, ice-H2O (10 mL), was 
added dropwise. The two layers were separated and the organic layer was dried (MgSO 4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 6:4 hexane-acetone as eluent gave diol 162 (619 mg, 
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93%) as a white solid, mp 55-57 °C (lit.,130 51-53 °C); RF (6:4 hexane-acetone) 0.2; IR 
(ATR) 3270 (OH), 2932, 1452, 1444, 1036, 1025, 744, 698, 547, 495 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.34-7.27 (m, 2H, Ph), 7.24-7.15 (m, 3H, Ph), 3.81 (ddd, J = 10.5, 3.5, 3.5 
Hz, 2H, OCH), 3.68 (ddd, J = 10.5, 7.0, 3.0 Hz, 2H, OCH), 2.63 (d, J = 7.5 Hz, 2H, 
CH2Ph), 2.19 (br s, 2H, OH), 2.13-2.02 (m, 1H, CH); 
13C NMR (100.6 MHz, CDCl3) δ 
139.8 (ipso-Ph), 128.9 (Ph), 128.4 (Ph), 126.1 (Ph), 65.7 (OCH2), 43.8 (CH), 34.2 (CH2Ph); 
MS (ESI) m/z 189 [(M + Na)+, 100]; HRMS (ESI) m/z calcd for C10H14O2 (M + Na)
+ 
189.0886, found 189.0891 (+2.7 ppm error). Spectroscopic data consistent with those 
reported in the literature.130,131 
Lab Book Reference: WSK/4/070 
 
2-Hexylpropane-1,3-diol 163 
 
(Scheme 3.50) 
A solution of hexylmalonate 160 (1.05 g, 4.3 mmol) in THF (5 mL) was added dropwise to 
a stirred suspension of LiAlH4 (711 mg, 17.2 mmol) in THF (15 mL) at 0 °C under Ar. The 
resulting suspension was stirred at rt for 3 h. Then, ice-H2O (5 mL) was added dropwise 
and the organic layer was dried (MgSO4) and evaporated under reduced pressure to give 
the crude product. Purification by flash column chromatography on silica with 7:3 hexane-
acetone as eluent gave diol 163 (581 mg, 85%) as a colourless oil, RF (7:3 hexane-acetone) 
0.2; 1H NMR (400 MHz, CDCl3) δ 3.82 (dd, J = 10.5, 4.0 Hz, 2H, OCH), 3.66 (dd, J = 
10.5, 7.5 Hz, 2H, OCH), 2.06 (br s, 2H, OH), 1.84-1.70 (m, 1H, CH), 1.38-1.17 (m, 10H), 
0.88 (t, J = 6.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) δ 66.8 (OCH2), 41.9 (CH), 
31.7 (CH2), 29.5 (CH2), 27.7 (CH2), 27.2 (CH2), 22.6 (CH2), 14.1 (Me). Spectroscopic data 
consistent with those reported in the literature.132 
Lab Book Reference: WSK/4/091 
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2,2-Dihexylpropane-1,3-diol 164 
 
(Scheme 3.50) 
A solution of dihexylmalonate 161 (1.65 g, 5.0 mmol) in THF (6 mL) was added dropwise 
to a stirred suspension of LiAlH4 (828 mg, 20.0 mmol) in THF (18 mL) at 0 °C under Ar. 
The resulting suspension was stirred at rt for 3 h. Then, ice-H2O (6 mL) was added 
dropwise and the organic layer was dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
85:15 hexane-acetone as eluent gave diol 164 (1.09 g, 90%) as a colourless oil, RF (85:15 
hexane-acetone) 0.2; IR (ATR)  3340 (OH), 2926, 2857, 1466, 1027 cm-1; 1H NMR (400 
MHz, CDCl3) δ 3.57 (d, J = 5.0 Hz, 4H, OCH2), 2.14 (t, J = 5.0 Hz, 2H, OH), 1.37-1.13 (m, 
20H, CH2), 0.88 (t, J = 7.0 Hz, 6H, Me); 
13C NMR (100.6 MHz, CDCl3) δ 69.6 (C(CH2)4), 
41.0 (CH2), 31.8 (CH2), 30.8 (CH2), 30.2 (CH2), 22.8 (CH2), 22.7 (CH2), 14.1 (Me); MS 
(ESI) m/z 267 [(M + Na)+, 100]; HRMS (ESI) m/z calcd for C15H32O2 (M + Na)
+ 267.2295, 
found 267.2289 (+2.1 ppm error). Spectroscopic data consistent with those reported in the 
literature.133 
Lab Book Reference: WSK/5/017 
 
2-Benzyl-3-hydroxypropyl 4-methylbenzenesulfonate 165 
 
n-BuLi (2.77 mL of a 2.0 M solution in hexanes, 5.5 mmol) was added dropwise to a 
stirred solution of diol 162 (920 mg, 5.5 mmol) in THF (35 mL) at 0 °C under Ar. The 
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resulting solution was stirred at 0 °C for 10 min. Then, a solution of p-TsCl (1.05 g, 5.5 
mmol) in THF (5 mL) was added. The resulting solution was stirred at 0 °C for 1 h and 
then allowed to warm to rt over 1 h. H2O (20 mL) was added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3   10 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 6:4 Et2O-
hexane as eluent gave tosylate 165 (1.46 g, 83%) as a colourless oil, RF (6:4 Et2O-hexane) 
0.2; IR (ATR) 3558 (OH), 2925, 1353, 1172, 944, 812, 665, 553 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.78 (d, J = 8.0 Hz, 2H, Ar), 7.34 (d, J = 8.0 Hz, 2H, Ar), 7.25-7.15 (m, 3H, Ar), 
7.08 (d, J = 8.0 Hz, 2H, Ar), 4.10 (dd, J = 10.0, 4.5 Hz, 1H, TsOCH), 3.99 (dd, J = 10.0, 
5.5 Hz, 1H, TsOCH), 3.65 (ddd, J = 11.0, 5.5, 5.5 Hz, 1H, HOCH), 3.57 (ddd, J = 11.0, 5.5, 
5.5 Hz, 1H, HOCH), 2.64 (dd, J = 11.5, 5.0 Hz, 1H, CHPh), 2.59 (dd, J = 11.5, 5.0 Hz, 1H, 
CHPh), 2.45 (s, 3H, Me), 2.20-2.03 (m, 1H, CH), 1.61 (t, J = 5.5 Hz, 1H, OH); 13C NMR 
(100.6 MHz, CDCl3) δ 144.9 (ipso-Ar), 138.6 (ipso-Ar), 132.7 (ipso-Ar), 129.9 (Ar), 128.9 
(Ar), 128.5 (Ar), 127.9 (Ar), 126.3 (Ar), 69.5 (TsOCH2), 61.3 (OCH2), 42.5 (CH), 33.5 
(CH2Ph), 21.6 (Me); MS (ESI) m/z 343 [(M + Na)
+, 100], 321 [(M + H)+, 100]; HRMS 
(ESI) m/z calcd for C17H20O4S (M + H)
+ 321.1155, found 321.1138 (+4.0 ppm error), (M + 
Na)+ 343.0975, found 343.0972 (+0.1 ppm error). Spectroscopic data consistent with those 
reported in the literature.131 
Lab Book Reference: WSK/4/071 
 
n-BuLi (1.18 mL of a 2.2 M solution in hexanes, 2.6 mmol) was added dropwise to a 
stirred solution of tosylate 165 (842 mg, 2.6 mmol) in THF (20 mL) at 0 °C under Ar. The 
resulting solution was stirred and heated at 60 °C for 6 h and then allowed to cool to rt over 
1 h. Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3   10 mL) and the combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 6:4 Et2O-hexane as eluent 
gave oxetane 168 (105 mg, 43%) as a colourless oil. 
Lab Book Reference: WSK/4/063 
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2-(Hydroxymethyl)octyl 4-methylbenzenesulfonate 166 
 
(Scheme 3.51) 
n-BuLi (4.0 mL of a 2.5 M solution in hexanes, 10.0 mmol) was added dropwise to a 
stirred solution of diol 163 (1.60 g, 10.0 mmol) in THF (60 mL) at 0 °C under Ar. The 
resulting solution was stirred at 0 °C for 10 min. Then, a solution of p-TsCl (1.90 g, 10.0 
mmol) in THF (5 mL) was added. The resulting solution was stirred at 0 °C for 1 h and 
then allowed to warm to rt over 1 h. H2O (40 mL) was added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3   40 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
EtOAc as eluent gave tosylate 166 (2.75 g, 88%) as a pale yellow oil, RF (8:2 hexane-
EtOAc) 0.1; IR (ATR) 3431 (OH), 2927, 1355, 1173, 942, 812, 666, 553 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H, o-SO2C6H4Me), 7.35 (d, J = 8.0 Hz, 2H, m-
SO2C6H4Me), 4.11 (dd, J = 10.0, 4.5 Hz, 1H, TsOCH), 4.03 (dd, J = 10.0, 6.0 Hz, 1H, 
TsOCH), 3.63 (dd, J = 11.0, 4.5 Hz, 1H, HOCH), 3.55 (dd, J = 11.0, 6.5 Hz, 1H, HOCH), 
2.45 (s, 3H, Me), 1.85-1.74 (m, 1H, CH), 1.34-1.14 (m, 10H), 0.86 (t, J = 6.5 Hz, 3H, 
CH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 144.8 (ipso-Ar), 132.9 (ipso-Ar), 129.9 (Ar), 
127.9 (Ar), 70.3 (TsOCH2), 61.9 (HOCH2), 40.5 (CH), 31.6 (CH2), 29.3 (CH2), 27.1 (CH2), 
26.7 (CH2), 22.6 (CH2), 21.6 (SO2C6H4Me), 14.1 (Me); MS (ESI) m/z 337 [(M + Na)
+, 
100]; HRMS (ESI) m/z calcd for C16H26O4S (M + Na)
+ 337.1444, found 337.1445 (+0.2 
ppm error). 
Lab Book Reference: WSK/4/098 
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2-(Hydroxymethyl)octyl 4-methylbenzenesulfonate 167 
 
(Scheme 3.51) 
n-BuLi (3.5 mL of a 2.5 M solution in hexanes, 8.9 mmol, 1.0 eq.) was added dropwise to 
a stirred solution of diol 164 (2.18 g, 8.9 mmol) in THF (60 mL) at 0 °C under Ar. The 
resulting solution was stirred at 0 °C for 10 min. Then, a solution of p-TsCl (1.70 g, 8.9 
mmol) in THF (5 mL) was added. The resulting solution was stirred at 0 °C for 1 h and 
then allowed to warm to rt over 1 h. H2O (40 mL) was added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3   40 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
EtOAc as eluent gave tosylate 167 (3.19 g, 90%) as a pale yellow oil, RF (8:2 hexane-
EtOAc) 0.3; IR (ATR) 3564 (OH), 2929, 2858, 1739, 1359, 1175, 956, 666, 554 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H, o-SO2C6H4Me), 7.35 (d, J = 8.0 Hz, 
2H, m-SO2C6H4Me), 3.68 (s, 2H, TsOCH2), 3.40 (d, J = 7.0 Hz, 1H, HOCH2), 2.45 (s, 3H, 
Me), 1.57 (br s, 1H, HOCH2), 3.88-3.80 (m, 20H, CH2), 0.87 (t, J = 6.5 Hz, 6H, Me); 
13C 
NMR (100.6 MHz, CDCl3) δ 144.8 (ipso-Ar), 132.9 (ipso-Ar), 129.9 (Ar), 127.9 (Ar), 72.3 
(TsOCH2), 64.3 (OCH2), 41.4 (CCH2), 31.7 (CH2), 29.9 (CH2), 29.8 (CH2), 22.6 (CH2), 
22.3 (CH2), , 21.0 (SO2C6H4Me), 14.2 (Me); MS (ESI) m/z 421 [(M + Na)
+, 100]; HRMS 
(ESI) m/z calcd for C22H38O4S (M + Na)
+ 421.2383, found 421.2375 (+2.7 ppm error).  
Lab Book Reference: WSK/5/021 
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3-Benzyl oxetane 168 
 
A solution of tosylate 165 (1.75 g, 5.5 mmol) in DMF (5 mL) was added dropwise to a 
stirred solution of NaH (657 mg of a 60% dispersion in mineral oil, 16.5 mmol) in DMF 
(20 mL) at 0 °C under Ar. The resulting mixture was then stirred at rt for 4 h. Ice-H2O (10 
mL) and EtOAc (10 mL) were added and the two layers were separated. The aqueous layer 
was extracted with EtOAc (3   10 mL). The combined organic layers were washed with 
brine (5   20 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 6:4 Et2O-hexane as 
eluent gave oxetane 168 (354 mg, 44%) as a colourless oil, RF (6:4 Et2O-hexane) 0.3; IR 
(ATR) 2957, 2955, 2865, 975, 850, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 
7.5, 7.0 Hz, 2H, Ph), 7.21 (t, J = 7.5 Hz, 1H, Ph), 7.12 (d, J = 7.0 Hz, 2H, Ph), 4.79 (dd, J 
= 7.5, 6.5 Hz, 2H, OCH), 4.48 (dd, J = 6.5, 6.5 Hz, 2H, OCH), 3.39-3.24 (m, 1H, CH), 
3.02 (d, J = 8.0 Hz, 2H, CH2Ph); 
13C NMR (100.6 MHz, CDCl3) δ 139.4 (ipso-Ph), 128.5 
(Ph), 128.3 (Ph), 126.3 (Ph), 77.2 (OCH2), 39.6 (CH2), 36.1 (CH); MS (ESI) m/z 171 [(M 
+ Na)+, 100]; HRMS (ESI) m/z calcd for C10H12O (M + Na)
+ 171.0780, found 171.0776 
(+2.7 ppm error). Spectroscopic data consistent with those reported in the literature.134 
Lab Book Reference: WSK/4/074 
 
3-Hexyloxetane 169 
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A solution of tosylate 166 (637 mg, 2.0 mmol) in DMF (8 mL) was added dropwise to a 
stirred solution of NaH (243 mg of a 60% dispersion in mineral oil, 6.1 mmol) in DMF (40 
mL) at 0 °C under Ar. The resulting mixture was then stirred at rt for 4 h. Ice-H2O (20 mL) 
and EtOAc (60 mL) were added and the two layers were separated. The aqueous layer was 
extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine 
(5 × 20 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 8:2 hexane-EtOAc as 
eluent gave oxetane 169 (204 mg, 71%) as a colourless oil, RF (9:1 hexane-EtOAc) 0.4; IR 
(ATR) 2955, 2922, 2856, 980 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.77 (dd, J = 8.0, 6.0 
Hz, 2H, OCH), 4.36 (dd, J = 6.0, 6.0 Hz, 2H, OCH), 3.02-2.88 (m, 1H, CH), 1.66 (dt, J = 
7.5, 7.5 Hz, 2H, CH2), 1.35-1.13 (m, 8H, CH2), 0.87 (t, J = 6.5 Hz, 3H, Me); 
13C NMR 
(100.6 MHz, CDCl3) δ 77.9 (OCH2), 35.3 (CH), 33.8 (CH2), 31.7 (CH2), 29.1 (CH2), 26.9 
(CH2), 22.6 (CH2), 14.1 (Me). Attempted characterisation by ESI mass spectrometry was 
not successful. 
Lab Book Reference: WSK/5/004 
 
 
A solution of tosylate 166 (637 mg, 2.0 mmol) in DMF (3 mL) was added dropwise to a 
stirred solution of NaH (243 mg of a 60% dispersion in mineral oil, 6.1 mmol) in DMF (10 
mL) at 0 °C under Ar. The resulting mixture was then stirred at rt for 4 h. Ice-H2O (10 mL) 
and EtOAc (10 mL) were added and the two layers were separated. The aqueous layer was 
extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with brine 
(3 × 10 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 8:2 hexane-EtOAc as 
eluent gave oxetane 169 (42 mg, 15%) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric hydroxy tosylates 171 (84 mg, 9%) as a colourless oil, RF 
(9:1 hexane-EtOAc) 0.4; 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.5 Hz, 2H, o-
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SO2C6H4Me), 7.34 (d, J = 8.5 Hz, 2H, m-SO2C6H4Me), 4.03 (dd, J = 9.5, 4.5 Hz, 0.5H, 
TsOCH), 4.02 (dd, J = 9.5, 4.5 Hz, 0.5H, TsOCH), 3.98 (dd, J = 9.5, 6.0 Hz, 1H, TsOCH), 
3.64 (dd, J = 11.0, 3.5 Hz, 0.5H, OCH), 3.63 (dd, J = 11.0, 3.5 Hz, 0.5H, OCH), 3.53 (dd, 
J = 11.0, 7.0 Hz, 1H, OCH), 3.48 (dd, J = 9.0, 4.0 Hz, 0.5H, OCH), 3.46 (dd, J = 9.0, 4.0 
Hz, 0.5H, OCH), 3.41-3.28 (m, 3H, OCH), 2.45 (s, 3H, Me), 1.91-1.80 (m, 2H, CH), 1.74 
(br s, 1H, OH), 1.30-1.17 (m, 20H, CH2), 0.88 (t, J = 6.5 Hz, 3H, Me), 0.86 (t, J = 7.0 Hz, 
3H, Me); 13C NMR (100.6 MHz, CDCl3) (mixture of diastereomers) δ 144.7 (ipso-Ar), 
132.9 (ipso-Ar), 129.8 (Ar), 127.9 (Ar), 74.9 (OCH2), 74.8 (OCH2), 70.4 (OCH2), 70.3 
(OCH2), 65.94 (OCH2), 65.91 (OCH2), 40.5 (CH), 38.6 (CH), 31.8 (CH2), 31.6 (CH2), 29.5 
(CH2), 29.3 (CH2), 28.0 (CH2), 27.6 (CH2), 27.2 (CH2), 26.63 (CH2), 22.62 (CH2), 22.56 
(CH2), 21.6 (Me), 14.08 (Me), 14.04 (Me); MS (ESI) m/z 479 [(M + Na)
+, 100], 457 [(M + 
H)+, 100]; HRMS (ESI) m/z calcd for C25H44O5S (M + Na)
+ 479.2802, found 479.2784 
(+3.2 ppm error), (M + H)+ 457.2982, found 457.2968 (+4.3 ppm error).  
Lab Book Reference: WSK/4/099 
 
Attempted formation of 33-dihexyloxetane 170 
 
A solution of tosylate 167 (3.74 g, 8.9 mmol) in DMF (20 mL) was added dropwise to a 
stirred solution of NaH (1.07 g of a 60% dispersion in mineral oil, 26.7 mmol) in DMF 
(150 mL) at 0 °C under Ar. The resulting mixture was then stirred at rt for 4 h. Ice-H2O (60 
mL) and EtOAc (150 mL) were added and the two layers were separated. The aqueous 
layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed 
with brine (3 × 50 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. The 1H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted.  
Lab Book Reference: WSK/5/023  
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2-(Dimethylphenylsilyl)benzyl-3-oxetane 172, 1-methylpropyldimethylphenylsilane  
128 
 
(Scheme 3.56) 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 3-
benzyl oxetane 168 (165 mg, 1.1 mmol) and TMEDA (167 mg, 217 µL, 1.4 mmol) in Et2O 
(7 mL) at ‒78 °C for 1 h and PhMe2SiCl (379 mg, 372 µL, 2.2 mmol) gave the crude 
product. Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as 
eluent gave silane 128 (215 mg, 77%) and a 66:34 mixture (by 1H NMR spectroscopy) of 
silylated oxetane 172 and PhMe2SiCl (91 mg, 49 mg (16%) of silylated oxetane 172 and 42 
mg, (11%) of PhMe2SiCl) as a colourless oil, RF (98:2 CH2Cl2-Et2O) 0.5. Diagnostic 
signals for silylated oxetane 172: 1H NMR (400 MHz, CDCl3) δ 4.57 (dd, J = 8.0, 6.0 Hz, 
1H, OCH), 4.44 (dd, J = 8.0, 6.0 Hz, 1H, OCH), 4.18 (dd, J = 6.0, 6.0 Hz, 1H, OCH), 4.13 
(dd, J = 6.0, 6.0 Hz, 1H, OCH), 3.69-3.56 (m, 1H, CH), 2.74 (d, J = 12.5 Hz, 1H, CHPh), 
0.19 (s, 6H, SiMe). 
Lab Book Reference: WSK/4/084 
 
Attempted lithiation-trapping of 3-benzyl oxetane 168 
 
(Scheme 3.57) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 3-
benzyl oxetane 168 (148 mg, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in Et2O 
(7 mL) at ‒40 °C for 2 h and PhMe2SiCl (369 mg, 331 µL, 2.0 mmol) gave the crude 
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product. Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as 
eluent gave an unidentifiable mixture (93 mg), RF (98:2 CH2Cl2-Et2O) 0.3. No starting 
material 168 or desired product 173 was found and therefore purification was not 
attempted. 
Lab Book Reference: WSK/4/079 
 
Attempted lithiation-trapping of 3-benzyl oxetane 168 
 
(Scheme 3.58) 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 3-
benzyl oxetane 168 (161 mg, 1.1 mmol) and TMEDA (163 mg, 211 µL, 1.4 mmol) in 
hexane (7 mL) at ‒40 °C for 2 h and PhMe2SiCl (369 mg, 331 µL, 2.0 mmol) gave the 
crude product. The 1H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted. 
Lab Book Reference: WSK/4/075 
 
Attempted lithiation-trapping of 3-benzyl oxetane 168 
 
(Scheme 3.59) 
Using general procedure E, s-BuLi (815 µL of a 1.3 M solution in hexanes, 1.0 mmol), 3-
benzyl oxetane 168 (121 mg, 0.8 mmol) and TMEDA (123 mg, 159 µL, 1.0 mmol) in 
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hexane (7 mL) at ‒40 °C for 1 h and a solution of benzophenone (297 mg, 1.6 mmol) in 
hexane (1 mL) gave the crude product. The 1H NMR spectrum of the crude product 
showed no identifiable products and therefore purification was not attempted.  
Lab Book Reference: WSK/4/068 
 
 
(Scheme 3.60) 
Using general procedure E, s-BuLi (1.3 mL of a 1.3 M solution in hexanes, 1.6 mmol), 3-
benzyl oxetane 168 (186 mg, 1.3 mmol) and TMEDA (189 mg, 244 µL, 1.6 mmol) in 
hexane (7 mL) at ‒20 °C for 1 h and PhMe2SiCl (427 mg, 413 µL, 2.5 mmol) gave the 
crude product. Purification by flash column chromatography on silica with 98:2 CH2Cl2-
Et2O as eluent gave silane 128 (77 mg, 25%) and an unidentifiable mixture (47 mg). No 
starting material 168 or desired product 173 was found. 
Lab Book Reference: WSK/4/075 
 
Attempted lithiation-trapping of 3-Hexyloxetane 175 
 
(Scheme 3.61) 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 3-
hexyl oxetane 169 (153 mg, 1.1 mmol) and TMEDA (162 mg, 209 µL, 1.4 mmol) in Et2O 
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(7 mL) at ‒78 °C for 1 h and benzaldehyde (227 mg, 218 µL, 2.1 mmol) gave the crude 
product which contained a 53:47 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 and starting material 169. Purification by flash column chromatography on 
silica with 99:1 CH2Cl2-Et2O as eluent gave a 50:50 mixture (by 
1H NMR spectroscopy) of 
diastereomeric alcohols 74 (147 mg, 64%) as a colourless oil and an starting material 169 
(88 mg, 57%) as a colourless oil.  
Lab Book Reference: WSK/5/008 
 
 
(Scheme 3.62) 
Using general procedure E, s-BuLi (1.3 mL of a 1.3 M solution in hexanes, 1.7 mmol), 3-
hexyl oxetane 169 (182 mg, 1.3 mmol) and TMEDA (193 mg, 249 µL, 1.7 mmol) in Et2O 
(7 mL) at ‒40 °C for 1 h and benzaldehyde (271 mg, 260 µL, 2.5 mmol) gave the crude 
product which contained a 56:44 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 and starting material 169. The 1H NMR spectroscopy of the crude product 
showed no desired product and therefore purification was not attempted.  
Lab Book Reference: WSK/5/016 
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(Scheme 3.63) 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 3-
hexyl oxetane 169 (155 mg, 1.1 mmol) and TMEDA (165 mg, 212 µL, 1.4 mmol) in 
hexane (7 mL) at ‒40 °C for 1 h and benzaldehyde (231 mg, 221 µL, 2.2 mmol) gave the 
crude product which contained a 58:42 mixture (by 1H NMR spectroscopy) of 
diastereomeric alcohols 74 and starting material 169. Purification by flash column 
chromatography on silica with 99:1 CH2Cl2-Et2O as eluent gave a 50:50 mixture (by 
1H 
NMR spectroscopy) of diastereomeric alcohols 74 (163 mg, 70%) as a colourless oil and 
an starting material 169 (99 mg, 64%) as a colourless oil.  
Lab Book Reference: WSK/5/018 
 
 
 
(Scheme 3.64) 
Using general procedure E, s-BuLi (0.8 mL of a 1.3 M solution in hexanes, 1.0 mmol), 3-
hexyl oxetane 169 (108 mg, 0.8 mmol) and TMEDA (114 mg, 148 µL, 1.0 mmol) in 
hexane (5 mL) at ‒20 °C for 1 h and benzaldehyde (161 mg, 154 µL, 1.5 mmol) gave the 
crude product which contained a 55:45 mixture (by 1H NMR spectroscopy) of 
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diastereomeric alcohols 74 and starting material 169. The 1H NMR spectroscopy of the 
crude product showed no desired product and therefore purification was not attempted.  
Lab Book Reference: WSK/5/024 
 
Attempted lithiation-trapping of 3-benzyl oxetane 169 
 
(Scheme 3.65) 
Using general procedure E, s-BuLi (0.8 mL of a 1.3 M solution in hexanes, 1.1 mmol), 3-
hexyl oxetane 169 (118 mg, 0.8 mmol) and TMEDA (125 mg, 161 µL, 1.1 mmol) in 
hexane (5 mL) at 0 °C for 1 h and benzaldehyde (176 mg, 168 µL, 1.6 mmol) gave the 
crude product. The 1H NMR spectroscopy of the crude product showed no desired product 
and therefore purification was not attempted.  
Lab Book Reference: WSK/5/025 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233 
 
(Table 3.6, entry 6) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
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mmol) in hexane (7 mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 233 (185 mg, 89%) as a white solid, mp 72-75 °C, RF (acetone) 0.2; IR (ATR) 
3124 (OH), 2939, 2854, 2808, 1449, 1118, 1104, 1029, 704 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.43-7.27 (m, 5H, Ph), 4.89 (d, J = 4.0 Hz, 0.5H, OCHPh), 4.52 (d, J = 8.0 Hz, 
0.5H, OCHPh), 4.03-3.92 (m, 1H, OCH), 3.79-3.67 (m, 1.5H, OCH), 3.62 (ddd, J = 11.0, 
8.0, 2.5 Hz, 0.5H, OCH), 3.13 (br s, 0.5H, OH), 2.77 (br s, 0.5H, OH), 2.66-2.58 (m, 1H, 
NCH), 2.48 (br d, J = 11.0 Hz, 0.5H, NCH), 2.33 (br d, J = 11.0 Hz, 0.5H, NCH), 2.23 (s, 
1.5H, NMe), 2.20 (s, 1.5H, NMe), 2.18-2.11 (m, 1H, NCH), 2.07 (dd, J = 11.0, 11.0 Hz, 
0.5H, NCH), 1.85 (dd, J = 11.0, 11.0 Hz, 0.5H, NCH); 13C NMR (100.6 MHz, CDCl3) δ 
134.0 (ipso-Ph), 139.6 (ipso-Ph), 128.5 (Ph), 128.3 (Ph), 128.2 (Ph), 127.6 (Ph), 127.1 (Ph), 
126.2 (Ph), 79.6 (OCHPh), 78.7 (OCHPh), 75.7 (OCH), 74.7 (OCH), 66.7 (OCH2), 66.7 
(OCH2), 56.4 (NCH2), 54.8 (NCH2), 54.6 (NCH2), 54.1 (NCH2), 46.3 (NMe), 46.2 (NMe); 
MS (ESI) m/z 208 [(M + H)+, 100]; HRMS (ESI) m/z calcd for C12H17NO2 (M + H)
+ 
208.1332, found 208.1329 (+1.4 ppm error).  
Lab Reference: WSK/4/023 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.6, entry 1) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒40 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 68:32 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
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diastereomeric mixture) and benzaldehyde (186 mg, 109 mg (51%) of 74 and 77 mg (36%) 
of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) of 
diastereomeric alcohols 233 (31 mg, 15%) as a white solid. 
Lab Reference: WSK/4/017 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.6, entry 2) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒40 °C for 3 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 (112 mg, 52%) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (88 mg, 42%) as a white solid. 
Lab Reference: WSK/4/019 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
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(Table 3.6, entry 3) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒30 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 (110 mg, 52%) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (83 mg, 40%) as a white solid. 
Lab Reference: WSK/4/018 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.6, entry 4) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒30 °C for 2 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 72:28 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
mixture of diastereomeric alcohols) and benzaldehyde (125 mg, 78 mg (37%) of 74 and 47 
mg (22%) of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (103 mg, 49%) as a white solid. 
Lab Reference: WSK/4/021 
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4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.6, entry 5) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒20 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 59:41 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
mixture of diastereomeric alcohols) and benzaldehyde (107 mg, 52 mg (24%) of 74 and 56 
mg (26%) of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (130 mg, 63%) as a white solid. 
Lab Reference: WSK/4/022 
 
(Table 3.6, entry 7) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at 20 °C for 30 min and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 (99 mg, 48%) as a white solid. 
Lab Reference: WSK/4/032 
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(Table 3.6, entry 8) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at 20 °C for 10 min and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 74 (137 mg, 66%) as a white solid. 
Lab Reference: WSK/4/032 
 
(Scheme 3.77) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in cyclohexane (7 mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 233 (169 mg, 82%) as a white solid. 
Lab Reference: WSK/4/036 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74, 4-Methyl-1phenylhexan-1-ol 73 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in Et2O (7 mL) at ‒40 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 mmol) 
gave the crude product. Purification by flash column chromatography on silica with 
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acetone as eluent gave a 50:50 mixture (by 1H NMR spectroscopy) of 74 and 73 (76 mg, 
47 mg (34%) of 74 and 29 mg (15%, 30% based on 2 equivalents of s-BuLi being 
consumed) of 73) as a colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) of 
diastereomeric alcohols 233 (33 mg, 16%) as a white solid. 
Lab Reference: WSK/4/014 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.7, entry 2) 
Using general procedure I, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (58 mg, 75 µL, 0.5 
mmol, 0.5 eq.) in hexane (7 mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 27:73 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
mixture of diastereomeric alcohols) and benzaldehyde (56 mg, 11 mg (5%) of 74 and 45 
mg (21%) of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (169 mg, 82%) as a white solid. 
Lab Reference: WSK/4/035 
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4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.7, entry 3) 
Using general procedure I, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (23 mg, 30 µL, 0.2 
mmol, 0.2 eq.) in hexane (7 mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
acetone as eluent gave a 35:65 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
mixture of diastereomeric alcohols) and benzaldehyde (67 mg, 17 mg (8%) of X and 50 mg 
(24%) of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) 
of diastereomeric alcohols 233 (164 mg, 79%) as a white solid. 
Lab Reference: WSK/4/037 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.7, entry 4) 
Using general procedure I, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (12 mg, 15 µL, 0.1 
mmol, 0.1 eq.) in hexane (7 mL) at 0 °C for 1 h and benzaldehyde (228 mg, 203 µL, 2.0 
mmol) gave the crude product. Purification by flash column chromatography on silica with 
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acetone as eluent gave a 33:67 mixture (by 1H NMR spectroscopy) of 74 (as a 50:50 
mixture of diastereomeric alcohols) and benzaldehyde (80 mg, 20 mg (9%) of 74 and 60 
mg (28%) of benzaldehyde) as a colourless oil and a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 233 (150 mg, 72%) as a white solid. 
Lab Reference: WSK/4/045 
 
4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.7, entry 5) 
Using general procedure I, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (150 µL of a 3.34 × 10-4 
M solution in hexane, 0.05 mmol, 0.05 eq.) in hexane (7 mL) at 0 °C for 2 h and 
benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with acetone as eluent gave a 33:67 mixture (by 1H 
NMR spectroscopy) of 74 (as a 50:50 mixture of diastereomeric alcohols) and 
benzaldehyde (84 mg, 20 mg (9%) of 74 and 60 mg (28%) of benzaldehyde) as a 
colourless oil and a 50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 
233 (142 mg, 68%) as a white solid. 
Lab Reference: WSK/4/050 
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4-Methyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 233, 2-methyl-1-phenylbutan-1-
ol 74 
 
(Table 3.7, entry 6) 
Using general procedure I, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (90 µL of a 1.11 × 10-4 
M solution in hexane, 0.01 mmol, 0.01 eq.) in hexane (7 mL) at 0 °C for 4 h and 
benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by flash 
column chromatography on silica with acetone as eluent gave a 50:50 mixture (by 1H 
NMR spectroscopy) of diastereomeric alcohols 74 (102 mg, 48%) as a colourless oil and a 
50:50 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 233 (55 mg, 27%) as 
a white solid. 
Lab Reference: WSK/4/060 
 
(Table 3.7, entry 7) 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
4-methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) in hexane (7 mL) at 0 °C for 1 h 
and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with acetone as eluent gave a 50:50 mixture (by 1H 
NMR spectroscopy) of diastereomeric alcohols 74 (159 mg, 74%) as a colourless oil. No 
desired product 233 was found. 
Lab Reference: WSK/4/024 
 
(Table 3.7, entry 8) 
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Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) and 
4-methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) in hexane (7 mL) at 0 °C for 2 h 
and benzaldehyde (228 mg, 203 µL, 2.0 mmol) gave the crude product. Purification by 
flash column chromatography on silica with acetone as eluent gave a 50:50 mixture (by 1H 
NMR spectroscopy) of diastereomeric alcohols 74 (191 mg, 89%) as a colourless oil. No 
desired product 233 was found. 
Lab Reference: WSK/4/086 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise to a 
stirred solution of 4-methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol, 1.0 eq.) in hexane 
(7 mL) at 0 °C under Ar. After stirring at 0 °C for 1 h, TMEDA (151 mg, 195 µL, 1.3 
mmol) was added dropwise. The resulting solution was stirred at 0 °C for 1 h. Then, 
benzaldehyde (228 mg, 203 µL, 2.0 mmol) was added and the resulting solution was 
stirred at 0 °C for 10 min. The solution was allowed to warm to rt over 1 h. Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3   10 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with acetone as eluent gave a 50:50 mixture (by 1H NMR 
spectroscopy) of diastereomeric alcohols 74 (26 mg, 12%) as a colourless oil and a 50:50 
mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 233 (135 mg, 65%) as a 
white solid. 
Lab Reference: WSK/4/085 
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(4-Methylmorpholin-2-yl)(phenyl)methanone 236 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at 0 °C for 1 h and a suspension of N,N-dimethylbenzamide (298 
mg, 2.0 mmol) in Et2O (2 mL) gave the crude product. Purification by flash column 
chromatography on silica with acetone as eluent gave benzoyl morpholine 236 (153 mg, 
75%) as a yellow oil, RF (acetone) 0.3; IR (ATR) 2938, 2848, 2794, 1689 (C=O), 1448, 
1118, 693 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J = 7.5 Hz, 2H, Ph), 7.57 (dd, J = 
7.5, 7.5 Hz, 1H, Ph), 7.46 (dd, J = 7.5, 7.5 Hz, 2H, Ph), 4.92 (dd, J = 7.5, 3.0 Hz, 1H, 
OCH), 4.06 (ddd, J = 11.0, 3.0, 2.0 Hz, 1H, OCH), 3.83 (ddd, J = 11.0, 11.0, 3.0 Hz, 1H, 
OCH), 3.04-2.98 (m, 1H, NCH), 2.72-2.65 (m, 1H, NCH), 2.33 (s, 3H, NMe), 2.29-2.18 
(m, 2H, NCH); 13C NMR (100.6 MHz, CDCl3) δ 196.7 (C=O), 134.9 (ipso-Ph), 133.5 (Ph), 
128.9 (Ph), 128.6 (Ph), 77.9 (OCH), 66.9 (OCH2), 56.7 (NCH2), 54.5 (NCH2), 46.3 (NMe); 
MS (ESI) m/z 206 [(M + H)+, 100], 228 [(M + Na)+, 100]; HRMS (ESI) m/z calcd for 
C12H15NO2 (M + H)
+ 206.1176, found 206.1184 (‒3.6 ppm error), (M + Na)+ 228.0995, 
found 228.0994 (+0.1 ppm error).  
Lab Book Reference: WSK/5/026 
 
2-(Dimethyl(phenyl)silyl)-4-methylmorpholine 234 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
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mmol) in hexane (7 mL) at 0 °C for 1 h and PhMe2SiCl (341 mg, 333 µL, 2.0 mmol) gave 
the crude product. Purification by flash column chromatography on silica with acetone as 
eluent gave silylated morpholine 234 (212 mg, 90%) as a yellow oil, RF (acetone) 0.2; IR 
(ATR) 2956, 2935, 2786, 1247, 1095, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.58-7.51 
(m, 2H, Ph), 7.41-7.32 (m, 3H, Ph), 3.87 (ddd, J = 11.0, 3.0, 1.5 Hz, 1H, OCH), 3.60 (ddd, 
J = 11.0, 11.0, 2.5 Hz, 1H, OCH), 3.52 (dd, J = 12.0, 2.5 Hz, 1H, OCH), 2.66 (dddd, J = 
11.0, 2.0, 2.0, 2.0 Hz, 1H, NCH), 2.58 (ddd, J = 12.0, 2.0, 2.0 Hz, 1H, NCH), 2.22 (s, 3H, 
NMe), 2.12 (ddd, J = 11.5, 11.5, 3.0 Hz, 1H, NCH), 2.04 (dd, J = 12.0, 12.0 Hz, 1H, NCH), 
0.33 (s, 3H, SiMe), 0.32 (s, 3H, SiMe); 13C NMR (100.6 MHz, CDCl3) δ 136.4 (ipso-Ph), 
134.1 (Ph), 129.3 (Ph), 127.8 (Ph), 71.1 (OCH), 68.8 (OCH2), 56.6 (NCH2), 55.7 (NCH2), 
46.4 (NMe), ‒5.2 (SiMe), ‒5.6 (SiMe); MS (ESI) m/z 236 [(M + H)+, 100]; HRMS (ESI) 
m/z calcd for C13H21NOSi (M + H)
+ 236.1465, found 236.1466 (+0.1 ppm error).  
Lab Book Reference: WSK/4/029 
 
4-Methyl-2-(1-hydroxy-1,1-diphenylmethyl)-morpholine 235 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
methyl morpholine 232 (101 mg, 110 µL, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at 0 °C for 1 h and a solution of benzophenone (364 mg, 2.0 
mmol) in hexane (1 mL) gave the crude product. Purification by flash column 
chromatography on silica with acetone as eluent gave hydroxyl morpholine 235 (256 mg, 
90%) as a white solid, mp 185-188 °C, RF (acetone) 0.3; IR (ATR) 2957, 2846, 2808, 1448, 
1116, 745, 699, 691 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.55-7.47 (m, 2H, Ph), 7.43-7.37 
(m, 2H, Ph), 7.35-7.27 (m, 4H, Ph), 7.24-7.15 (m, 2H, Ph), 4.52 (dd, J = 10.0, 2.5 Hz, 1H, 
OCH), 3.96 (ddd, J = 11.0, 3.5, 1.5 Hz, 1H, OCH), 3.84 (ddd, J = 11.0, 11.0, 2.5 Hz, 1H, 
OCH), 3.33 (s, 1H, OH), 2.64 (br d, J = 11.0 Hz, 1H, NCH), 2.30-2.23 (m, 1H, NCH), 2.20 
(s, 3H, NMe), 2.19-2.10 (m, 2H, NCH); 13C NMR (100.6 MHz, CDCl3) δ 146.1 (ipso-Ph), 
143.2 (ipso-Ph), 128.2 (Ph), 128.1 (Ph), 126.9 (Ph), 126.8 (Ph), 126.4 (Ph), 125.5 (Ph), 
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78.4 (OCPh), 77.9 (OCH), 66.8 (OCH2), 54.6 (NCH2), 46.5 (NMe); MS (ESI) m/z 284 [(M 
+ H)+, 100]; HRMS (ESI) m/z calcd for C18H21NO2 (M + H)
+ 284.1645, found 284.1647 
(‒0.8 ppm error). 
Lab Reference: WSK/4/030 
 
4-Benzyl morpholine 237 
 
BnBr (2.94 g, 2.0 mL, 17.2 mmol, 1.5 eq.) was added to a stirred solution of morpholine 
(999 mg, 1.0 mL, 11.4 mmol, 1.0 eq.) and Et3N (3.4 g, 4.7 mL, 34.4 mmol, 3.0 eq.) in THF 
(90 mL) at rt. The resulting solution was stirred at rt for 16 h. Saturated NH4Cl(aq) (30 mL) 
was added and the two layers were separated. The aqueous layer was extracted with Et2O 
(3   30 mL) and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromato graphy 
on silica with 1:1 hexane-EtOAc as eluent gave 4-benzyl morpholine 237 (1.94 g, 95%) as 
a colourless oil, RF (1:1 hexane-EtOAc ) 0.3; 
1H NMR (400 MHz, CDCl3) δ 7.35-7.22 (m, 
5H, Ph), 3.71 (t, J = 4.5 Hz, 4H, OCH2), 3.50 (s, 2H, CH2Ph), 2.45 (t, J = 4.5 Hz, 4H, 
NCH2); 
13C NMR (100.6 MHz, CDCl3) δ 137.7 (ipso-Ph), 129.2 (Ph), 128.2 (Ph), 127.1 
(Ph), 67.0 (OCH2), 63.5 (NCH2Ph), 53.6 (NCH2). Spectroscopic data consistent with those 
reported in the literature.135 
Lab Reference: WSK/4/067 
 
BnCl (570 mg, 518 µL, 4.5 mmol, 1.5 eq.) was added to a stirred solution of morpholine 
(261 mg, 262 µL, 3.0 mmol, 1.0 eq.) and Et3N (310 mg, 418 µL, 9.0 mmol, 3.0 eq.) in 
THF (15 mL) at rt. The resulting solution was stirred at rt for ove16 h. Saturated NH4Cl(aq) 
(20 mL) was added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3   20 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash column 
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chromatography on silica with 1:1 hexane-EtOAc as eluent gave 4-benzyl morpholine 237 
(258 mg, 49%) as a colourless oil.  
Lab Reference: WSK/4/040 
 
Morpholine (435 mg, 436 µL, 5.0 mmol, 1.0 eq.) was added to a stirred suspension of 
K2CO3 (1.38 g, 10.0 mmol, 2.0 eq.) in THF (50 mL) at rt. The resulting solution was 
stirred at rt for 15 min. Then, BnCl (633 mg, 575 µL, 5.0 mmol, 1.0 eq.) was added and the 
reaction mixture was stirred at rt for 48 h. Saturated NH4Cl(aq) (20 mL) was added and the 
two layers were separated. The aqueous layer was extracted with Et2O (3   20 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. The 1H NMR spectrum of the crude product showed no desired 
product 237 and therefore purification was not attempted.136 
Lab Reference: WSK/4/034 
 
Morpholine (261 mg, 261 µL, 3.0 mmol, 1.0 eq.) was added to a stirred solution of acetyl 
chloride (707 mg, 640 µL, 9.0 mmol, 3.0 eq.) in MeOH (20 mL) at rt. The resulting 
solution was stirred at rt for 16 h. Then, the solvent was evaporated under reduced pressure. 
MeOH (20 mL), Et3N (910 mg, 418 µL, 9.0 mmol, 3.0 eq.) and BnCl (456 mg, 414 µL, 3.6 
mmol, 1.2 eq.) were added and the reaction mixture was stirred at rt for 48 h. Saturated 
NH4Cl(aq) (20 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3   20 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. The 1H NMR spectrum of the 
crude product showed no desired product 237 and therefore purification was not attempted.  
Lab Reference: WSK/4/039 
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(4-Benzylmorpholin-2-yl)(phenyl)methanone 239,  
2-((4-benzylmorpholin-2-yl)(phenyl)methanone)-4-ylmethyl-benzophenone 240 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 4-
benzyl morpholine 237 (188 mg, 1.1 mmol) and TMEDA (160 mg, 207 µL, 1.4 mmol) in 
hexane (7 mL) at 0 °C for 1 h and a suspension of N,N-dimethylbenzamide (320 mg, 2.0 
mmol) in hexane (1 mL) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave di-substituted benzoyl 
morpholine 240 (56 mg, 14%) as a yellow oil, RF (98:2 CH2Cl2-acetone) 0.5; IR (ATR) 
2816, 1690 (C=O), 1660 (C=O), 1596, 1447, 1312, 1273, 1204, 1119, 763,694, 638 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.89-7.82 (m, 4H, Ar), 7.60-7.52 (m, 2H, Ar), 7.51-7.34 (m, 
7H, Ar), 7.30-7.23 (m, 1H, Ar), 4.31 (dd, J = 10.5, 3.0 Hz, 1H, OCH), 3.75 (ddd, J = 11.0, 
3.0, 1.0 Hz, 1H, OCH), 3.52 (d, J = 14.0 Hz, 1H, NCHAr), 3.48 (d, J = 14.0 Hz, 1H, 
NCHAr), 3.26 (ddd, J = 11.0, 11.0, 3.0 Hz, 1H, OCH), 2.68 (ddd, J = 11.5, 3.0, 1.0 Hz, 1H, 
NCH), 2.32-2.24 (m, 1H, NCH), 2.16 (ddd, J = 11.5, 11.0, 3.0 Hz, 1H, NCH), 2.09 (dd, J = 
11.5, 10.5 Hz, 1H, NCH); 13C NMR (100.6 MHz, CDCl3) δ 197.5 (C=O), 196.3 (C=O), 
139.2 (ipso-Ar), 137.8 (ipso-Ar), 137.4 (ipso-Ar), 134.6 (C=OPh), 133.4 (Ar), 132.6 (Ar), 
129.6 (Ar), 129.2 (Ar), 129.1 (Ar), 128.9 (Ar), 128.5 (Ar), 128.2 (Ar), 127.4 (Ar), 77.2 
(OCH), 66.3 (OCH2), 60.5 (NCH2Ar), 54.1 (NCH2), 5.6 (NCH2) (one Ar signal not 
resolved); MS (ESI) m/z 408 [(M + Na)+, 20], 386 [(M + H)+, 100]; HRMS (ESI) m/z calcd 
for C25H23NO3 (M + Na)
+ 408.1570, found 408.1573 (‒0.5 ppm error), (M + H)+ 386.1751, 
found 386.1757 (‒0.5 ppm error); and mono-substituted benzoyl morpholine 239 (133 mg, 
44%) as a yellow oil, RF (98:2 CH2Cl2-acetone) 0.4; IR (ATR) 2812, 1689, 1448, 1118, 
694 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.00-7.94 (m, 2H, Ph), 7.60-7.53 (m, 1H, Ph), 
7.48-7.38 (m, 3H, Ph), 7.36-7.28 (m, 4H, Ph), 4.93 (dd, J = 10.0, 2.5 Hz, 1H, OCH), 4.04 
(ddd, J = 11.5, 3.5, 2.5 Hz, 1H, OCH), 3.83 (ddd, J = 11.0, 11.0, 3.0 Hz, 1H, OCH), 3.60 
(d, J = 13.0 Hz, 1H, NCHPh), 3.51 (d, J = 13.0 Hz, 1H, NCHPh), 3.07 (br ddd, J = 11.5, 
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2.0, 2.0 Hz, 1H, NCH), 2.75-2.67 (m, 1H, NCH), 2.37-2.23 (m, 2H, NCH); 13C NMR 
(100.6 MHz, CDCl3) δ 196.8 (C=O), 135.0 (ipso-Ph), 133.4 (ipso-Ph), 129.1 (Ph), 128.9 
(Ph), 128.5 (Ph), 128.3 (Ph), 127.3 (Ph), 127.0 (Ph), 78.03 (OCH), 67.1 (OCH2), 63.2 
(NCH2Ph), 55.1 (NCH2), 52.5 (NCH2); MS (ESI) m/z 282 [(M + H)
+, 100]; HRMS (ESI) 
m/z calcd for C18H19NO2 (M + H)
+ 282.1489, found 282.1482 (+2.7 ppm error).137 
Lab Book Reference: WSK/5/032 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 4-
benzyl morpholine 237 (188 mg, 1.1 mmol) and TMEDA (160 mg, 207 µL, 1.4 mmol) in 
hexane (7 mL) at ‒20 °C for 1 h and a suspension of N,N-dimethylbenzamide (320 mg, 2.0 
mmol) in hexane (1mL) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave di-substituted benzoyl 
morpholine 240 (20 mg, 9%) as a yellow oil and mono-substituted benzoyl morpholine 239 
(120 mg, 39%) as a yellow oil. 
Lab Book Reference: WSK/5/031 
 
 
A solution of a 50:50 mixture of diastereomeric alcohols 206 (50 mg, 0.17 mmol, 1.0 eq.) 
in CH2Cl2 (2 mL) was added dropwise to a stirred suspension of DMP (82 mg, 0.19 mmol, 
1.1 eq.) at 0 °C under Ar. The resulting solution was allowed to warm to rt and stirred at rt 
for 2 h. Saturated NaHCO3 (aq) (5 mL) was added and the solution was stirred at rt for 16h. 
The solids were removed by filtration and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (3 × 10 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. The 
1H NMR 
spectrum of the crude product showed that benzoyl morpholine 239 was formed but no 
further purification was attempted.  
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Lab Book Reference: WSK/5/036 
 
 
A solution of a diastereomeric mixture of alcohols 241 (50 mg, 0.13 mmol, 1.0 eq.) in 
CH2Cl2 (2 mL) was added dropwise to a stirred suspension of DMP (60 mg, 0.14 mmol, 
1.1 eq.) at 0 °C under Ar. The resulting solution was allowed to warm to rt and stirred for 
at rt 2 h. Saturated NaHCO3 (aq) (5 mL) was added and the solution was stirred at rt for 16h. 
The solids were removed by filtration and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (3 × 10 ml) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave di-
substituted benzoyl morpholine 240 (10 mg, 21%) as a yellow oil.  
Lab Book Reference: WSK/5/037 
 
(4-Benzylmorpholin-2-yl)diphenylmethanol 244 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 4-
benzyl morpholine 237 (195 mg, 1.1 mmol) and TMEDA (166 mg, 214 µL, 1.4 mmol) in 
hexane (7 mL) at 0 °C for 1 h and a solution of benzophenone (400 mg, 2.2 mmol) in 
hexane (1 mL) gave the crude product. Purification by flash column chromatography on 
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silica with 1000:9:1 CH2Cl2-MeOH-NH4OH as eluent gave hydroxy morpholine 244 (175 
mg, 44%) as a white solid, mp 95-98 °C; RF (1000:9:1 CH2Cl2-MeOH-NH4OH) 0.5; IR 
(ATR) 1961, 1448, 1114, 744, 695 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.56-7.50 (m, 2H, 
Ph), 7.41-7.36 (m, 2H, Ph), 7.35-7.13 (m, 11H, Ph), 4.54 (dd, J = 9.0, 3.0 Hz, 1H, OCH), 
3.92 (ddd, J = 11.0, 2.5, 1.5 Hz, 1H, OCH), 3.77 (ddd, J = 11.0, 11.0, 3.0 Hz, 1H, OCH), 
3.59-3.51 (d, J = 13.0 Hz, 1H, NCHPh), 3.55 (br s, 1H, OH), 3.24 (d, J = 13.0 Hz, 1H, 
NCHPh), 2.62-2.54 (m, 1H, NCH), 2.40-2.26 (m, 2H, NCH), 2.10 (ddd, J = 11.0, 11.0, 3.0 
Hz, 1H, NCH); 13C NMR (100.6 MHz, CDCl3) δ 146.0 (ipso-Ph), 143.2 (ipso-Ph), 137.4 
(ipso-Ph), 129.2 (Ph), 128.2 (Ph), 128.1 (Ph), 127.9 (Ph), 127.1 (Ph), 126.8 (Ph), 126.7 
(Ph), 126.5 (Ph), 125.5 (Ph), 78.7 (COH), 77.7 (OCH), 66.7 (OCH2), 63.4 (NCH2Ph), 53.5 
(NCH2), 52.0 (NCH2); MS (ESI) m/z 360 [(M + H)
+, 100]; HRMS (ESI) m/z calcd for 
C24H25NO2 (M + H)
+ 360.1958, found 360.1956 (+0.6 ppm error).  
Lab Book Reference: WSK/5/033 
 
2-(Dimethyl(phenyl)silyl)-4-benzylmorpholine 242, 4-(o-Dimethyl(phenyl)silyl 
benzyl)-2-(Dimethyl(phenyl)silyl)-4-benzylmorpholine 243 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), 4-
benzyl morpholine 237 (199 mg, 1.1 mmol) and TMEDA (169 mg, 219 µL, 1.4 mmol) in 
hexane (7 mL) at 0 °C for 1 h and PhMe2SiCl (384 mg, 384 µL, 2.2 mmol) to give the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
Et2O with 2% Et3N as eluent gave di-silylated morpholine 243 (77 mg, 15%) as a 
colourless oil, RF (8:2 hexane-Et2O) 0.5; IR (ATR) 2953, 2802, 1427, 1247, 1086, 812, 729, 
699 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.50-7.45 (m, 1H, Ar), 7.44-7.37 (m, 2H, Ar), 
7.36-7.30 (m, 2H, Ar), 7.29-7.07 (m, 9H, Ar), 3.60-3.53 (m, 1H, OCH), 3.31-3.18 (m, 3H), 
3.04 (d, J = 13.0 Hz, NCHAr), 2.29-2.23 (m, 1H, NCH), 2.24-2.18 (m, 1H, NCH), 1.82-
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1.67 (m, 2H, NCH), 0.47 (s, 3H, SiMe), 0.45 (s, 3H, SiMe), 0.16 (s, 3H, SiMe), 0.13 (s, 3H, 
SiMe); 13C NMR (100.6 MHz, CDCl3) δ 144.3 (ipso-Ar), 139.5 (ipso-Ar), 137,0 (ipso-Ar), 
136.7 (ipso-Ar), 135.9 (Ar), 134.1 (Ar), 133.8 (Ar), 129.6 (Ar), 129.2 (Ar), 128.7 (Ar), 
127.7 (Ar), 127.7 (Ar), 126.3 (Ar), 70.7 (OCH), 68.6 (OCH2), 63.6 (NCH2), 54.9 (NCH2), 
53.3 (NCH2), ‒0.5 (SiMe), ‒0.8 (SiMe), ‒5.2 (SiMe), ‒5.3 (SiMe) (one Ar signal not 
resolved); MS (ESI) m/z 446 [(M + H)+, 100]; HRMS (ESI) m/z calcd for C27H35NOSi2 (M 
+ H)+ 446.2330, found 446.2342 (‒0.1 ppm error); and mono-silylated morpholine 242 
(149 mg, 42%) as a colourless oil, RF (8:2 hexane-Et2O) 0.2; IR (ATR) 2954, 2801, 1427, 
1247, 1086, 731, 697, 466 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.56-7.45 (m, 2H, Ph), 
7.38-7.16 (m, 8H, Ph), 3.80 (ddd, J = 11.0, 3.0, 1.5 Hz, 1H, OCH), 3.59-3.49 (m, 2H), 3.53 
(d, J = 13.0 Hz, 1H, NCHPh), 3.28 (d, J = 13.0 Hz, 1H, NCHPh), 2.65 (ddd, J = 11.0, 2.0, 
1.5 Hz, 1H, NCH), 2.61 (dddd, J = 11.0, 3.0, 2.0, 2.0 Hz, 1H, NCH), 2.16 (dd, J = 12.0, 
12.0 Hz, 1H, OCH), 2.08 (ddd, J = 12.0, 12.0, 2.0 Hz, 1H, NCH), 0.29 (s, 3H, SiMe), 0.28 
(s, 3H, SiMe); 13C NMR (100.6 MHz, CDCl3) δ 137.8 (ipso-Ph), 136.5 (ipso-Ph), 134.1 
(Ph), 129.2 (Ph), 129.2 (Ph), 128.2 (Ph), 127.8 (Ph), 127.0 (Ph), 71.0 (OCH), 68.9 (OCH2), 
63.5 (NCH2Ph), 55.4 (NCH2), 53.5 (NCH2), ‒5.2 (SiMe), ‒5.4 (SiMe); MS (ESI) m/z 312 
[(M + H)+, 100]; HRMS (ESI) m/z calcd for C19H25NOSi (M + H)
+ 312.1778, found 
312.1780 (‒0.8 ppm error).  
Lab Book Reference: WSK/5/034 
 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
benzyl morpholine 237 (185 mg, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in 
hexane (7 mL) at ‒30 °C for 1 h and PhMe2SiCl (222 mg, 215 µL, 2.0 mmol) gave the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
Et2O with 2% Et3N as eluent gave di-substituted silylated morpholine 243 (26 mg, 6%) as 
a colourless oil, and mono-silylated morpholine 242 (121 mg, 37%) as a colourless oil.  
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Lab Book Reference: WSK/5/044 
 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), 4-
benzyl morpholine 237 (185 mg, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 mmol) in 
hexane (7 mL) at ‒30 °C for 3 h and PhMe2SiCl (222 mg, 215 µL, 2.0 mmol) gave the 
crude product. Purification by flash column chromatography on silica with 8:2 hexane-
Et2O with 2% Et3N as eluent gave a 60:40 mixture (by 
1H NMR spectroscopy) of mono-
silylated morpholine 242 and PhMe2SiCl (241 mg, 134 mg (40%) of 242 and 107 mg (29%) 
of PhMe2SiCl) as a colourless oil and recovered starting material 237 (52 mg, 27%). 
Lab Book Reference: WSK/5/053 
 
4-benzyl-2-(1-hydroxy-1-phenylmethyl)-morpholine 206, 
4-(o-Dimethyl(phenyl)silyl benzyl)-2-(1-hydroxy-1-phenylmethyl)-morpholine 241 
 
Using general procedure E, s-BuLi (1.4 mL of a 1.3 M solution in hexanes, 1.8 mmol), 4-
benzyl morpholine 237 (249 mg, 1.4 mmol) and TMEDA (212 mg, 274 µL, 1.4 mmol) in 
hexane (7 mL) at 0 °C for 1 h and benzaldehyde (298 mg, 285 µL, 2.8 mmol) gave the 
crude product. Purification by flash column chromatography on silica with 75:25 hexane-
EtOAc as eluent gave recovered starting material 237 (30 mg, 12%) as a colourless oil, a 
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50:50 mixture (by 1H NMR spectroscopy) of diastereomeric mono-substituted morpholines 
206 (223 mg, 56%) as a yellow oil, RF (75:25 hexane-EtOAc) 0.2; IR (ATR) 2814, 1452, 
1113, 1024, 697 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.42-7.18 (m, 10H, Ph), 4.88 (d, J = 
4.5H, 0.5H, OCHPh), 4.57 (d, J = 7.5 Hz, 0.5H, OCHPh), 3.99-3.90 (m, 0.6H), 3.82-3.76 
(m, 0.4H), 3.73-3.62 (m, 2H), 3.56 (d, J = 7.0 Hz, 0.5H, NCHPh), 3.53 (d, J = 7.0 Hz, 
0.5H, NCHPh), 3.33 (d, J = 10.0 Hz, 0.5H, NCHPh), 3.28 (d, J = 10.5 Hz, 0.5H, NCHPh), 
2.68-2.52 (m, 2H), 2.47 (br s, 0.5H, OH), 2.44 (br s, 0.5H, OH), 2.27-2.02 (m, 2H); 13C 
NMR (100.6 MHz, CDCl3) δ 139.9 (ipso-Ph), 137.4 (ipso-Ph), 137.4 (ipso-Ph), 129.2 (Ph), 
129.1 (Ph), 128.4 (Ph), 128.3 (Ph), 128.2 (Ph), 128.1 (Ph), 127.2 (Ph), 126.9 (Ph), 126.3 
(Ph), 79.4, 78.5, 75.4, 75.3, 66.7, 66.5, 63.4, 63.2, 55.1, 52.8, 52.5, 52.2 (four Ph signals 
not resolved); MS (ESI) m/z 284 [(M + H)+, 100]; HRMS (ESI) m/z calcd for C18H21NO2 
(M + H)+ 284.1645, found 284.1656 (‒3.6 ppm error) and a 48:32:12:8 mixture (by 1H 
NMR spectroscopy) of diastereomeric di-substituted morpholines 241 (95 mg, 17%) as a 
yellow oil, RF (75:25 hexane-EtOAc) 0.2; 
1H NMR (400 MHz, CDCl3) δ 7.51-6.91 (m, 
14H, Ar), 5.84 (br s, 0.4H, OCH), 5.69 (br s, 0.6H, OCH), 4.94 (dd, J = 4.0 Hz, 0.2H, 
OCH), 4.55-4.47 (m, 0.8H), 4.00-3.80 (m, 1.5H), 3.77-3.58 (m, 2.5H), 3.53-3.48 (m, 0.5H), 
3.28-3.22 (m, 0.5H), 3.03-2.95 (m, 0.5H), 2.93-2.79 (m, 1H), 2.65-2.46 (m, 2.5H), 2.16-
2.00 (m, 2H); 13C NMR (100.6 MHz, CDCl3) δ 144.6 (ipso-Ar), 144.5 (ipso-Ar), 143.8 
(ipso-Ar), 142.9 (ipso-Ar), 139.7 (ipso-Ar), 139.3 (ipso-Ar), 134.5 (ipso-Ar), 134.5 (ipso-
Ar), 132.4 (Ar), 132.1 (Ar), 131.1 (Ar), 129.8 (Ar), 128.7 (Ar), 128.5 (Ar), 128.4 (Ar), 
128.1 (Ar), 127.8 (Ar), 127.7 (Ar), 127.4 (Ar), 127.1 (Ar), 126.9 (Ar), 126.7 (Ar), 126.4 
(Ar), 126.2 (Ar), 126.0 (Ar), 125.3 (Ar), 125.2 (Ar), 79.8, 79.1, 78.8, 76.9, 75.4, 75.0, 74.8, 
74.1, 66.6, 66.4, 66.2, 61.9, 61.7, 61.6, 54.4, 54.2, 51.9, 51.8, 51.2, 51.1, 30.9 (Ar not 
resolved); MS (ESI) m/z 390 [(M + H)+, 100].138,139 
Lab Book Reference: WSK/5/035 
 
(S)-4-(1-Phenylethyl) morpholine 246 
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K2CO3 (2.68 g, 19.4 mmol, 5.0 eq.) and KI (1.42 g, 8.5 mmol, 2.2 eq.) were added to a 
stirred solution of (S)-(-)-α-methylbenzylamine (0.47 g, 0.5 mL, 3.8 mmol) in n-BuOH (15 
mL) at 0 °C. The resulting solution was stirred at 0 °C for 15 min. Then, 2,2'-
dichlorodiethyl ether (1.10 g, 0.91 mL, 7.7 mmol, 2.0 eq.) was added, and the reaction 
mixture was stirred and heated at 100 °C for 16 h. The reaction mixture was allowed to 
cool to rt and the solids were removed by filtration. CH2Cl2 (50 mL) was added to the 
filtrate and washed with H2O (2 × 10 mL) and saturated brine (10 mL). The organic layer 
was dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 1:1 hexane-EtOAc as eluent 
gave morpholine 246 (321 mg, 43%) as a pale yellow oil, [α]D ‒25.4 (c 0.5 in CHCl3); RF 
(1:1 hexane-EtOAc) 0.4; 1H NMR (400 MHz, CDCl3) δ 7.35-7.28 (m, 4H, Ph), 7.28-7.21 
(m, 1H, Ph), 3.73-3.64 (m, 4H, OCH), 3.29 (q, J = 7.0 Hz, 1H, NCHMe), 2.55-2.43 (m, 2H, 
NCH), 2.42-2.31 (m, 2H, NCH), 1.34 (d, J = 7.0 Hz, NCHMe); 13C NMR (100.6 MHz, 
CDCl3) δ 143.9 (ipso-Ph), 128.2 (Ph), 127.6 (Ph), 127.0 (Ph), 67.2 (OCH2), 65.4 NCHPh), 
51.3 (NCH2), 19.8 (NCHMe). Spectroscopic data consistent with those reported in the 
literature.140 
Lab Book Reference: WSK/5/038 
 
K2CO3 (10.81 g, 78.2 mmol, 5.0 eq.) and KI (5.77 g, 34.7 mmol, 2.2 eq.) were added to a 
stirred solution of (S)-(-)-α-methylbenzylamine (1.88 g, 2.0 mL, 15.5 mmol) in n-BuOH 
(60 mL) at 0 °C. The resulting solution was stirred at 0 °C for 15 min. Then, 2,2'-
dichlorodiethyl ether (4.43 g, 3.6 mL, 31.0 mmol, 2.0 eq.) was added, and the reaction 
mixture was stirred and heated at 100 °C for 60 h. The reaction mixture was allowed to 
cool to rt and the solids were removed by filtration. CH2Cl2 (50 mL) was added to the 
filtrate and washed with H2O (2 × 10 mL) and saturated brine (10 mL). The organic layer 
was dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 1:1 hexane-EtOAc as eluent 
gave morpholine 246 (2.80 g, 94%) as a pale yellow oil. 
Lab Book Reference: WSK/5/041 
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A reaction mixture of (S)-(-)-α-methylbenzylamine (0.47 g, 0.5 mL, 3.88 mmol, 1.0 eq.), 
2,2'-dichlorodiethyl ether (721 mg, 591 µL, 5.04 mmol, 1.3 eq.), K2CO3 (2.15 g, 15.5 
mmol, 4.0 eq.) and KI (129 mg, 0.78 mmol, 0.2 eq.) in EtOH (40 mL) was heated at reflux 
for 4 days. Then, the reaction mixture was allowed to cool to rt. The solution was diluted 
with CH2Cl2 (50 mL) and washed with H2O (2 × 10 mL) and saturated brine (10 mL). The 
organic layer was dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 1:1 hexane-EtOAc as 
eluent gave morpholine 246 (200 mg, 29%) as a pale yellow oil.141 
Lab Book Reference: WSK/5/039 
 
2-(R/S)-2-(Dimethyl(phenyl)silyl)-4-((S)-1-phenylethyl)morpholine 247a and 247b 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), (S)-
4-(1-phenylethyl) morpholine 246 (211 mg, 1.1 mmol) and TMEDA (117 mg, 215 µL, 1.4 
mmol) in hexane (7 mL) at 0 °C for 1 h and PhSiMe2Cl (377 mg, 365 µL, 2.2 mmol) gave 
the crude product, which contained a 50:50 mixture of 247a and 247b (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 8:2 hexane-
EtOAc as eluent gave silylated morpholine 247a (83 mg, 23%) as a colourless oil, [α]D 
‒5.0 (c 0.5 in CHCl3); RF (8:2 hexane-EtOAc) 0.3; IR (ATR) 2954, 2801, 1247, 1106, 1089, 
814, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.59-7.54 (m, 2H, Ph), 7.41-7.33 (m, 3H, Ph), 
7.33-7.19 (m, 5H, Ph), 3.74 (ddd, J = 11.0, 3.0, 1.5 Hz, 1H, OCH), 3.60 (dd, J = 11.5, 2.0 
Hz, 1H, OCH), 3.50 (ddd, J = 11.0, 11.0, 2.0 Hz, 1H, OCH), 3.19 (q, J = 7.0 Hz, 1H, 
NCHMe), 2.91 (ddd, J = 11.5, 2.0, 1.5 Hz, 1H, NCH), 2.48 (dd, J = 11.5, 2.0 Hz, 1H, 
NCH), 2.12 (dd, J = 11.5, 11.5 Hz, 1H, NCH), 1.98 (ddd, J = 11.5, 11.0, 3.0 Hz, 1H, NCH),  
1.28 (d, J = 7.0 Hz, 3H, NCHMe), 0.34 (s, 3H, SiMe), 0.33 (s, 3H, SiMe); 13C NMR (100.6 
MHz, CDCl3) δ 144.1 (ipso-Ph), 136.6 (ipso-Ph), 134.1 (Ph), 129.2 (Ph), 128.3 (Ph), 127.8 
(Ph), 127.6 (Ph), 126.9 (Ph), 71.0 (OCH), 69.1 (OCH2), 65.8 (NCH), 52.3 (NCH2), 52.2 
(NCH2), 20.3 (NCHMe), ‒5.1 (SiMe), ‒5.3 (SiMe); MS (ESI) m/z 326 [(M + H)
+, 100]; 
HRMS (ESI) m/z calcd for C20H27NOSi (M + H)
+ 326.1943, found 326.1935 (‒3.3 ppm 
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error), silylated morpholine 247b (133 mg, 37%) as a colourless oil, [α]D ‒39.0 (c 0.5 in 
CHCl3); RF (8:2 hexane-EtOAc) 0.2; IR (ATR) 2955, 2802, 1247, 1098, 814, 698 cm
-1; 1H 
NMR (400 MHz, CDCl3) δ 7.49-7.42 (m, 2H, Ph), 7.37-7.15 (m, 8H, Ph), 3.89 (ddd, J = 
11.0, 3.0, 1.5 Hz, 1H, OCH), 3.63 (ddd, J = 11.0, 11.0, 2.0 Hz, 1H, OCH), 3.46 (dd, J = 
12.0, 2.0 Hz, 1H, OCH), 3.28 (q, J = 7.0 Hz, 1H, NCHMe), 2.85 (dd, J = 12.0, 2.0 Hz, 1H, 
NCH), 2.48 (ddd, J = 11.5, 2.0, 1.5 Hz, 1H, NCH), 2.20 (ddd, J = 11.5, 11.0, 3.0 Hz, 1H, 
NCH), 2.03 (dd, J = 12.0, 12.0 Hz, 1H, NCH), 1.31 (d, J = 7.0 Hz, 3H, NCHMe), 0.24 (s, 
3H, SiMe), 0.20 (s, 3H, SiMe); 13C NMR (100.6 MHz, CDCl3) δ 143.7 (ipso-Ph), 136.6 
(ipso-Ph), 133.9 (Ph), 129.1 (Ph), 128.1 (Ph), 127.7 (Ph), 127.6 (Ph), 126.8 (Ph), 71.2 
(OCH), 69.0 (OCH2), 65.1 (NCH), 52.8 (NCH2), 50.7 (NCH2), 19.1 (NCHMe), ‒5.3 
(SiMe); MS (ESI) m/z 326 [(M + H)+, 100]; HRMS (ESI) m/z calcd for C20H27NOSi (M + 
H)+ 326.1943, found 326.1935 (‒3.2 ppm error) and recovered starting material X (29 mg, 
14%). The total yield of silyl morpholines 247a and 247b was 60%. 
Lab Reference: WSK/5/046 
 
2-(R/S)-2-(Dimethyl(phenyl)silyl)-4-((S)-1-phenylethyl)morpholine 247, 1-
methylpropyl dimethylphenylsilane 128 
 
Using general procedure E, s-BuLi (675 µL of a 1.3 M solution in hexanes, 0.8 mmol), (S)-
4-(1-phenylethyl) morpholine 246 (99 mg, 0.7 mmol) and TMEDA (100 mg, 129 µL, 0.9 
mmol) in hexane (7 mL) at ‒30 °C for 1 h and PhSiMe2Cl (227 mg, 222 µL, 1.3 mmol) 
gave the crude product, which contained a 50:50 mixture of 247a and 247b (by 1H NMR 
spectroscopy). Purification by flash column chromatography on silica with 8:2 hexane-
EtOAc as eluent gave silane 128 (122 mg, 74%) as a colourless oil, RF (8:2 hexane-EtOAc) 
0.7, silylated morpholine 247a (25 mg, 8%) as a colourless oil and silylated morpholine 
247b (18 mg, 12%) as a colourless oil. The total yield of silylated morpholines 247a and 
247b was 20%. 
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Lab Reference: WSK/5/043 
 
2-(R/S)-2-(Diphenyl)-4-((S)-1-phenylethyl)morpholin-2-yl)methanol 248a and 248b 
 
Using general procedure E, s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol), (S)-
4-(1-phenylethyl) morpholine 246 (207 mg, 1.1 mmol) and TMEDA (163 mg, 211 µL, 1.4 
mmol) in hexane (7 mL) at 0 °C for 1 h and a solution of benzophenone (395 mg, 2.2 
mmol) in hexane (1 mL) gave the crude product, which contained a 50:50 mixture of 248a 
and 248b (by 1H NMR spectroscopy). Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-acetone as eluent gave hydroxyl morpholine 248a (62 mg, 15%) as 
a white solid, [α]D ‒77.0 (c 0.5 in CHCl3); mp 90-93 °C; RF (98:2 CH2Cl2-acetone) 0.4; IR 
(ATR) 3026, 2971, 1491, 1448, 1116, 748, 696 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.63-
7.59 (m, 1H, Ph), 7.56-7.51 (m, 2H, Ph), 7.42-7.37 (m, 2H, Ph), 7.36-7.27 (m, 5H, Ph), 
7.25-7.14 (m, 5H, Ph), 4.52 (dd, J = 9.5, 3.0 Hz, 1H, OCH), 3.88 (ddd, J = 11.0, 3.0, 3.0 
Hz, 1H, OCH), 3.72 (ddd, J = 11.0, 11.0, 3.0 Hz, 1H, OCH), 3.61 (br s, 1H, OH), 3.21 (q, J 
= 6.5 Hz, NCHMe), 2.55-2.45 (m, 2H, NCH), 2.20 (dd, J = 11.0, 9.5 Hz, 1H, NCH), 2.05 
(dd, J = 11.0, 3.0 Hz, 1H, NCH), 1.17 (d, J = 6.5 Hz, 3H, NCHMe); 13C NMR (100.6 MHz, 
CDCl3) δ 146.0 (ipso-Ph), 143.4 (ipso-Ph), 143.2 (ipso-Ph), 128.3 (Ph), 128.0 (Ph), 127.6 
(Ph), 127.0 (Ph), 126.8 (Ph), 126.7 (Ph), 126.5 (Ph), 126.0 (Ph), 125.5 (Ph), 79.0 (OCPh), 
77.8 (OCH), 66.7 (OCH2), 65.4 (NCMe), 50.5 (NCH2), 50.5 (NCH2), 19.7 (NCMe) (one 
Ph signal not resolved); MS (ESI) m/z 374 [(M + H)+, 100]; HRMS (ESI) m/z calcd for 
C25H27NO2 (M + H)
+ 374.2115, found 374.2119 (‒0.2 ppm error), a 60:40 mixture of 248b 
and 248a (89 mg, 22%, i.e. 13% of 248b and 9% of 248a) as a white solid, hydroxyl 
morpholine 248b (61 mg, 15%) as a white solid, mp 90-93 °C; RF (98:2 CH2Cl2-acetone) 
0.3; IR (ATR) 3536 (OH), 3027, 2974, 2807, 1492, 1446, 1111, 747, 693 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.57-7.46 (m, 2H, Ph), 7.35-7.05 (m, 13H, Ph), 4.43 (dd, J = 8.5, 3.0 
Hz, 1H, OCH), 3.99 (ddd, J = 11.0, 3.0, 3.0 Hz, 1H, OCH), 3.84 (br s, 1H, OH), 3.78 (ddd, 
J = 11.0, 10.5, 3.0 Hz, 1H, OCH), 3.37 (q, J = 7.0 Hz, 1H, CHMe), 2.67 (br d, J = 11.5 Hz, 
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1H, NCH), 1.33-1.23 (m, 3H, NCH), 1.28 (d, J = 7.0 Hz, 3H, NCMe); 13C NMR (100.6 
MHz, CDCl3) δ 145.9 (ipso-Ph), 143.6 (ipso-Ph), 142.6 (ipso-Ph), 128.1 (Ph), 127.98 (Ph), 
127.90 (Ph), 127.5 (Ph), 126.9 (Ph), 126.7 (Ph), 126.5 (Ph), 126.4 (Ph), 125.3 (Ph), 79.1 
(OCPh), 77.9 (OCH), 66.6 (OCH2), 64.3 (NCMe), 50.4 (NCH2), 49.3 (NCH2), 17.5 
(NCMe); MS (ESI) m/z 374 [(M + H)+, 100]; HRMS (ESI) m/z calcd for C25H27NO2 (M + 
H)+ 374.2115, found 374.2111 (+1.2 ppm error) and recovered starting material 246 (36 
mg, 18%) as a pale yellow oil. The total yield of hydroxyl morpholines 248a and 248b was 
52%. 
Lab Reference: WSK/5/047 
 
Using general procedure E, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol), (S)-
4-(1-phenylethyl) morpholine 246 (196 mg, 1.0 mmol) and TMEDA (151 mg, 195 µL, 1.3 
mmol) in hexane (7 mL) at ‒40 °C for 5 h and a solution of benzophenone (372 mg, 2.0 
mmol) in hexane (1 mL) gave the crude product, which contained a 50:50 mixture of 248a 
and 248b (by 1H NMR spectroscopy), a 25:20:55 mixture of 248a, 248b and starting 
material 246 (by 1H NMR spectroscopy). Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-acetone as eluent gave hydroxyl morpholine 248a (62 mg, 16%) as 
a white solid, a mixture of 248a and 248b (76 mg, 20%) as a white solid, hydroxyl 
morpholine 248b (18 mg, 5%) as a white solid and recovered starting material 246 (90 mg, 
46%) as a pale yellow oil. The total yield of hydroxyl morpholine 248a and 248b was 41%.  
Lab Reference: WSK/5/048 
 
s-BuLi (1.1 mL of a 1.3 M solution in hexanes, 1.4 mmol) was added dropwise to a stirred 
solution of (S)-4-(1-phenylethyl) morpholine 246 (215 mg, 1.1 mmol) and (+)-sparteine 
surrogate (283 mg, 1.4 mmol) in hexane (7 mL) at ‒40 °C under Ar. The resulting solut ion 
was stirred at ‒40 °C for 5 h. Then, a solution of benzophenone (408 mg, 2.2 mmol) in 
hexane (1 mL) was added and the resulting solution was stirred at the at ‒40 °C for 10 min. 
Saturated NH4Cl(aq) (10 mL) was added at ‒40 °C and the resulting solution was allowed to 
warm to rt over 1 h. The two layers were separated and the aqueous layer was extracted 
with Et2O (3   10 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product, which contained a 50:50 mixture of 248a 
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and 248b (by 1H NMR spectroscopy). Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-acetone as eluent gave a 50:50 mixture of 248a and 248b (262 mg, 
63%) as a white solid and recovered starting material 246 (23 mg, 11%) as a pale yellow 
oil. 
Lab Reference: WSK/5/048 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was added dropwise to a stirred 
solution of (S)-4-(1-phenylethyl) morpholine 246 (196 mg, 1.0 mmol) and (‒)-sparteine 
(305 mg, 306 µL, 1.3 mmol) in hexane (7 mL) at ‒40 °C under Ar. The resulting solution 
was stirred at ‒40 °C for 5 h. Then, a solution of benzophenone (373 mg, 2.0 mmol) in 
hexane (1 mL) was added and the resulting solution was stirred at the at ‒40 °C for 10 min. 
Saturated NH4Cl(aq) (10 mL) was added at ‒40 °C and the resulting solution was allowed to 
warm to rt over 1 h. The two layers were separated and the aqueous layer was extracted 
with Et2O (3   10 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product, which contained a 65:20:15 mixture of 
starting material 246, 248a and 248b (by 1H NMR spectroscopy). Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave a 55:45 mixture 
of 248a and 248b (119 mg, 31%) as a white solid and recovered starting material 246 (120 
mg, 62%) as a pale yellow oil.  
Lab Reference: WSK/5/048 
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Abbreviations 
aq. 
Ar 
Atm 
BDO 
Bn 
Boc  
Bu 
bp  
br 
δ 
d 
DCE 
dd 
ddd 
dddd 
DMAN 
DMF 
DMP 
DPBP 
dr 
er 
E+ 
ESI 
eq. 
Et 
Et2O 
Aqueous 
Aryl 
Atmospheres 
1,4-Butanediol 
benzyl 
t-Butoxycarbonyl 
Butyl 
Boiling point 
Broad 
Chemical shift 
Doublet 
1,2-Dichloroethene 
Doublet doublet 
Doublet doublet doublet 
Doublet doublet doublet doublet 
1,8-Bis(dimethylamino)-naphthalene 
Dimethylformamide 
Dess–Martin periodinane 
Bidentate phosphine 
Diastereomeric ratio Enantiomeric 
Enantiomeric ratio 
Electrophile 
Electrospray ionisation 
 Equivalent(s) 
Ethyl 
Diethyl ether 
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g 
GBL 
GVL 
h 
HMF 
HMPA 
HRMS 
Hz 
iPr 
IR 
J 
LDA 
µL 
m 
M 
M+ 
Me 
mg 
min 
mL 
mmol 
mp 
MS 
MTBE 
m/z 
NMR 
Petrol 
Gram(s) 
γ-Butyrolactone 
Valerolacetone 
Hour(s) 
Hydroxymethylfurfural 
Hexamethylphosphoramide 
High resolution mass spectrometry 
Hertz 
Isopropyl 
Infra-red 
Coupling constant in Hz 
Lithium diisopropylamide 
Microlitres 
Multiplet 
Molar 
Molecular ion 
Methyl 
Milligrams 
Minute(s) 
Millilitre(s) 
Millimole(s) 
Melting point 
Mass spectrometry 
Methyl tert-butyl ether 
Mass to charge ratio 
Nuclear Magnetic Resonance 
Petroleum ether (fraction which boiling at 40-60 °C) 
Abbreviations 
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Ph 
ppm 
q 
RF 
rt 
s 
(+)-sp.surr. 
t 
Tf 
TBME 
THF 
THP 
TMEDA 
TMP 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phenyl 
Parts per million 
Quartet 
Retention factor 
Room temperature 
Singlet 
(+)-Sparteine surrogate 
Triplet 
Trifluoromethylsulfonyl trifluoroacetic 
tert-Butyl methyl ether 
Tetrahydrofuran 
Tetrahydropyran 
N,N,N’,N’-tetramethylethylenediamine  
2,2,6,6-Tetramethylpiperidine 
 
 
 
 
 
 
 
 
 
 
 
 
  
Reference 
 
239 
 
Reference 
                                                 
1 Pinhey, J. T.; Ritchie, E.; Taylor, W. C. Aust. J. Chem. 1961, 14, 106. 
2 Daly, J. W. Fortschr. Chem. Org, Naturist., 1982, 41, 205. 
3 Vacca, J. P.; Dorsey, B. D.; Schleif, W. A.; Levin, R. B.; McDaniel, S. L.; Darke, P. L.; 
Zugay, J.; Quintero, J. C.; Blahy, O. M.; Roth, E. Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 
4096. 
4 Clarke, R. L.; Harris, S. L. J. Med. Chem., 1962, 5, 77. 
5 Alsters, P. L.; Jary, W.; Nardello-Rataj, V.; Aubry, J-M. Org. Process Res. Dev., 2010, 
14, 259. 
6 Brenner, E.; Baldwin, R. M.; Tamagnan, G. Org. Lett., 2005, 7, 937. 
7 Beak, P.; Lee, W. K. Tetrahedron Lett.,1989, 30, 1197. 
8 McDermott, B. P.; Campbell, A. D.; Ertan. A. Synlett, 2008, 875. 
9 Xiong, H.; Frietze, W.; Andisik, D. W.; Ernst, G. E.; Palmer, W. E.; Hinkley, L.; Varnes, 
J. G.; Albert, J. S.; Veale, C. A. Tetrahedron. Lett, 2010, 51, 6741. 
10 Klapars, A.; Campos, K. R.; Waldman, J. H.; Zewge, D.; Dormer, P. G.; Chen, C. Y. J. 
Org. Chem., 2008, 73, 4986. 
11 Firth, J. D.; O'Brien, P. PhD Thesis, University of York, 2014.  
12 Beak, P.; Lee, W. K. J. Org. Chem., 1993, 58, 1109. 
13 Berkheij, M.; van der Sluis, L.; Sewing, C.; den Boer, D. J.; Terpstra, J. W.; Hiemstra, 
H.; Iwema Bakker, W. I.; van den Hoogenband, A.; van Maarseveen, J. H. Tetrahedron 
Lett. 2005, 46, 2369. 
14 Firth, J. D.; O'Brien, P.; Ferris, L. J. Am. Chem. Soc., 2016, 138, 651. 
15 Barker, G.; O’Brien, P.; Campos K. R. Org. Lett., 2010, 12, 4176.  
16 Anastas, P. T.; Warner, J. C. Green Chemistry: Theory and Practice, Oxford, University 
Press: New York, 1998, 30. 
17 Hansen, T. S.; Barta, K.; Anastas, P. T.; Ford, P. C.; Riisager, A. Green Chem., 2012, 14, 
2457. 
18 Pace, V.; Castoldi, L.; Alcantara A. R.; Holzer, W. Green Chem., 2012, 14, 1859. 
19 Pace, V.; Hoyos, P.; Fernandez, M; Sinisterra, J. V.; Alcantara A. R.  Green Chem., 2010, 
12, 1380. 
20 Vu, V. H.; Louafi, F.; Girard, N.; Marion, R.; Roisnel, T.; Dorcet, V.; Hurvois, J.-P. J. 
Org. Chem., 2014, 79, 3358. 
Reference 
 
240 
 
                                                                                                                                                    
21 Gardette, D.; Gelas-Mialhe, Y.; Gramain, J.-C.; Perrin, B.; Remuson, R. Tetrahedron: 
Asymmetry, 1998, 9, 1823. 
22 Chackalamannil, S.; Davies, R. J.; Wang, Y.; Asberom, T.; Doller, D,; Wong, J.; Leone, 
D. J. Org. Chem., 1999, 64, 1932. 
23 Tanoury, G. J.; Chen, M.; Dong, Y.; Forslund, R.; Jurkauskas, V.; Jones, A. D.; Belmont, 
D. Org. Process Res. Dev., 2014, 18, 1234. 
24 Kerrick, S. T.; Beak, P. J. Am. Chem. Soc. 1991, 113, 9708. 
25 Beak, P.; Kerrick, S. T.; Wu, S.; Chu, J. J. Am. Chem. Soc., 1994, 116, 3231. 
26 Dearden, M. J.; Firkin, C. R.; Hermet, J. R.; O'Brien, P. J. Am. Chem. Soc., 2002, 124, 
11870. 
27 Bailey, W. F.; Beak, P.; Kerrick, S. T.; Ma, S.; Wiberg, K. B. J. Am. Chem. Soc., 2002, 
124, 1889. 
28 Stead, D.; Carbone, G.; O'Brien, P.; Campos, K. R.; Coldham, I.; Sanderson, A. J. Am. 
Chem. Soc., 2010, 132, 7260. 
29 Firth, J. D.; O'Brien, P.; Ferris, L. J. Am. Chem. Soc., 2016, 138, 651. 
30 Hoppe, I.; Marsch, M.;Harms, K.; Boche, G.; Hoppe, D. Angew. Chem. Int. Ed., 1995, 
34, 2158. 
31 Wu, S.; Lee, S.; Beak, P. J. Am. Chem. Soc., 1996, 118, 715. 
32 Huang, J.; O'Brien, P. Chem. Commun., 2005, 5696. 
33 Carbone, G.; O'Brien, P.; Hilmersson G. J. Am. Chem. Soc., 2010, 132, 15445. 
34 Gelardi, G.; Barker, G.; O’Brien, P.; Blakemore, D. C.  Org. Lett., 2013, 15, 5424. 
35 Gawley, R. E.; Zhang, Q. J. Am. Chem. Soc., 1993, 115, 7515. 
36 Coldham, I.; Dufour, S.; Haxell, T. F. N.; Patel, J. J.; SanchezJiminez, G. J. Am. Chem. 
Soc., 2006, 128, 10943. 
37 Stead, D.; O’Brien, P.; Sanderson, A. Org. Lett. 2008, 10, 1409. 
38 Klapars, A.; Campos, K. R.; Waldman, J. H.; Zewge, D.; Dormer, P. G.; Chen, C.-y. J. 
Org. Chem. 2008, 73, 4986. 
39 Clayden, J. 'Organolithiums: Selectivity for Synthesis', Elsevier, 2002. 
40 Bauer,W.;Winchester,W. R.; Schleyer, P. v. R. Organometallics, 1987, 6, 2371. 
41 Gilman, H; Gaj, B. J. J. Org. Chem., 1957, 22, 1165. 
42 Maercker, A.; Demuth, W. Angew. Chem. Int. Ed., 1973, 12, 75. 
43 Maercker, A. Angew. Chem. Int. Ed., 1987, 26, 972. 
44 Stanetty, P.; Mihovilovic M. D. J. Org. Chem., 1997, 62, 1514. 
Reference 
 
241 
 
                                                                                                                                                    
45 Honeycutt, S. J. Organomet. Chem., 1971, 29, 1. 
46 Bates, R. B.; Kroposki, L. M.; Potter, D. E. J. Org. Chem., 1972 3¸7, 560. 
47 Fleming, I.; Mack, S. R.; Clark, B. P. Chem. Commun, 1998, 713. 
48 Baldwin, J. E. J. Chem. Soc., Chem., Commun,, 1976, 734. 
49 Clayden, J.; Yasin, S. A. New J. Chem., 2002, 26, 191. 
50 Cohen, T.; Stokes, E. Tetrahedron. Lett., 1993, 34, 8023. 
51 Kadam, A.; Nguyen, M.; Kopach, M.; Richardson, P.; Gallou, F.; Wan, Z.-K. Green 
Chemistry, 2013, 15, 1880. 
52 Horváth, I. T.; Anastas, P. T. Chem. Rev., 2007, 107, 2167. 
53 Horváth, I. T.; Anastas, P. T. Chem. Rev., 2007, 107, 2169. 
54 HernáiZ, M. J.; Alcántara, A. R.; García, J. I.; Sinisterra, J. V. Chem. Eur. J., 2010, 16, 
9422. 
55  Pinkos, R.; Lorenz, R. E.; Beste, Y. A. US. Appl., to BASF Aktiengesellschaft, US 
7759531 B2, 2010 
56 Lee, E. K.; Baek, Y. H. US. Appl., to Hyosung Corporation, US 2008/0161585 A1, 2008. 
57 Nexant, CHEMSYSTEMSPREP PROGRAM, Report abstract – Maleic anhydride 07/08-
8, 2009 
58 Hansen, T. S.; Barta, K.; Anastas, P. T.; Ford, P. C.; Riisager, A. Green Chem., 2012, 14, 
2457. 
59 Kottke, R.; Furan & Derivatives, Kirk-Othmer Encyclopedia Chem. Technol., 1998, S, 
155. 
60 Aycock, D. F. Org. Process Rev. Dev., 2007, 11, 156. 
61 Pace, P.; Alcántara, A. R.; Holzer, W. Green Chem., 2011, 13, 1986. 
62 Farmer, T. J.; Mascal, M. Platform Molecules, Introduction to Chemicals from Biomass 
2nd Ed., Wiley, 2015. 
63 Lai, D.; Deng, L.; Li, J.; Liao, B.; Guo, Q. Fu, Y. ChemsusChem, 2011, 4, 55. 
64 Shi, N.; Liu, Q.; Zhang, Q.; Wang, T.; Ma, L. Green Chem., 2013, 15, 1967. 
65 Binder, J. B.; Raines, R. T. J. Am. Soc., 2009, 131, 1979. 
66 Wang, P.; Yu, H.; Zhan, S.; Wang, S. Bioresour. Technol., 2011, 102, 4179. 
67 Climent, M. J.; Corma, A.; Iborra, S. Green Chem., 2011, 13, 520. 
68 Zakrzewska, M. E.; Bogel-Lukasik, E.; Bogel-Lukasik, R. Chem. Rev., 2011, 111, 197. 
69 Gürbüz, E. I.; Gallo, J. M. R.; Alonso, D. M.; Wettstein, S. G.; Lim, W. Y.; James A. 
Dumesic, J. A. Angew. Chem. Int. Ed., 2013, 52, 1270. 
Reference 
 
242 
 
                                                                                                                                                    
70 Dhepe, P. L.;Sahu, R. Green Chem., 2010, 12, 2153. 
71 Baldwin, S. D. Cellulose and Paper Recycling: A Pragmatic View, Plastics, Rubber, and 
Paper Recycling, ACS Symposium Series, 2009.  
72 Gallezot, P. Chem. Soc. Rev., 2012, 41, 1538. 
73 Manaer, L.E. Appl. Catal, A, 2004, 272, 249. 
74  Geilen, F. M. A.; Engendahl, B.; Harwardt, A.; Marquardt, W.; Klankermayer, J.; 
Leitner, W. Angew. Chem. Int. Ed., 2010, 49, 5510. 
75 Delhomme, C.; Weuster-Botz, D.; Kuhn, F. Green Chem., 2009, 11, 13. 
76 Bechthold, I.; Bretz, K.; Kabasci, S.; Kopitzky, R,; Springer, A. Chem. Eng. Technol., 
2008, 31, 647. 
77 Dutta, S.; Wu, L.; Mascal, M. Green Chemistry, 2015, 17, 2335. 
78 Antonucci  V.; Coleman, J.; Ferry J. B.; Johnson, N.; Mathe, M.; Scott, J. P.; Xu, J. Org. 
Process Res. Dev. 2011, 15, 939-941. 
79 Gessner, V. H., Strohmann, C. J. Am. Chem. Soc., 2008, 130, 14412. 
80 Jung, M. E.; Blum, R. B. Tetrahenfron Lett., 1977, 43, 3791. 
81 Lehmann, R.; Schlosser, M. Tetrahedron. Lett., 1984, 25, 745. 
82 Kennedy, A. R.; Klett, J.; Mulvey, R. E.; Wright, D. S. Science, 2009, 326, 706. 
83 Crosbie, E.; Garcίa-Álarez, P.; Kennedy, A. R.; Klett, J.; Mulvey, R. E.; Robertson, S. D. 
Angew. Chem. Int. Ed., 2010, 49, 9388. 
84 Coppi, D. I.; Salomone, A.; Maria, F.; Capriati, V. Chem. Commun., 2013, 49, 10160. 
85 Cicco, L.; Addante, V.; Temperini, A.; Donau, C. A.; Karaghiosoff, K.; Perna, F. M.; 
Capriati, V. Eur. J. Org. Chem., 2016, 3157. 
86 Coppi, D. I.; Salomone, A.; Perna, F. M.; Capriati, V. Chem. Commun., 2011,47, 9918. 
87 Coldham, I.; Patel, J. J.; Sanchez-Jimenez, G. Chem. Commun., 2005, 3083. 
88 Sawyer, J. S.; Kucerovy, A.; Macdonald, T. L.; McGarvey, G.J. J. Am. Chem. Soc., 1988, 
110, 842. 
89 Cohen, T.; Lin, M. T. J. Am. Chem. Soc., 1984, 106, 1130. 
90 Eaborn, C.; Hancock, A. R.; Stańczyk, W. A. J. Organomet. Chem, 1981, 218, 147. 
91 Raffier, L.; Piva, O. Eur. J. Org. Chem., 2003, 1124. 
92  Wolf, E.; Kennedy, I. A.; Himmeldirk, K.;.Spenser, I. D.  Canadian Journal of 
Chemistry, 1997, 942. 
93 Baldwin, J. E. J. Chem. Soc., Chem., Commun,, 1976, 734. 
Reference 
 
243 
 
                                                                                                                                                    
94 Wuitschik, G.; Carreira, E. M.; Wagner, B.; Fischer, H.; Parrilla, I.; Schuler, F.; Roger-
Evans, M.; Müller, K. J. Med. Chem., 2010, 53, 3227. 
95  Wuitschik, G.; Roger-Evans, M.; Müller, K.; Fischer, H.; Wagner, B. ; Schuler, F.; 
Polonchuk, L.; Carreira, E. M. Angew. Chem. Int. Ed., 2006, 45, 7736. 
96  Wuitschik, G.; Roger-Evans, M.; Buckl, A.; Bernasconi, M.; Marki, M.; Godel, T.; 
Fischer, H.; Wagner, B.; Parrilla, I.; Schuler, F.; Schneider, J.; Alker, A.; Schweizer, W. B.; 
Müller, K.; Carreira, E. M. Angew. Chem. Int. Ed., 2008, 47, 4512. 
97 Burkhard, J. A.; Wuitschik, G.; Rogers-Evans, M.; Müller, K.;Carreira, E. M. Angew. 
Chem. Int. Ed., 2010, 49, 9052. 
98 Omura, S.; Murata, M.; Imamura, N.; Iwai, Y.; Tanaka, H.; Furusaki, A.; Matsumoto, T.; 
J. Antibiot., 1984, 37, 1324. 
99 Loh, J.; Carlson, R. W.; York, W. S.; Stacey, G. Proc. Natl. Acad. Sci. USA, 2002, 99, 
14446. 
100 Xu, R.; Czarniecki, M.; Man, J. d.; Pan, J.; Qiang, L.; Root, Y.; Ying, S.; Su, J.; Sun, X.; 
Zhang, Y., Yu, T.; Zhang, Yang; Hu, T.; Chen, S. Tetrahedron Lett., 2011, 52, 3266. 
101 Davis, O. A.; Bull, J. A. Angew. Chem. Int. Ed., 2014, 53, 1. 
102 Vigo, D.; Stasi, L.; Gagliardi, S. Tettrahedron Lett., 2011, 565. 
103 Kummer, D. A.; Chain, W. J.; Morales, M. R.; Quiroga, O.; Myers, A. G. J. Am. Chem. 
Soc., 2008, 130, 13231. 
104 Lee, D.; Williamson, C. L.; Chan, L.;Taylor, M. S. J. Am. Chem. Soc., 2012, 134, 8260. 
105 Nielsen, C. B.; Bjørnholm, T. Macromolecules, 2005, 38, 10379. 
106 Chae,P. S.; Rana, R. R.; Gotfryd, K.; Rasmussen, S. G. F.; Kruse, A. C.; Cho, K. H.; 
Capaldi, S.; Carlsson, E.; Kobilka, B.; Loland, C. J.; Gether, U.; Banerjee, S.; Byrne, B.; 
Lee, J. K.; Gellman, S. H. Chem. Commun., 2013, 49, 2287. 
107 Kato, S.; Fujiwara, I.; Yoshida, N. Nitrogen-containing heteroalicycles with serotonin 
receptor binding affinity: Development of gastroprokinetic and antiemetic agents., Med. 
Res. Rev., 11999, 9, 25. 
108 S. C. Bobzin, D. J. Faulkner, J. Org. Chem., 1991, 56, 4403. 
109 Gharpure, S. J., Prasad, J. V. K. J. Org. Chem., 2011, 76, 10325. 
110 Hajos, M.; Fleisharker, J. C.; Filipiak-Reisner, J. K.; Brown, M. T.; Wong, E. H. F. 
CNS Drug Rev., 2004, 10, 23. 
Reference 
 
244 
 
                                                                                                                                                    
111 Weldy, N. M.; Schafer, A. G.;Owens, C. P.;Herting, C. J.;Varela-Alvarez, A.;Chen, 
S.;Niemeyer, Z.;Musaev, D. G. Sigman, M. S. Davies, H. M. L.; Blakey, S. B. Chem. Sci., 
2016, 7,3142. 
112 D' Arrigo, P.; Lattanzio, M.; Fantoni, G. P.; Servi, S. Tetraheron: Asymmetry, 1998, 9, 
4021. 
113 O'Reilly, M.; Lindsley, C. W. Org. Lett., 2012, 14, 2910.  
114 Brenner, E.; Baldwin, R. M.; Tamagnan, G. Org. Lett., 2005, 7, 937. 
115 Métro, T. X.; Pardo, D. G.;Cossy, J. J. Org. Chem., 2008, 73, 707. 
116  Khan,K. M.; Khan, M. Z.; Taha, M.; Maharvi, G. M.; Saify, Z. S.; Parveen, S.; 
Choudhary, M. I. Natural product research, 2009, 23, 479. 
117 Zhang, T.; Zhang, Y.; Zhang, W.; Luo, M. Advanced Synthesis & Catalysis, 2013, 355, 
2775. 
118 Philippe, C.; Kaffy, J.; Milcent, T.; Bonnet-Delpon, D. Journal of Fluorine Chemistry, 
2012, 134, 136. 
119 Chapman, T. M.; Osborne, S. A.; Wallace, C.; Birchall, K.; Bouloc, N.; Jones, H. M.; 
Ansell, K. H.;Taylor, D. L.; Clough, B.; Green, J. L.; Holder, A. A. J. Med. Chem., 2014, 
57, 3570. 
120 Dieter, K. R.; Li, S. J. Org. Chem. 1997, 62, 7726. 
121 Bilke, J. L.; Moore, S. P.; O’Brien, P.; Gilday, J. Org. Lett. 2009, 11, 1935. 
122 Klapars, A.; Campos, K. R.; Waldman, J. H.; Zewge, D.; Dormer, P. G.; Chen, C. Y. J. 
Org. Chem., 2008, 73, 4986. 
123  Xiong, H.; Frietze, W.; Andisik, D. W.; Ernst, G. E.; Palmer, W. E.; Hinkley, L.; 
Varnes, J. G.; Albert, J. S.; Veale, C. A. Tetrahedron. Lett, 2010, 51, 6741. 
124 Eaborn, C.; Hancock, A. R.; Stańczyk, W. A. J. Organomet. Chem, 1981, 218, 147. 
125 Baylis, A. M.; Helliwell, M.; Regan, A. C.; Thomas, E. J. J. Chem. Soc. Perkin Trans., 
1993, 411. 
126 Hatzakis, N.S.; Smonou, I. Bioorg. Chem., 2005, 33, 325. 
127 Sawyer, J. S.; Kucerovy, A.; Macdonald, T. L.; McGarvey, G. J. J. Am. Chem. Soc., 
1988, 110, 842. 
128  Xiong, H.; Frietze, W.; Andisik, D. W.; Ernst, G. E.; Palmer, W. E.; Hinkley, L.; 
Varnes, J. G.; Albert, J. S.; Veale, C. A. Tetrahedron. Lett, 2010, 51, 6741. 
Reference 
 
245 
 
                                                                                                                                                    
129 Sumino, S.; Fusano, A.; Ryu, I. Org. Lett, 2013, 15, 2826. 
130 Choi, Y. M.; Emblidge, R. W. J. Org. Chem., 1989, 54, 1198. 
131 Lee, D.; Williamson, C. L.; Chan, L.;Taylor, M. S. J. Am. Chem. Soc., 2012, 134, 8260. 
132 Nielsen, C. B.; Bjørnholm, T. Macromolecules, 2005, 38, 10379. 
133 Chae,P. S.; Rana, R. R.; Gotfryd, K.; Rasmussen, S. G. F.; Kruse, A. C.; Cho, K. H.; 
Capaldi, S.; Carlsson, E.; Kobilka, B.; Loland, C. J.; Gether, U.; Banerjee, S.; Byrne, B.; 
Lee, J. K.; Gellman, S. H. Chem. Commun., 2013, 49, 2287. 
134 Yamaguchi, M.; Nobayashi, Y.; Hirao, I. Tetrahedron, 1984, 40, 4261. 
135 Zhang, T.; Zhang, Y.; Zhang, W.; Luo, M. Advanced Synthesis & Catalysis, 2013, 355, 
2775. 
136  Khan,K. M.; Khan, M. Z.; Taha, M.; Maharvi, G.  M.; Saify, Z. S.; Parveen, S.; 
Choudhary, M. I. Natural product research, 2009, 23, 479. 
137 Philippe, C.; Kaffy, J.; Milcent, T.; Bonnet-Delpon, D. Journal of Fluorine Chemistry, 
2012, 134, 136. 
138 Son, S.; Lee, H. J. Org. Chem., 2013, 78, 8396. 
139 Allen, A. J.; Kelsey, D. K. US. Appl., to Elililly and Company, US 2006/0241188 A1, 
2006. 
140 Zhu, S.; Niljianskul, N.;Buchwald, S. L. J. Am. Chem. Soc., 2013, 135, 15746. 
141  Briner, K.; Doecke, C. W. D.; Mancuso, V.; Martinelli, M. J.; Richardson, T. I.; 
Rothhaar, R. R.; Shi, Q,; Xie, C. Piperazine- and piperidine-derivatives as melanocortin 
receptor agonists, US 2004/0082590 A1, 2004. 
